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 ABSTRACT 
 
BEHAVIORAL TRAINING FOR OROPHARYNGEAL DYSPHAGIA: TWO META- 
ANALYSES AND AN EXPERIMENT USING SURFACE ELECTROMYOGRAPHIC 
BIOFEEDBACK 
 
James L. Coyle, Ph.D. 
University of Pittsburgh, 2008
 
 
Behavioral treatments performed in patients with dysphagia are designed to produce immediate 
or short-term outcomes that eliminate physiologic or biomechanical impairments of 
oropharyngeal swallowing.  These short-term outcomes are expected to reduce aspiration of 
swallowed food into the respiratory system, and improve delivery of swallowed material into the 
digestive system.  In the long-term these interventions are justified by expectations that they will 
reduce patient risk for dysphagia-related consequences such as pneumonia, malnutrition, and 
death. 
Two distinct investigations were performed in this dissertation.  The first, a meta-
analysis, was performed to evaluate available evidence regarding the efficacy of individually 
administered dysphagia interventions in neurogenic dysphagia, and the effectiveness of 
systematic, institutional dysphagia protocols at mitigating public health risks associated with 
dysphagia.  The second investigation, an experimental study, was executed to evaluate whether 
the addition of surface electromyographic biofeedback to traditional training of the Mendelsohn 
maneuver, a common individually administered dysphagia intervention, altered the initial (first 
training session) efficacy of volitional prolongation of muscle activity responsible for upper 
esophageal sphincter opening during the swallow. 
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The meta-analysis revealed that well designed investigations of individually administered 
treatments for short-term elimination of biomechanical impairments demonstrated small to large 
effect sizes (r = .13 - .45) for these treatments, all but one of which were statistically significant, 
and that overall, their combined effect size was small to medium (r = .29) and significant (p = 
.03).  However studies of institutionally deployed dysphagia protocols demonstrated moderate 
effect sizes (Odds Ratio = .44 - .79) which, combined, were not statistically significant (p = .08).  
Overall, few published investigations of sufficiently robust evidence quality were found to 
justify their inclusion in the meta-analysis, suggesting that more research of this type is needed. 
The experiment revealed that training of the Mendelsohn maneuver with and without 
surface electromyographic biofeedback, produced significantly increased duration (p < .01) and 
average amplitude (p = .02) of swallowing myoelectric activity.  There were no significant 
differences between treatment groups in swallow duration or amplitude, however a trend toward 
increased preparatory myoelectric consistency was observed for the biofeedback trained group  
(p = .052) compared to the non-biofeedback trained group. 
 v 
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1.0  INTRODUCTION 
The human upper aerodigestive tract (UAT) routinely alternates its respiratory functions with 
those of the individual’s digestive needs hundreds of times each day.  Oropharyngeal 
swallowing, the digestive function of the UAT, is a complex sequence of physiological actions 
by which food and liquids are transferred from the oral cavity, propelled through the pharynx, 
and into the esophagus over a span of about 1 to 2 seconds (Logemann, 1998).  The respiratory 
function of the UAT is to provide the conduit for air to flow into the respiratory system where it 
can interact with the respiratory membrane and contribute to the homeostasis of respiratory 
blood gases.  With few exceptions, alternating access to the UAT for digestive and respiratory 
functions occurs seamlessly and without consequence.   
In disease, the digestive and respiratory functions of the UAT can become asynchronous.  
Under these circumstances, swallowed material may enter the airway and course into lower 
respiratory structures and contribute to increases in choking, pneumonia, and atelectasis.  
Because normal swallowing occurs over such a brief time span, the timing of the necessary 
biomechanical events which prevent bolus misdirection must remain relatively constant to 
prevent misdirection of swallowed material.  If the larynx is not closed as the food or liquid 
bolus enters the hypopharynx for delivery into the esophagus, aspiration invariably occurs. 
The process of aging introduces physiological changes in performance that mimic mild 
levels of impairment in the absence of pathology.  Some of the age-related changes seen in 
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healthy individuals are associated with deterioration in neuromuscular functions throughout the 
human musculoskeletal and neuromuscular systems.  The potential effect of these changes to 
muscle strength, bone mass, and neuromuscular transmission velocity may predispose the normal 
elderly to a higher risk of injury, or increased morbidity following trauma or disease (Fiatarone 
& Evans, 1993).  Investigators have documented similar kinds of physiological changes with 
regard to the timing of events and structure of normal swallowing among healthy, non-
dysphagic, elderly subjects (Robbins, Hamilton, Lof, & Kempster, 1992; Robbins, Levine, 
Wood, Roecker, & Luschei, 1995; Shaker et al., 1994).  Therefore, age-related changes in 
swallowing function may enter the realm of pathology (dysphagia) and have greater impact on 
frail elderly individuals with or without co-occurring disease conditions (Ekberg & Feinberg, 
1991).   
Oropharyngeal dysphagia is common following a number of disease processes associated 
with aging, especially stroke.   As many as half the adults diagnosed with cerebrovascular 
accident and other neurological conditions exhibit dysphagia at some point after onset (Dziewas 
et al., 2004).  In addition, dysphagia can result from head and neck cancer and its treatment, and 
other iatrogenic etiologies, such cranial or peripheral nerve damage secondary to head, neck, or 
chest surgeries.  Dysphagia increases a patient’s overall likelihood for developing pneumonia, 
malnutrition, or other sequelae of impaired swallowing function and airway protection.  
Rehabilitation literature reports that patients benefit from interventions which compensate for 
acquired sensorimotor deficits associated with aspiration.  Some of these interventions require 
behavioral training by the speech-language pathologist to teach  patients to swallow safely using 
one or more novel maneuvers (Logemann, 1999).  Unfortunately, many published investigations 
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of dysphagia lack sufficient numbers of subjects to produce robust evidence of anticipated 
therapeutic success.   
1.1 OVERVIEW OF DISSERTATION 
1.1.1 Goals 
One goal of this dissertation was to conduct a research synthesis to quantify the collective 
strength of published evidence regarding the effects of dysphagia interventions on various health 
and biomechanical outcomes.  Application of the principles of evidenced based practice (EBP) is 
an imminent reality for rehabilitative service providers.  EBP offers practitioners a powerful tool 
with which to evaluate published treatment methodologies to enable selection of interventions 
with the best likelihoods of successful outcomes with individual or groups of patients.  This goal 
was accomplished through the completion of two meta-analyses of the effects of dysphagia 
interventions for patients with neurogenic dysphagia. 
A second goal of this dissertation was to systematically investigate the differences 
between traditional (i.e., primarily verbal instruction and tactile cuing) and instrumentally-
mediated (i.e., traditional training + visual biofeedback) training methods in two groups of 
normal subjects trained to perform a common therapeutic swallowing maneuver.  
Instrumentation can be a valuable adjunct to some types of behavioral training because it 
provides immediate sensory feedback of targeted performance parameters (Crary, Carnaby 
Mann, Groher, & Helseth, 2004).  In the field of speech-language pathology, this is a relevant 
clinical issue.  There are practitioners who allege great success in providing dysphagia treatment 
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using sEMG biofeedback training from regions of the face and neck (Huckabee & Cannito, 
1999).  Although biofeedback seems logical and defensible from a biological standpoint, clinical 
efficacy studies in dysphagia management have not been done in controlled clinical trials or 
subjected to rigorous single subject design. 
1.1.2 Synopsis of Dissertation   
Chapter 2 will review relevant background information on the field of dysphagia, surface and 
intramuscular EMG investigations of swallowing musculature, and biofeedback literature in 
physical rehabilitation to establish the credibility and potential of biofeedback treatment in 
swallowing remediation. 
Chapter 3 will discuss the anatomy and physiology of normal and abnormal UES 
function and the biomechanics of the Mendelsohn maneuver.  This maneuver is the focus of the 
experimental portion of this dissertation and also a common treatment strategy used by speech-
language pathologists. 
The economic and social impact of dysphagia and its consequences will be discussed in 
Chapter 4.  The justification for using statistical evaluation to determine the effectiveness of 
published dysphagia strategies believed to reduce aspiration will be established. 
Chapter 5 will include two rigorously conducted meta-analyses of clinical research 
reporting the efficacy of individually administered interventions for neurogenic dysphagia 
impairments, and studies reporting the effectiveness of organized, institutional dysphagia 
protocols on mitigating global health outcomes such as pneumonia. 
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Results of the experimental portion of this dissertation will be reported in Chapter 6.  
Selected parameters of sEMG submental musculature will be analyzed in subjects trained to 
perform a swallowing maneuver with and without biofeedback. 
A comprehensive summary of the major implications of the meta-analyses and the 
experiment will be presented in Chapter 7.      
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2.0  BACKGROUND INFORMATION ON EMG AND BIOFEEDBACK 
2.1 BACKGROUND:  USE OF BIOFEEDBACK IN PHYSICAL REHABILITATION  
Surface electromyographic (sEMG) biofeedback programs have been an effective adjunct to 
rehabilitation designed to restore independence in locomotion, self care, and other daily 
activities.  In patients with disorders affecting neuromuscular functions, sEMG biofeedback can 
assist patients’ neuromuscular reeducation and/or strengthening of limb and trunk function, 
bladder training, and rehabilitation of other impairments.  For example, efforts to rehabilitate 
urinary incontinence in patients with spinal cord injury, cerebral palsy, and female stress 
incontinence using electromyographic biofeedback technology have demonstrated moderate 
success within small subject groups (Dannecker, Wolf, Raab, Hepp, & Anthuber, 2005; Jerkins, 
Noe, Vaughn, & Roberts, 1987; Yamanishi et al., 2000).  Restoration of anal sphincter control in 
patients with fecal incontinence has also been described both with and without adjunct 
manometry biofeedback (Mahony et al., 2004).  On the whole, these studies support the clinical 
use of biofeedback with patients. 
Physical rehabilitation of gait using electromyographic biofeedback in patients with a 
variety of neurogenic sensorimotor syndromes has also been investigated (Dursun, Dursun, & 
Alican, 2004; Jerkins et al., 1987; Jones & Lees, 2003; Mahony et al., 2004; Yamanishi et al., 
2000).  Dursun et al. (2004) observed significant improvements in ankle joint strength and range 
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of motion in children with cerebral palsy whose treatment was supplemented with sEMG 
biofeedback compared to a group treated conventionally.  In another study, patients with spinal 
cord injury who used a full-time portable sEMG biofeedback unit regained near normal gait 
when compared to patients treated with intermittent biofeedback used only in the clinic 
(Petrofsky, 2001).   
Use of sEMG biofeedback in stroke rehabilitation has received a great deal of attention.  
One double-blind investigation compared sEMG treated stroke patients to those treated with a 
placebo sEMG unit (Intiso, Santilli, Grasso, Rossi, & Caruso, 1994).  These investigators found 
that some improvements in strength, ADL independence and mobility were seen in the 
biofeedback-treated group; however those improvements were not significantly different from 
the control/placebo group.  These investigators also found that overall gait was significantly 
improved in biofeedback-treated patients when compared to patients treated with conventional 
physical therapy alone (Intiso et al., 1994).   
A meta-analysis performed by Moreland, Thomson, and Fuoco (1998) reviewed and 
measured the effect of sEMG biofeedback-mediated rehabilitation of lower extremity 
impairments after stroke.  This study indicated that effects of biofeedback-mediated therapy on 
gait, speed, and ankle angle during gait could be expected to be moderate (with effect sizes 
between d = .31 to d = .50) to large (d = 1.17) for ankle dorsiflexion during gait. 
2.2 BACKGROUND:  PHYSIOLOGICAL INVESTIGATIONS OF SWALLOWING 
Early investigations of intramuscular oral and pharyngeal myoelectric activity in animals 
revealed an orderly firing sequence of various floor-of-mouth (FOM) and related musculature 
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during swallowing (Doty & Bosma, 1955).  Many human studies have outlined the roles of 
individual FOM muscles and the FOM complex during swallowing.  Seminal investigations 
compared concurrent recordings of surface and intramuscular myoelectric activity to verify that 
sEMG was a valid representation of FOM activation during swallowing.  Researchers 
demonstrated that FOM sEMG signals were reliable correlates to simultaneous intramuscular 
recordings of individual FOM muscles obtained with needle electrodes without significant 
influence or crosstalk from adjacent musculature (i.e., platysma and genioglossus), (Palmer, 
Luschei, Jaffe, & McCulloch, 1999; Spiro, Rendell, & Gay, 1994).  These researchers cleared the 
way for clinical use of less invasive sEMG procedures for measuring myoelectric activity in the 
FOM or submental musculature. 
By using combined methodologies of videofluoroscopy and EMG, researchers began to 
link patterns of muscular activation to concomitant biomechanical swallowing events.   
Researchers described the ways in which FOM myoelectric activity correlated with displacement 
of hyolaryngeal structures throughout the swallow (Dodds, Stewart, & Logemann, 1990; 
Kahrilas, Logemann, Krugler, & Flanagan, 1991).  Additional studies have used simultaneous 
sEMG recording of FOM musculature and image-tracking of laryngeal displacement to replicate 
earlier findings.  Taken together, all research supports reliable use of the less invasive 
methodology of sEMG to sample regional myoelectric activity related to swallowing (Ertekin et 
al., 1995). 
Other instrumentation has been piloted in the exploration of swallowing physiology.  
Investigators have attempted to quantify selected swallowing parameters using 
electroglottograph, and ultrasound (Litvan, Sastry, & Sonies, 1997; Logemann & Kahrilas, 1990; 
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Miller & Watkin, 1997; Perlman & Grayhack, 1991).  By and large, these methodologies are not 
user-friendly, nor have they been adapted for use in a routine clinical setting.   
2.3 BACKGROUND:  USE OF BIOFEEDBACK IN TREATMENT OF DYSPHAGIA 
Lingual strengthening programs have generated interest in rehabilitation of dysphagia (Robbins 
et al., 2005b).  Efforts are underway to track changes in lingual strength with biomechanical 
events of swallowing.   Robbins et al. (2005b) reported that fine and gross lingual movements are 
under significant volitional motor control, whereas other buccopharyngeal musculature is far less 
amenable to volitional control.   
Electromyography enables direct investigation of skeletal muscle electrical activity at rest 
and during swallowing.  With the validation and refinement of surface electrode technology/data 
processing, sEMG has become a clinically useful, noninvasive approach to the investigation of 
volitional movements and behavioral training for specific forms of dysphagia.  Because studies 
have shown that sEMG is a valid indicator of swallowing myoelectric activity, and can be used 
reliably in sampling swallow-related muscle activity, interest in its use as a biofeedback tool in 
dysphagia rehabilitation has risen dramatically.  Clinical reports of case studies of combining 
sEMG and videofluoroscopic procedures has helped outline the potential clinical applications as 
well as methods for surface electrode placement.   
Crary (1995) reported on a series of brainstem stroke patients trained to increase duration 
and amplitude of swallow-related myoelectric activity using visual biofeedback to monitor 
performance.  SEMG measurements were obtained from an anatomical site defined as “between 
the larynx and hyoid” rather than the FOM region.  This region contains several layers of 
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musculature, some of which act to elevate the larynx (i.e., thyrohyoid) and others that depress the 
larynx (i.e., sternohyoid and sternothyroid) (Ludlow et al., 2007).  Unfortunately, this 
investigator provided only descriptive statistics to characterize the treatment effects of using 
sEMG biofeedback training.   
The same investigators used sEMG in a similar design to compare myoelectric signals of 
normal subjects and brainstem stroke patients while swallowing (Crary & Baldwin, 1997).  
Results indicated significant differences in timing and amplitude measures between the 
disordered and healthy groups.  This investigation was useful in its use of videofluoroscopy to 
match sEMG to swallowing events and in its descriptions of the typical sEMG waveform 
associated with oropharyngeal swallowing.  This, however, was also a descriptive study rather 
than an investigation of treatment effects.   
Huckabee and Cannito (1999) employed FOM sEMG biofeedback methodology as a 
component of their dysphagia rehabilitation protocol to train patients to execute the Mendelsohn 
maneuver.  Though investigators reported a treatment effect (i.e., prolonged duration of FOM 
sEMG activity during swallowing), they did not establish which modality of reinforcement (i.e., 
types of feedback/cues used in conjunction with biofeedback) or how much (i.e., dosage) was 
responsible for increasing the duration of sEMG activity.  In addition, researchers did not 
indicate whether these measures reflected a change in status of a patient’s overall dysphagia 
severity in terms of meaningful treatment outcomes (i.e., diet advancement, occurrence of 
aspiration pneumonia, etc.).  Though results sounded promising, there were some major flaws in 
the study design that would preclude replication. 
To date, use of physiologic monitoring devices in treating dysphagia has not been the 
subject of rigorous clinical investigation.  Reasons for this include prohibitive equipment costs as 
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well as availability and environmental considerations of the traditional clinical setting.  Recent 
advances in both software and hardware technology for personal computers have greatly 
facilitated clinical investigation of physiologic, neuromuscular activities, coordination, and 
timing of events of the UAT during swallowing.  Aggressive marketing of these systems to a 
variety of rehabilitative settings and clinics on the basis of affordability, trim design, and 
software programs that make it easy for clinicians to devise objective treatment goals has also 
contributed to the recent popularity in using therapeutic biofeedback to treat dysphagic patients.  
Current practice involves speech-language pathologists using biofeedback training with 
dysphagic patients.  However, the evidence base underlying this type of treatment in the head 
and neck musculature has not been clearly established. 
Future research should focus on providing clinicians with useful and sufficiently robust 
expectations of success and enough clarity to enable replication.  Studies should also include a 
control group to account for the potential placebo effect in studies which provide a single 
intervention.  Careful investigation of reinforcement should be undertaken to determine which 
type of training (i.e., verbal/traditional, visual, or a combination of the two), and which patterns 
and schedules of reinforcement and withdrawal, are most efficient in training patients given time 
pressures inherent in the traditional clinical setting.   
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3.0  DEGLUTITION:  HISTORY, PHYSIOLOGY, AND MANAGEMENT 
Oropharyngeal swallowing has been described since the early work of Francois Magendie.  He 
first discussed the role of the epiglottis during deglutition and found that internal laryngeal 
closure was an important aspect of airway protection (Magendie, 1813).  Stevenson and Guthrie 
(1949) reestablished the importance of Magendie’s early investigations of swallowing function.  
In the 1950’s, investigation of oropharyngeal swallowing was of primary interest to researchers 
involved in pediatrics and dentistry.  Doty and Bosma (1955) studied swallowing in children 
using electromyography and published one of the first descriptions of deglutitive muscle 
activation in the head and neck.  In the 1970’s, researchers began probing oropharyngeal 
swallowing function in postoperative head and neck cancer.   
Manofluorography revolutionized the scientific study of swallowing function.  McConnel 
and his colleagues perfected a technique which combined simultaneous recordings of the 
dynamic events of swallowing using cinefluoroscopy and the pressure changes within the 
oropharynx using manometry (McConnel, Mendelsohn, & Logemann, 1986; Mendelsohn & 
McConnel, 1987).  Around this time, gastroenterologists became interested in exploring the 
interrelations between “upper” oropharyngeal and “lower” esophageal transfer of swallowed 
material employing McConnel’s methodology (Dodds et al., 1988; Shaker, Cook, Dodds, & 
Hogan, 1988).  Jerilyn Logemann, a professor of Speech Language Pathology and collaborator in 
McConnel’s research, realized the importance of rehabilitation of disordered swallowing and 
decided to focus her expertise in anatomy and physiology of the head and neck on dysphagia.  
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She wrote the first textbook on the evaluation and treatment of swallowing disorders in 1983 
(Logemann, 1983).  The next twenty years saw dramatic growth in the number of published 
investigations of swallowing disorders and its management from all three professions and the 
birth of the Dysphagia Research Society in 1992.   
3.1 OROPHARYNGEAL PHYSIOLOGY:  UPPER ESOPHAGEAL SPHINCTER 
(UES) FUNCTION 
Oropharyngeal swallowing physiology and biomechanics have been analyzed using a 
combination of instrumental methods.  Historically, imaging studies using real-time 
videofluoroscopy have been used to track the flow of contrast-enhanced materials through the 
digestive system.  Current descriptions of oropharyngeal deglutitive events focus on the 
movement of the bolus in relation to structural landmarks from the mouth to the esophagus.  
Visual imaging studies yield a two-dimensional view of bolus flow and movement of anatomic 
structures in the UAT.  However bolus movement takes place over all three dimensions of space, 
and is additionally reliant upon development of pressure gradients, maintenance of intrabolus 
pressure, and intricately timed and coordinated movement of structures toward and past one 
another.  The onset and end of the components of this brief event tend to overlap with other sub-
events, thereby rendering any linear discussion of their nature semantically difficult.  For 
discussion purposes, oropharyngeal swallowing is artificially separated into stages which 
characterize groups of events in terms of timing of structural landmarks and bolus movement.  
For the purposes of this dissertation, details of this section will focus upon the component of 
deglutition (i.e., UES opening) modified by the experimental treatment technique (i.e., 
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Mendelsohn maneuver) investigated.  A detailed discussion of all other stages of normal 
swallowing can be found in Appendix A.  This is included as a reference to the discussions of 
swallowing abnormalities and treatment strategies which were targeted in some of the articles 
selected for the meta-analyses portions of this dissertation.   
3.1.1 UES Opening during Swallowing 
Several forces contribute to UES opening during swallowing.  The main source of intrabolus 
pressure arises from compression of the bolus by the tongue and pharyngeal constrictors.  
Leakage of material from this pressurized bolus is prevented through a combination of factors 
including closure of the system’s many valves, bolus volume and viscosity, pre-pharyngeal stage 
inhibition of UES resting tone, and muscular traction forces applied to the sphincter itself.  
Traction forces contribute to the anterior and superior displacement of the UES (Jacob, Kahrilas, 
Logemann, Shah, & Ha, 1989; Logemann, 1998).  McConnel and his colleagues referred to the 
cumulative outcome of these co-occurring events as the hypopharyngeal suction pump 
(McConnel, Cerenko, & Mendelsohn, 1988). 
These traction forces arise from suprahyoid musculature that make up the floor of the 
mouth (FOM) or submental muscle complex:  the geniohyoid (GH), anterior belly of the 
digastric (ABD), and the mylohyoid (MH).  Combined concentric forces of this FOM complex 
are transferred from their fixed origins on the mandible to their insertions on the hyoid bone 
(Logemann & Kahrilas, 1990).  The laryngeal framework is suspended from the hyoid through 
muscular and connective tissue attachments and is sometimes referred to as the hyolaryngeal 
complex.  Contraction of these muscles generates the traction forces that produce anterior and 
superior displacement of the hyoid and larynx during swallowing which contributes to UES 
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opening.  The posterior wall of the larynx is shared as the anterior wall of the UES.   Studies 
using electromyography in conjunction with fluorographic and ultrasonic imaging techniques 
have verified the displacement of the hyoid bone and concurrent distension of the UES resulting 
from FOM contraction during swallowing (Dodds et al., 1990; Jacob et al., 1989; Kelly, 2000; 
Miller & Watkin, 1997).   
The UES has also been shown to “relax” somewhat from its resting state of tonic closure 
due to vagal inhibition (Miller, 1986), immediately preceding the onset of hyolaryngeal 
excursion during the pharyngeal phase of normal swallowing.  Some researchers hypothesize 
that pre-pharyngeal stage vagal inhibition of sphincteric resting tone is responsible for reduction 
of UES intraluminal pressure during normal deglutition (Cook et al., 1989b).  Others have 
demonstrated reduced UES tone in response to electrical vagal stimulation (Broniatowski, 
Dessoffy, Shields, & Strome, 1999).  This “relaxation” or increased compliance is thought to 
facilitate sphincteric opening efforts supplied by traction and other forces (Fukushima et al., 
2003; Miller, 1997).   
3.1.2 Causes of UES Impairment during Swallowing 
Dysphagia caused by UES dysfunction is associated with reduced duration and/or diameter of 
UES opening.  Patients who experience incomplete bolus clearance into the esophagus with 
residual hypopharyngeal residue often report a sensation of food ‘sticking in the throat.’  
Severity can range from minimal separation of the bolus tail to complete absence of esophageal 
bolus entry.  Some research suggests that normal aging causes reductions in the duration and 
diameter of UES opening (Ekberg & Feinberg, 1991; Frederick, Ott, Grishaw, Gelfand, & Chen, 
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1996).  Thus, the combined effects of age-related UES functional changes and disease processes 
in the elderly could have negative implications on overall swallow safety and efficiency. 
Impaired bolus flow through either the pharynx or the UES has been associated with 
irradiation treatments to the head and neck for carcinoma, stroke, pathological and iatrogenic 
sources of injury to vagal peripheral efferents, cricopharyngeal bar, and Zenker’s diverticulum 
(Beutler, Sweeney, & Connolly, 2001; Eisbruch et al., 2002; Fukushima et al., 2003; Jacobs et 
al., 1999; Robbins & Levine, 1993; Smith-Hammond, Davenport, Hutchison, & Otto, 1997).  
Among the aforementioned conditions, the majority of patients with central brainstem lesions 
and specific nuclear and peripheral cranial nerve injuries consistently experience impaired UES 
opening during deglutition (Kwon, Lee, & Kim, 2005; Robbins & Levine, 1993; Smith-
Hammond et al., 1997).  Electrophysiologic and videomanometric investigations of swallowing 
physiology in these populations lend support to one model which centers around a swallowing 
pattern generator within the medulla and associated reticular formation (Amri, Car, & Jean, 
1984; Aydogdu et al., 2001; Ertekin & Aydogdu, 2002; Prosiegel, Holing, Heintze, Wagner-
Sonntag, & Wiseman, 2005).  Researchers have demonstrated that these “centers” can be 
influenced by afferent peripheral buccopharyngeal input, and in turn influence motor outflow to 
structures innervated by efferent branches of the glossopharyngeal, vagus, hypoglossal, facial, 
and trigeminal nerves emanating from the pons and medulla. 
Investigations of swallowing function in postoperative head and neck cancer resections 
have been invaluable tools for clinicians in terms of predicting the nature of and/or developing 
treatment models based on the surgical paralysis or ablation of various structures involved in 
deglutition.  One model that clearly illustrates the postoperative impairments to UES traction 
forces is that of total laryngectomy.  Laryngectomy involves removal of the entire larynx 
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including all inferior attachments to the trachea up to superior and anterior attachments to the 
suprahyoid musculature and tongue base.  Hyoid insertions for the suprahyoid muscle complex 
are removed anteriorally as well as the rigid anterior wall of the UES upon which suprahyoid 
traction forces act during swallowing.  Additionally, removal of the cricoid cartilage eliminates 
the site of origins of the cricopharyngeal segment of the inferior constrictor.  After complete 
laryngectomy, the UES can be characterized as a flaccid, tonically closed sphincter with little to 
no structural foundation for the generation of traction forces (McConnel et al., 1986).  The 
laryngectomy patient must rely upon residual structures above the FOM to generate enough 
intrabolus pressure to propel the bolus into the esophagus.  In many cases, these patients learn to 
compensate for absent UES function by making adjustments in posture and/or bolus placement 
which maximize potential for generating oral and pharyngeal intrabolus pressure (McConnel et 
al., 1986; Nishizawa, Mesuda, Kobashi, Takahashi, & Inuyama, 2001).  Findings illustrate that 
patients can influence UES function during deglutition. 
3.2 BEHAVIORAL MANAGEMENT OF IMPAIRED UES OPENING  
Mistiming of biomechanical events while swallowing and impaired sensorimotor function of the 
UAT produce abnormalities in the bolus flow.  Traditionally, these abnormalities are detected 
with videofluoroscopy, or modified barium swallows (MBS).  Investigators have described 
numerous compensatory strategies intended to influence the timing and/or specific properties of 
swallowing events.  These compensatory maneuvers must be used every time food or liquids are 
swallowed to facilitate bolus clearance and airway protection.  Among the many biomechanical 
abnormalities that could result in aspiration are (a) delayed onset of the pharyngeal response, (b) 
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impaired clearance of swallowed material into the esophagus, and (c) incomplete airway closure 
during the swallow.  Appendix B contains descriptions of dysphagia interventions used to 
remediate these specific biomechanical problems.  Of particular interest in this dissertation is a 
behavioral maneuver called the Mendelsohn maneuver, a strategy designed to improve UES 
opening while swallowing. 
3.2.1 Biomechanics of the Mendelsohn Maneuver 
The Mendelsohn maneuver requires the individual to consciously prolong the duration of each 
swallow (Logemann, 1998).  This technique was named after the investigator responsible for 
first describing post-general anesthesia aspiration syndromes spawning an interest in 
oropharyngeal swallowing physiology and disorders.  It is difficult for a clinician to teach 
patients and more difficult to perform accurately (personal communication, J.A. Logemann, 
October 24, 2005).  Appendix E contains the verbal instructions and cues used by the examiner 
to train subjects to perform the Mendelsohn Maneuver for the experimental portion of this 
dissertation. 
Volitional prolongation of duration of UES opening was described by Kahrilas et al.  
(1991) in healthy subjects using simultaneous videofluoroscopy and pharyngoesophageal 
manometry.  The maneuver is selected for individuals with radiographic evidence of incomplete 
bolus clearance related to (1) UES function or (2) failure of other components of the 
oropharyngeal pressure pump to completely drive a bolus through the UES into the esophagus 
(Kahrilas et al., 1991).  Some studies investigating behavioral interventions for dysphagia have 
demonstrated that accurate execution of this maneuver produces prolonged and wider diameter 
UES opening during the pharyngeal stage, thereby enabling increased hypopharyngeal clearance 
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(Dodds et al., 1990; Logemann, 1998).  Others have identified changes in duration of pharyngeal 
contraction and intrabolus pressure generation while using this maneuver (Boden, Hallgren, & 
Witt, 2006).       
 The Mendelsohn maneuver has been reported as effective in managing dysphagia caused 
by UES dysfunction in patients with adequate cognition (Logemann, 1998; Robbins & Levine, 
1993).  The Mendelsohn maneuver is challenging for the average individual to perform and 
increasingly difficult for individuals with cognitive or language impairments (personal 
communication, J.A. Logemann, October 24, 2005).  Logemann et al. (1990) successfully trained 
a patient with dysphagia caused by brainstem stroke to prolong UES opening when swallowing.  
Using sEMG of submental musculature in combination with videofluoroscopy, these researchers 
were able to verify that prolonged UES opening resulted in less post-swallow pharyngeal 
residue; thus reducing this patient’s risk of postprandial aspiration.  Some studies have shown 
that increased intrabolus pressure a is secondary outcome of performance of the Mendelsohn 
Maneuver, suggesting greater effort may be applied during its performance by some individuals 
(Bulow, Olsson, & Ekberg, 1999). 
This maneuver is also somewhat difficult for a clinician to demonstrate because the 
structures involved are located within the neck musculature.  Ordinarily, clinicians rely upon 
palpation of the laryngeal framework to formulate impressions about the relative quality and 
timing of hyolaryngeal excursion associated with swallowing.  They train patients to self-palpate 
these structures while verbally instructing them to “hold the larynx up” longer.  Unfortunately, 
no studies have demonstrated the accuracy or reliability of clinicians in detection of swallow-
related hyolaryngeal motion, or the ability to discriminate between it and hyolaryngeal motion 
associated with mandible and lingual movements.  Data are needed to determine the precision of 
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the clinicians’ subjective impressions of hyolaryngeal movement during swallowing and its 
relationship to the judgment of the effects of training on swallowing biomechanics.  
In summary, accurate performance of the Mendelsohn maneuver causes the subject to 
lengthen the duration and possibly increase the amplitude of suprahyoid musculature contraction 
during each swallow.  The expected effect of this maneuver is to maintain hyolaryngeal elevation 
for the purposes of augmenting airway closure and prolonging the duration of UES opening.  The 
desired outcomes include more complete bolus clearance through the UES, and a reduction in 
post-swallow, hypopharyngeal residue which contributes to an increased risk of postprandial 
aspiration (Eisenhuber et al., 2002; Logemann, 1998).   
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4.0  CLINICAL RELEVANCE OF DYSPHAGIA TREATMENT AND ASPIRATION 
SYNDROMES 
4.1 MEDICAL AND ECONOMIC COSTS OF DYSPHAGIA 
The most clinically important, health-related outcomes associated with oropharyngeal dysphagia 
are caused by misdirection of swallowed food or liquids into the upper airway, or aspiration.  
Aspiration and airway obstructions (choking) occur when any portion of a bolus courses into the 
airway inlet (or larynx).  Aspirated material may progress further into the trachea, smaller 
airways, and alveoli.  Pneumonia is a major consequence of oropharyngeal dysphagia when 
aspiration is present.  Hospitalization rates for aspiration pneumonia (AP) have grown 
dramatically in the past two decades.  Between 1991 and 1998, admissions for AP increased by 
94.5% (Baine, Yu, & Summe, 2001).  Dozens of diseases trigger some degree of dysphagia in 
addition to stroke, traumatic brain injury, neurodegenerative diseases, and iatrogenic disruption 
of sensorimotor substrates of head and neck function.  Given the reality of rising medical costs, 
public healthcare would greatly benefit from research supporting the refinement of non-invasive, 
therapeutic techniques that would effectively minimize or eliminate deglutitive aspiration.   
Studies have estimated that the cost of providing medical care for dysphagic stroke 
patients ranges between $6,000 for those who successfully regain safe oral intake, and $12,000 
for those eventually requiring enteral feeding tubes to ensure safe nutrition and hydration 
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(Wojner & Alexandrov, 2000).  Non-oral management of dysphagia involves surgical placement 
of an enteral feeding tube, or gastrostomy, presumably to reduce the risk of AP and malnutrition.  
Ironically, there is little published evidence that non-oral dysphagia management provides 
measurable benefit in terms of cost or survival.  Callahan, Buchanan, and Stump  (2001) reported 
that complications of gastrostomy placement due to either the surgery or the device itself could 
result in treatment costs in excess of $31,000.  Moreover, dysphagic patients undergoing 
gastrostomy placement may have coexisting esophageal motility disorders (e.g., transient lower 
esophageal sphincter relaxation or gastroesophageal reflux disease) which put them at greater 
risk for developing aspiration with a feeding tube than without (Ciocon, Silverstone, Graver, & 
Foley, 1988; Erdil et al., 2005; Finucane & Bynum, 1996).  Non-oral dysphagia management 
does not completely eliminate the risk of patients developing AP, and in fact, can actually cause 
the problem.  Since treatment costs vary with setting, effective dysphagia treatment without 
hospitalization would be more cost-efficient than inpatient treatment (Kruse, Boles, Mehr, 
Spalding, & Lave, 2003). 
4.1.1 Pneumonia   
According to the Centers for Disease Control and Prevention (2006), the seventh leading cause 
of death in the United States was attributed to influenza and pneumonia, the latter producing the 
majority of their combined mortalities.  In 2003, annual pneumonia-related deaths totaled 63,241 
and occurred at a rate of 224 per 10,000 in elderly adults, age 65 and older (National Center for 
Health Statistics, 2003).  Pneumonia is the most frequent cause of death by infectious disease in 
the United States (Marston et al., 1997).   
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Community acquired pneumonia (CAP) is caused by microorganisms that thrive in 
respiratory epithelium.  Among bacterial causes of CAP, pneumococcus (streptococcus 
pneumoniae) is the most common, and results in 40,000 deaths annually (Centers for Disease 
Control and Prevention, 2006).  Other forms of bacterial pneumonia include (a) nosocomial 
pneumonia, caused by pathogens typical in hospitals and nursing homes, (b) ventilator-
associated pneumonia, caused by contamination of mechanical ventilator circuits, (c) Legionella, 
and (c) mycoplasma pneumonia (Centers for Disease Control and Prevention, 2006).  Viral 
forms of pneumonia include respiratory syncytial virus.  A relatively recent category of 
pneumonia, also classified as CAP, is associated with aspiration of swallowed food or liquids 
mixed with bacterial pathogens common to saliva.  
CAP originates from a number of causative factors and accounts for the majority of 
pneumonia diagnoses.  Seasonal and other cyclic increases in the pool of available pathogens in 
the community and an increased tendency of indoor activity during winter months raise the 
infection and cross-infection rates.  Additional risk factors shown to be associated with CAP 
include underlying pulmonary disease, immunocompromise, inactivity, damaged airway 
mucociliary clearance, and other chronic illnesses including neurological conditions.   
Conditions that cause temporary or permanent changes in sensorimotor function often 
compromise airway protection during swallowing.  In elderly patients with stroke, pneumonia 
increases mortality.  In a large, population-based study of 11,286 stroke patients without co-
occurring terminal disease or advance directives requiring “do not resuscitate” management, the 
mortality rate was six times higher (26.9%) in patients who developed pneumonia after onset of 
stroke compared to those that did not develop pneumonia (4.4%) (Katzan, Cebul, Husak, 
Dawson, & Baker, 2003).  After adjustments for various underlying factors affecting mortality, 
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the relative risk of death (RRD) of stroke patients who developed pneumonia within 30 days 
post-onset was 2.99 (i.e., the probability of death was about three times higher) compared to 
stroke patients without pneumonia. 
Many patients survive severe stroke because of aggressive management in intensive care 
units, however acquiring pneumonia during the post-onset phase significantly reduces both the 
quality and likelihood of survival.  Hilker et al. (2003) prospectively compiled data from the 
medical records of stroke patients admitted to a neurological intensive care unit.  Twenty-one 
percent of their cohort acquired stroke-associated pneumonia (SAP).  Within the SAP group, 
mortality was three times more likely (both short-term and long-term), and these patients had 
significantly less rehabilitative success compared to stroke patients without SAP (Hilker et al., 
2003).   
The incidence of AP has increased dramatically in recent years.  In fact, Baine et al. 
(2001) reported that diagnoses of AP had reached epidemic proportions according to an 
epidemiological study which sought to estimate the prevalence of aspiration pneumonia from 
Medicare data.  Baine and colleagues (2001) reviewed 5% of all Medicare hospital inpatient bills 
from 1991 through 1998 to determine the estimated number of hospitalizations for AP in the 
United States.  Their 5% sample revealed that the frequency of hospitalization for all categories 
of pneumonia grew from 30,292 to 37,153 during that seven year period.  Of those admissions, 
the rate of AP admissions doubled (i.e., from 2974 to 5756 patients) and ranked second only to 
‘unspecified causes of pneumonia’ as coded in hospital discharge summaries (Baine et al., 2001).  
Extrapolating these data to the population, an estimated 743,000 pneumonia admissions occurred 
in 1998, with AP constituting 115,120 or 15.5% of Medicare hospital admissions for pneumonia 
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that year.  AP carried the highest case-fatality rate during hospitalization (23.1%) of all 
pneumonia diagnoses. 
In another analysis of Medicare source data, Niederman, McCombs, Unger, Kumar, and 
Popovian (1998) determined that more than $8 billion was spent treating hospital inpatients for 
CAP, at an average cost per stay of $6,000 to $7,000.  Combining information from both of the 
aforementioned Medicare review studies, the proportion of CAP inpatient hospital cost for AP 
was 15.5% of $8.4 billion, or approximately $1.3 billion.  Given these figures, the impact of a 
modest ten percent reduction in either hospital admissions or in length of stay for AP could save 
the health care system hundreds of millions of dollars each year.   
4.2 PREDICTING ASPIRATION SYNDROMES 
Treatment of oropharyngeal dysphagia has become common in modern health care institutions.  
Pneumonia caused by prandial aspiration is the most frequently cited adverse outcome associated 
with oropharyngeal dysphagia (Doggett et al., 2001).  Patients who develop pneumonia because 
of dysphagia exhibit a 5% mortality rate (Almirall et al., 2000).  Recent studies suggest that 
about half of all stroke patients demonstrate clinically significant dysphagia affecting safe oral 
intake (Mann, Hankey, & Cameron, 2000).  Even when dysphagic stroke patients received 
temporary enteral nutrition via nasogastric tube, prevalence of pneumonia was as high as 44% 
(Dziewas et al., 2004). 
Among the most likely sequelae of abnormal deglutition is aspiration of swallowed food 
or liquids which contain colonized bacteria typically present in oropharyngeal secretions (Marik, 
2001; Marik & Kaplan, 2003; Tablan, Anderson, Besser, Bridges, & Hajjeh, 2007).   Researchers 
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have shown that aspiration of colonized bacterial contained in saliva is one of the most 
predictable risk factors for pathogenesis of AP among patients who have a history of aspiration 
(Langmore et al., 1998; Loeb, Becker, Eady, & Walker-Dilks, 2003; Millns, Gosney, Jack, 
Martin, & Wright, 2003).  Langmore et al. (1998) identified risk factors for pneumonia among a 
cohort of 189 dysphagic adults from acute care and long-term care settings.  Patients dependent 
upon staff for feeding and oral care, those with dental caries or periodontal disease, and/or those 
who smoked had significantly higher rates of AP compared to other patients.   
The level to which the bolus is aspirated is another factor predictive of pulmonary or 
airway consequences of dysphagia (Langmore et al., 1998).  In a study of 381 hospitalized 
patients undergoing modified barium swallow (MBS) for suspected dysphagia, pneumonia rates 
for patients who swallow without material penetrating the airway were only 3% to 4% (Pikus et 
al., 2003).  Conversely, the pneumonia rate for patients exhibiting laryngeal penetration (i.e., 
material penetrated the larynx and remained above the plane of the true vocal folds) on the MBS 
was 12%.  Many patients aspirating at meals are completely unnoticed because their response to 
aspiration is absent.  Of the group reported by Pikus et al. (2003), 27% showed evidence of 
tracheal aspiration, (i.e., below the vocal cords) and almost one-third of these aspirators (31%) 
did not exhibit any clinical evidence that they had aspirated, such as coughing (i.e., they were 
asymptomatic or silent aspirators).  Interventions that can effectively minimize or reduce the 
likelihood of aspiration in dysphagic patients and subsequently mitigate pneumonia and other 
morbidities, are worthy of careful investigation. 
Many adverse health sequelae caused by oropharyngeal dysphagia are reversible and 
transient.  Recovery from the acute stages of stroke, for example, results in dramatic 
improvements in swallowing safety (Johnston et al., 1998; Smithard et al., 1997).  The incidence 
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of pneumonia in stroke patients is estimated at 5% to 20%; therefore, prevention of health 
sequelae in the acute post-onset stages of stroke is a principal focus of clinical practice in many 
medical settings.   
For more than twenty years, clinical investigators have been interested in strategies and 
maneuvers that prevent bolus misdirection.  Scientists and clinicians worldwide and across 
disciplines contribute to this body of literature, including Speech-Language Pathology, 
Gastroenterology, Otolaryngology, Gerontology, Neurology and Neurosurgery, Physiatry, 
Occupational and Physical Therapy, Nutrition and Dietetics.  One of the most significant 
obstacles to generating this type of research is diminished funding (Logemann, Baum, & 
Robbins, 2001).  
Despite this universal interest in reducing aspiration syndromes related to biomechanical 
impairments, clinicians continue to seek methods whose published reports provide sufficiently 
repeatable methods, statistical power, and predictive value.  Research synthesis provides 
consumers of clinical research with the opportunity to carefully assess the value of available 
research.  Studies that represent a common underlying construct can be combined in a met-
analysis for the purpose of estimating their overall effectiveness.  Ultimately, this will enable 
clinicians to select more appropriate treatments to maximize the potential therapeutic success for 
their patients. 
4.3 SPECIFIC AIMS 
Though empirical evidence of the effectiveness of individually administered 
interventions for neurogenic dysphagia exists, most studies either lack clear descriptions of 
 27 
methodology suitable for replication (e.g. Freed, et al., 2001) or have contained serious 
methodological flaws (e.g. Bulow et al., 2003).  Case studies of dysphagic patients offer 
descriptions of and/or graphic representation of raw data without establishing the patient’s pre-
intervention abilities (Burke et al., 2000).  Without sufficient baseline information, it is difficult 
to attribute observed changes to the intervention provided (Bryant, 1991; Logemann & Kahrilas, 
1990; Robbins & Levine, 1993).  Additionally, sEMG biofeedback rehabilitation of disordered 
swallowing musculature has been investigated in combination with traditional therapy without 
evidence that it offers a significant benefit to traditional behavioral intervention alone (Crary et 
al., 2004; Huckabee & Cannito, 1999).  Therefore, the purposes of this dissertation are twofold.  
First, the quality and importance of published evidence describing treatment of oropharyngeal 
dysphagia and prevention of its associated global health outcomes will be statistically evaluated 
via modern meta-analytic methods.  Secondly, two groups of normal subjects will be trained to 
use a common compensatory swallowing strategy (i.e., the Mendelsohn maneuver) to determine 
whether or not the addition of visual biofeedback to traditional training has an effect on post-
training submental sEMG activity while swallowing.  Both studies will be conducted using 
standardized protocols, including a priori decision matrices and judgment criteria (in the meta-
analyses) and subject randomization (in the experiment) in order to facilitate future replication 
and to address some of the problems identified in prior meta-analyses and investigations of the 
effects of sEMG. 
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4.4 HYPOTHESES 
Two independent studies comprise this dissertation: a meta-analytic synthesis of research, and a 
traditional experiment.   
4.4.1 Hypotheses for Meta-Analyses 
Based on the trends observed in this literature review and years of clinical experience, it is 
hypothesized that individual therapeutic interventions for dysphagia will demonstrate measurable 
and significant beneficial physiologic effects.  Furthermore, research will show that 
implementation of these strategies produces a positive impact on global health outcomes such as 
pneumonia incidence, nutrition status, and mortality.   
4.4.2 Hypotheses for Experimental Investigation 
It is hypothesized that a group of healthy normal subjects will demonstrate significantly 
increased duration and amplitude of submental myoelectric activity while swallowing after they 
undergo a single training session in the performance of the Mendelsohn maneuver, regardless of 
which training method is used.  Because biofeedback affords the subject the ability to alter 
muscular physiology “online,” it is hypothesized that subjects whose training includes sEMG 
biofeedback will produce significantly greater duration, mean and peak amplitudes of 
myoelectric activity while swallowing as compared to subjects having just traditional training.  It 
is also hypothesized that subjects whose training includes biofeedback will exhibit more uniform 
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patterns and consistent performance of the Mendelsohn maneuver than those with traditional 
training alone (i.e., no biofeedback). 
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5.0  TWO META-ANALYSES: EFFICACY OF INDIVIDUALLY ADMINISTERED 
DYSPHAGIA TREATMENT, AND EFFECTIVENESS OF INSTITUTIONAL 
DYSPHAGIA PROTOCOLS 
Speech language pathologists practicing as swallowing-disorders clinicians are often consulted 
when patients are suspected of having developed pneumonia, malnutrition, or dehydration due to 
oropharyngeal dysphagia.  After conducting a diagnostic evaluation, dysphagia therapy is 
subsequently designed to reduce or eliminate biomechanical swallowing impairments that allow 
the misdirection of swallowed material into the airway, because the therapy is believed to 
increase the patient’s long-term ability to safely eat and drink by mouth.  This improved 
biomechanical function caused by dysphagia therapy is then expected to mitigate the patient’s 
risk of dysphagia related diseases such as aspiration pneumonia.  The reduction of swallowing 
impairments and the prevention of swallowing-related disease are extremely important and 
interdependent goals of dysphagia therapy.   
Specific treatment methods are designed and implemented because they have been shown 
to modify oropharyngeal biomechanics and physiology, thereby reducing aspiration of 
swallowed material into the respiratory system, and increasing delivery to the digestive system.  
The management of bolus misdirection is important.  However these interventions are of little 
value to the individual patient or to the maintenance of public health unless the elimination of 
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bolus misdirection results in a predictable reduction in the risk of pneumonia, malnutrition, 
dehydration, or mortality.   
Public health consequences of dysphagia include disease, decompensation and death due 
to aspiration-related respiratory tract infections, airway obstruction, and reduced physiologic 
reserve caused by malnutrition.  Dysphagia also increases the overall cost of medical care due to 
recurrent hospitalizations for pneumonia, and the need for artificial enteral feeding tube usage.  
Pneumonia, the most common cause of death by infectious disease in the United States (Marston 
et al., 1997), occurs at an annual rate of 224 cases per 10,000 persons over age 65 (National 
Center for Health Statistics, 2003).  Among pneumonia diagnoses within acute care hospitals in 
the United States, aspiration pneumonia, which is caused by the misdirection of swallowed 
material into the respiratory system (Marik, 2001), ranks second only to “unspecified causes of 
pneumonia” among coded hospital discharge diagnoses, while carrying the highest case fatality 
rate among all pneumonia diagnoses (Baine et al., 2001).  The actual mortality rate after stroke 
has been shown to increase as much as six-fold when stroke patients develop pneumonia (Hilker 
et al., 2003; Katzan et al., 2003). 
The economic cost of oropharyngeal dysphagia emphasizes the public health importance 
of its rehabilitation.  In 1998, the cost of treating pneumonia caused by oropharyngeal dysphagia 
exceeded $1 billion (Niederman, McCombs, Unger, Kumar, & Popovian, 1998).  Artificial 
nutrition is another costly alternative to oral intake in some dysphagic patients.  Restoring 
nutrition safely by rehabilitating oropharyngeal swallowing function, has been shown to be half 
as costly as implementing non-oral means of nutrition through the use of enteral feeding tubes 
(Wojner & Alexandrov, 2000).  
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As illustrated above, modest reductions in the incidence of post-stroke pneumonia and 
need for enteral feeding could generate a significant decline in morbidity, mortality, and the cost 
of health care in patients with neurogenic dysphagia.  Therefore the overall value of the 
treatment of individually administered interventions for neurogenic dysphagia must be measured 
in terms of concomitant reductions in mortality, morbidity, and expense.  Individual and public 
health outcomes, including economic outcomes, must constitute the clinical end points that 
determine the value of therapeutic intervention for dysphagia as a disorder within the public 
health domain.   
Patients with dysphagia are typically managed with one or more therapeutic interventions 
because dysphagia-producing neurological diseases such as stroke, amyotrophic lateral sclerosis 
and Parkinson’s disease, cause multiple swallowing impairments.  Each individual dysphagia 
treatment modality should be selected because it has been demonstrated to be effective at 
eliminating a specific swallowing impairment.  When combined to address multiple 
impairments, properly selected modalities should produce a combination of beneficial 
physiological changes to swallowing function, such as reductions in aspiration of swallowed 
food into the respiratory system and increased clearance of food into the digestive system.  After 
implementing these interventions, the clinician should be able to estimate the predictive 
potential, or prognosis, that the interventions will produce beneficial treatment outcomes such as 
increased nutrition without artificial support, or reduced likelihood of pneumonia and mortality.  
When such a prediction can be reliably made, the dysphagia treatments themselves can be 
justified as clinically valuable (Doggett et al., 2001).  Therefore, the effects of individual 
treatments themselves, as well as the long-term health benefits caused by these treatments, must 
be ascertained, and reliably predicted, in order for all stakeholders (i.e., clinicians, patients, third 
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party payers, and policy makers) to make more informed decisions, and ultimately, to determine 
the value of dysphagia therapy on public health.   
The development of individual therapeutic methods begins with stepwise, systematic 
research into the nature of a target disorder, and evolves into elucidation of tactics that 
manipulate the patient’s disordered physiology in ways that are believed to generate some 
measurable benefit.  When research is properly conducted, the investigators substantiate the 
validity and reliability of their conclusions through the use and reporting of soundly designed 
methods.  The finest of these experimental investigations employ numerous safeguards to reduce 
misinterpretation of experimental results.  They are designed prospectively, use rigorous 
methods of subject selection and assignment as well as predefined criteria for instructing subjects 
and evaluating data before and after treatment.   
There are literally hundreds of published studies, available to the clinician and researcher, 
describing the effects of dysphagia therapy on swallow physiology or health outcomes associated 
with dysphagia.  Researchers observe or assemble cohorts of patients with similar disorders and 
systematically employ a therapeutic intervention to determine its effects on the impairment of 
interest.  The scientific methods and conduct employed by investigators are published, and can 
therefore be judged by the research consumer to determine whether the results of the studies 
themselves confirm that the investigated treatments are worthy of clinical adoption with specific 
patients with corresponding swallowing impairments.  In the same manner that researchers 
assemble individual patients to generate a group with whom a specific clinical question can be 
rigorously tested, research articles investigating methods representing a sufficiently similar 
clinical construct, can be assembled and tested to provide the research consumer with evidence 
regarding the overall value of the underlying clinical construct they represent. 
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Meta-analysis, a prospective form of research synthesis whose “participants” are 
published research studies (vs. groups of patients), enables researchers to gather, sort, evaluate, 
and when appropriate, combine prior research to determine the collective clinical value and 
statistical significance of the findings.  The studies selected for inclusion in a proper meta-
analysis are screened and evaluated using prospective methods to ensure that they meet rigorous 
eligibility criteria.  These studies are ultimately included and analyzed as a group of 
“participants” because they are sufficiently homogeneous, contain a predetermined level of 
sufficiently robust design quality and integrity, and they represent a similar, defined, underlying 
construct (Cooper & Hedges, 1994). 
To assess the effects of dysphagia treatments on swallowing impairments, as well as on 
the global health impact of dysphagia management, two meta-analytic syntheses of published 
research were conducted.  The first was designed to determine the effect of clinical, non-surgical, 
therapeutic modalities for remediating biomechanical impairments in dysphagic patients with 
stroke or clearly diagnosed neurological disease.  The second meta-analysis investigated the 
effects of institutional dysphagia protocols on long-term adverse health outcomes such as 
malnutrition and pneumonia, and mortality. 
Figure 1 illustrates the steps performed in the two meta-analyses.  Sections 5.2 and 5.3 
describe the search strategy and retrieval and the scoring method employed in both meta-
analyses.  Sections 5.4 and 5.5 describe specific procedures that were unique to the first and 
second meta-analyses, respectively.  
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5.1 HYPOTHESES 
Based on the trends observed in this literature review and years of clinical experience, it 
is hypothesized that high quality investigations of individually administered interventions for 
neurogenic dysphagia will demonstrate measurable and significant beneficial effects toward the 
mitigation of biomechanical impairments of oropharyngeal deglutition.  Furthermore, it is 
hypothesized that high quality research will show that implementation of systematically 
administered institutional dysphagia protocols produce significantly beneficial global health 
outcomes such as reduction of pneumonia incidence, improvements in nutrition status, and 
reduced mortality. 
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 Figure 1.  Steps Performed in Meta-Analyses 
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5.2 LITERATURE SEARCH STRATEGY 
For both meta-analyses, a single literature search strategy was developed by the principal 
investigator, in collaboration with the consultant research librarian for the School of Health and 
Rehabilitation Sciences of the University of Pittsburgh.  The principal investigator is a speech-
language pathologist with 19 years clinical experience, who has participated in NIH funded 
clinical research projects as a regional principal investigator, researcher, judge, manuscript 
preparer and presenter of results at national and international scientific meetings and 
conferences.  His qualifications include formal coursework in meta-analytic procedures, previous 
performance and presentation of treatment meta-analysis in peer reviewed, national professional 
conferences, and recognition as a specialist by the Specialty Recognition Board for Swallowing 
and Swallowing Disorders.   
The search strategy was designed to retrieve published research that would be available 
to clinicians working with patients with neurogenic dysphagia in health care institutions in the 
United States.  It was developed by creating and combining MeSH terms using the Ovid © 
search engine (Wolters-Kluwer Health, 2006) and was limited to the time between 1966 and 
2006.  Ovid © databases used in the search were Medline, Cumulative Index to Nursing and 
Allied Health Literature (CINAHL), Health and Psychosocial Instruments (HAPI), Database of 
Abstracts of Reviews of Effects (DARE), Cochrane Database of Systematic Reviews (CDSR), 
American College of Physicians (ACP) Journal Club, and the Cochrane Central Register of 
Controlled Trials (CCTR).  The search sought all published studies coded with any of the 
following search terms:  randomized controlled trial, controlled clinical trial, random allocation, 
double-blind method, single-blind method, placebo, random, multicenter studies, prospective 
studies, intervention studies, cross-over studies, meta-analysis, control, human, deglutition, 
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deglutition disorders, dysphagia, and swallow.  Diagnostic search terms used in the search 
strategy for meta-analyses were:  cerebrovascular accident, amyotrophic lateral sclerosis, 
muscular diseases, multiple sclerosis, myasthenia gravis, Parkinson’s disease, and 
neurodegenerative diseases.  The root word embedded within the various diagnostic labels was 
included separately to ensure completeness of electronic search.  The complete search strategy 
appears in Appendix C. 
The date of initial search was February 14th, 2006.  The Medline search generated 351 
citations, while the combined search of the remaining databases produced 182 citations.  Of the 
latter group of citations, 166 (92%) were duplicates of articles identified in the Medline search.  
Therefore, only the 16 unique citations were added to the meta-analysis pool, bringing the total 
to 367 citations.  The search was repeated on December 29th, 2006, yielding 128 new citations.  
Of those, 25 were unique citations and became part of the final meta-analyses.  Three-hundred 
ninety two unique citations constituted the initial sample of articles retrieved. 
Other search strategies were also employed.  Hand search and requests to international 
colleagues were used to cast as wide a search net as possible for articles investigating treatment 
of oropharyngeal dysphagia.  One article was translated from German into English to enable it to 
be evaluated.  Authors of some of the retrieved citations were contacted to clarify their methods 
when the published methods were insufficiently clear.  Unpublished manuscripts and abstracts 
were not sought as they either did not represent the range of material available to clinicians 
working with patients (unpublished manuscripts), or contained insufficient methodological and 
information and data to enable replication or meta-analysis.  This search resulted in the addition 
of 16 articles that had not been electronically identified.  A final total of 408 articles was 
reviewed for the meta-analyses. 
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5.3 FRAMEWORK OF STEPS FOR THE TWO META-ANALYSES 
The aforementioned search strategy was used to cast as wide a net as possible in order to identify 
all articles that might be eligible for both meta-analyses, and was followed by a “first-pass” 
screening of retrieved citations. 
5.3.1 First-Pass Screening 
After the broad search was implemented, the investigator screened the retrieved articles to 
determine their appropriateness for inclusion into either meta-analysis.  A complete bibliography 
of all retrieved “hits” that included article identification number, abstract, article title, authors, 
and MeSH terms was printed.  The bibliography was used to screen articles for inclusion. 
A large number of retrieved articles were considered ineligible for meta-analysis because 
they did not investigate an individually administered intervention for neurogenic dysphagia.  In 
fact, the majority of citations discarded in the initial screening reported the results of diagnostic 
comparisons (new clinical tests vs. gold standard instrumental examinations), or were strictly 
descriptive in nature without systematically maintaining participant assignment to randomized 
treatments or follow up to outcome.  Additional citations were excluded because their 
investigations involved the treatment of neurological diseases themselves, reduction of stroke 
risk, or treatment to increase post-stroke survival with surgical and medical interventions, 
without components addressing the management of post-stroke dysphagia.  Specifically, many 
excluded studies looked at the effects of anticoagulation on cardioembolic stroke risk after first 
stroke, carotid endarterectomy on stroke risk, effects of intravenous immunoglobulin treatment 
on exacerbation recovery in multiple sclerosis, and effects of tissue plasminogen activator on 
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stroke evolution after early presentation of symptoms of stroke.  Other studies deemed 
inappropriate for this meta-analysis addressed surgical or pharmaceutical interventions on some 
aspect of the underlying disease that caused dysphagia within populations of neurologically 
impaired patients.  It is apparent that this set of excluded articles was retrieved by the search 
strategy because the presence of neurogenic dysphagia was mentioned in their abstracts. 
  Some studies were ineligible because they did not contain data or were subjective in 
nature.  Articles which reported results or opinions produced through anecdote, case report, 
editorial, or letters to editors, and studies that were overtly observational or retrospective in 
nature, were excluded to ensure adequate evidence quality (Straus, Richardson, Glasziou, & 
Haynes, 2005).  The capture of these citations was unexpected given the meticulously planned 
search strategies used.  However electronic databases captured citations that contained search 
terms in the publication’s title or abstract, or in the key words provided by the authors.  As a 
result studies of individual cases, whose abstracts discussed the need for a randomized controlled 
trial, were captured by the electronic search. 
Several articles did not investigate treatment methods in patients with stroke or other 
neurogenic dysphagia.  Investigations of treatment methods in normal healthy subjects, studies 
describing the natural history of dysphagia in various diseases, and those in which intervention 
consisted of diagnosis alone, were also excluded as they did not pertain to the constructs under 
investigation.   
Other studies were excluded because they investigated predictive value of clinical tests 
(i.e., bedside evaluation), compared two or more types of enteral feeding tube outcomes in 
patients with and without swallowing disorders, or they evaluated treatments that mitigated or 
prevented the primary disease (i.e., stroke) without a focus on oropharyngeal dysphagia. 
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5.3.2 Evaluation of Retrieved Citations 
Once inappropriate studies were discarded, a priori inclusion criteria were applied to the 
remaining citations to detect any articles that did not meet minimum acceptable criteria for 
research design, sample size, and level of controls used by investigators to ensure adequate 
internal and external validity.  The principal investigator conducted all evaluation of citations 
and he was not blinded from authors’ names. 
After the initial first-pass screening procedures, 60 citations remained.  These studies fell 
within two distinct and complementary constructs of oropharyngeal dysphagia treatment and 
management.  Forty-seven of these 60 remaining studies investigated the efficacy of individually 
administered dysphagia interventions for treating discrete, instrumentally measured 
biomechanical impairments in patients with neurogenic dysphagia in controlled experimental 
conditions.  Thirteen of these 60 studies investigated the effectiveness of institutional dysphagia 
protocols in reducing global health outcomes such as pneumonia and mortality in patients with 
neurogenic dysphagia.  Since these two types of studies were incompatible for combination into 
a single meta-analysis, it was deemed necessary to conduct two meta-analyses to adequately 
assess both types of data (i.e., short-term dysphagia treatment effects, and long-term global 
health outcomes).  Ultimately, six studies were entered into the first meta-analysis of the effects 
of individually administered interventions for neurogenic dysphagia, and three remained in the 
second meta-analysis of the effects of organized, institutional dysphagia management protocols 
on public health outcomes.  
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5.3.2.1 System Used to Rate Evidence Quality 
Evaluation of evidence quality for both meta-analyses was performed using methods published 
by Baker and Tickle-Degnen (2001), which were reduced to a screening form (Appendix D), to 
evaluate the quality of retrieved studies.  This rating system is used to classify studies on the 
basis of four parameters:  investigational design, sample size, experimental controls for internal 
validity, and experimental controls for external validity.  This rating system is clearer and more 
informative to the consumer of the meta-analysis than other publication ranking systems because 
it maintains separate scores for each of the four parameters of interest rather than forming a 
single composite score. 
Research design is scored on the basis of the type of investigation.  Randomized 
controlled experimental trials (RCT) and repeated-measures trial with randomized sequence of 
treatments receiving the highest design ranking (“I”) using this system.  Non-randomized 
controlled trials, two-group non-randomized including a treatment and control group, and non-
randomized, repeated measures designs with at least two conditions, received a design score of 
“II”.  A score of “III” is assigned to non-RCT studies of a single group, and single group pre-post 
studies.  Studies consisting of single subject or one-person pre-post studies, and case studies are 
scored “IV” and “V”, respectively.  These latter scores were ineligible for inclusion in either 
meta-analysis. 
Sample size is scored “A” for 20 or more participants or observations per group, and “B” 
for fewer than 20.  In the studies representing the construct of the first meta-analysis of 
individually administered interventions for neurogenic dysphagia, few studies of 20 or more 
participants were available, so the minimum sample size score was set at “B”.  In the final 
sample of six studies, three had samples of greater than 20 participants.  However the studies 
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representing the construct for the second meta-analysis included large scale investigations of at 
least 50 participants.  For this reason, a sample size score of “B” was considered acceptable for 
the first meta-analysis, and “A” for the second meta-analysis. 
Controls for internal validity judged by this coding system include the rigor in which a) 
randomized assignment of patients to treatment was conducted, or efforts to create similar groups 
were carried out, b) judges were blinded to patient assignment, c) judges were masked to 
measures performed by other judges, d) patients were analyzed in the groups to which they had 
been randomized and there was no unaccounted for attrition of participants, e) the authors 
presented justifiable, scientific rationale for the proposed effects of the intervention under 
investigation.  A score of “1” (high internal validity) is assigned to studies in which no 
alternative explanation for the observed outcome is probable, and in which controls to eliminate 
internal experimental sources of error and bias were excellent.  A score of “2” indicates moderate 
internal validity, with evidence of reasonable attempts to control for biases imposed by lack of 
randomization or other errors.  A score of “3”, low internal validity, indicates that two or more 
serious alternate explanations for the treatment outcome exist, or in which serious bias is evident.  
Control for attrition of subjects is an important characteristic of well controlled scientific 
investigation.  For this reason, studies that exhibited attrition of more than 10% of participants 
were scored “3” in this category.  Studies scoring “3” in internal validity were not eligible for 
either meta-analysis.   
Controls for external validity judged by this coding system include the degree to which a) 
the patients investigated represented the population of interest, b) the sample of patients was 
sufficiently homogeneous to enable the ability to discern the treatment effects on the target 
population, c) the treatments represent current practice, or are publicly available and feasible 
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methods in clinical settings.  A score of “a” indicates high external validity, with the participants 
investigated homogeneously representing the target population and the intervention methods 
representing current clinical practice.  A score of “c” is assigned to studies with heterogeneous 
samples, the inability to determine whether treatment effects differed by diagnosis, or the 
interventions do not represent current clinical practice.  A score of “b”, moderate external 
validity, is assigned to studies with characteristics between high and low external validity.  
Studies scoring “c” in external validity were not eligible for either meta-analysis. 
Minimum acceptable inclusion criteria are specified fully in the appropriate subsections 
of this chapter.  The next sections of this chapter describe all procedures performed for the two 
meta-analyses:  section 5.4 discusses the procedures used in the first meta-analysis, and section 
5.5 summarizes the procedures used in the second meta-analysis. 
5.3.2.2   Measurements Performed on Included Studies 
Studies which remained eligible after all evaluative processes were completed, underwent 
calculation of individual effect size and computation of the summary effect size for all articles 
included in each meta-analysis.    Each meta-analysis underwent testing to determine individual 
and summary effect sizes, statistical significance, and homogeneity of the sample (as seen in 
flow-chart diagram-Figure 1).  Statistical procedures differed between the two meta-analyses 
because the types of data in the first meta-analysis produced effect sizes that cannot be combined 
with those in the second meta-analysis.  However each meta-analysis included the same four 
components: testing of the individual studies to determine their effect sizes, calculation of 
combined effect sizes for all studies included in the meta-analysis, testing of statistical 
significance of the results of the combined effect size calculations, and evaluation of the 
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homogeneity of the sample.  The different methods employed in each meta-analysis will be 
addressed in subsequent sections of this chapter. 
5.4 META-ANALYSIS OF INDIVIDUALLY ADMINISTERED INTERVENTIONS 
FOR NEUROGENIC DYSPHAGIA 
5.4.1 Evaluation of Citations: Evidence Quality for Inclusion 
5.4.1.1 Acceptable Dependent Variables 
To be eligible for inclusion in this meta-analysis of individually administered behavioral and 
physiologic treatments designed to eliminate biomechanical swallowing impairments, studies 
were required to objectively measure the intervention’s effect on the investigated dependent 
variables.  The dependent variables were required to be objective, and they had to either directly 
indicate the abnormal flow of swallowed material into the airway (e.g., aspiration, laryngeal 
penetration-aspiration scores) or incomplete flow of material into the digestive system (e.g., 
bolus separation by prematurely closing UES).  Other dependent variables that were acceptable 
for this meta-analysis were those that can be observed with instrumental testing (i.e. 
videofluoroscopic evaluation of swallowing, fiberoptic evaluation of swallowing), and had been 
previously and established as predictors of the misdirection of swallowed material into the upper 
airway (e.g., incomplete laryngeal closure, prolonged duration of stage transition), or of 
incomplete clearance of swallowed material into the digestive system (e.g., reduced diameter or 
duration of UES opening).  Appendix B includes a review of several of these impairments and 
descriptions of their effects on pulmonary health and nutrition. 
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Since stroke and neurological disease impair swallowing function and cause patients to 
aspirate swallowed material, the biomechanical dependent variables influenced by the studies’ 
treatment modalities must have been previously validated as objective risk factors for aspiration 
or reduced intake of nutrients and fluids into the digestive system. 
Biomechanical Impairments Leading to Aspiration 
To be considered a validated objective risk factor for aspiration or inadequate oral intake, 
the dependent variables in eligible studies had to first predispose the patient to aspiration of some 
or all of the swallowed food or liquid, or result in ineffective transfer of swallowed material into 
the digestive system.  Second, each acceptable dependent variable had to previous show to 
increased risk of pneumonia, reduced nutritional intake, or dehydration in dysphagic patients.   
For example, prandial aspiration is well documented as a primary source of aspiration 
pneumonia.  However unlike aspiration, other swallowing outcomes, such as the need for the 
patient to swallow more than once to completely deliver a bolus of food into the esophagus, do 
not directly influence the risk of dysphagia-related pulmonary disease or nutritional compromise.  
Hence, elimination or reduction of aspiration during swallowing qualified as an acceptable 
dependent variable for this meta-analysis, while the need to swallow more than once to clear a 
swallowed bolus did not qualify as an acceptable dependent variable, unless the need to swallow 
more than once was caused by other impairment such as impaired UES opening during the 
swallow.  
Biomechanical Impairments Affecting Digestive Function 
Eligible studies were required to demonstrate the existence of biologically defensible 
evidence that their investigated treatment methods were protective of the airway during 
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swallowing and/or were beneficial for the effective transfer of swallowed material into the 
digestive system.  Studies exclusively reporting data relating to outcomes that lacked sufficient 
evidence of established validity, such as percent of bolus aspirated, percent of bolus retained in 
pharynx, and subjective swallow function scales without evidence of validation and 
standardization, were deemed ineligible. 
Description of Acceptable Dependent Variables 
The biomechanical variables of deglutition qualifying as acceptable dependent variables 
for included articles in this meta-analysis were those that could be modified by direct treatment.  
They included a) the duration of specific physiologic events and phases of swallowing, such as 
the duration of pharyngeal transit, duration of airway closure, and duration of upper esophageal 
sphincter opening; b) the distance of motion of anatomical structures responsible for safe and 
efficient swallowing, such as displacement of the hyolaryngeal complex, which is largely 
responsible for closure of the upper airway and distension of the upper esophageal sphincter;  c) 
closure of the larynx  during the swallow.  (Please note that the phases of normal swallowing and 
aspects of swallowing that can be modified were discussed in detail in Appendices A and B, 
respectively).   
Specifically, the duration of specific physiologic events, such as oral to pharyngeal stage 
transition (also known as pharyngeal delay time), total swallow duration, pharyngeal response 
duration (duration of pharyngeal activity during the swallow), pharyngeal transit duration 
(duration of bolus flow through the pharynx), duration of upper esophageal sphincter opening, 
and duration of laryngeal closure, expressed in standard units of time, were eligible dependent 
variables for this meta-analysis (Logemann, 1998; Robbins, 1987).  Measures expressing 
distance in standard units of length, including vertical and horizontal hyolaryngeal displacement, 
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laryngeal closure diameter, lingual to posterior pharyngeal wall contact range, and diameter of 
opening of the upper esophageal sphincter, were also eligible (Cook et al., 1989b; McConnel et 
al., 1988; Robbins et al., 1992; Robbins, Levine, Maser, Rosenbek, & Kempster, 1993).  
Objective observations of aspiration or UES opening, expressed in dichotomous terms, were also 
acceptable. 
For a published study’s dependent variable to be considered an objective biomechanical 
or physiologic measure, it had to have been obtained through an objective instrumental 
procedure such as videofluoroscopy.  By including only studies measuring objective dependent 
variables, the validity of the observations could be more readily ensured. The use of imaging 
data enabled the judges in the various studies to continuously observe and quantify the targeted 
oropharyngeal structures (i.e., their dependent variables) throughout all swallow events.  In 
addition, the dependent variables must have been recorded/measured both before and after 
treatment in single group studies and in studies with two or more groups.   
Qualitative measures of ineffective or inefficient bolus transfer including measures of 
postprandial, hypopharyngeal residue, were eligible if they had previously been validated as 
predictive of postprandial aspiration (Eisenhuber et al., 2002; Murray, Langmore, Ginsberg, & 
Dostie, 1996; Perlman, Booth, & Grayhack, 1994). 
Eligible airway compromise dependent variables were required to be dichotomous 
(aspiration present or absent), or continuous, using validated instruments.  For example, the 
Penetration Aspiration Scale scores airway compromise using an ordinal eight-point scale 
containing descriptors of anatomic depth of airway compromise and patient response to airway 
compromise  (Rosenbek, Robbins, Roecker, Coyle, & Wood, 1996a). 
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Data Types Acceptable for Inclusion 
Studies were required to have reported either continuous or dichotomous measures from their 
dependent variables, to be eligible for inclusion in both meta-analyses, though ultimately, studies 
eligible for the first meta-analysis overwhelmingly reported continuous data, and those eligible 
for for the second meta-analysis reported dichotomous data.   
5.4.2 Acceptable Treatment Methods 
The system used to rate the quality of published studies considered for inclusion, has been 
reviewed in section 5.3.2.1.  The overall minimum acceptable score for this meta-analysis was 
“III, B 2 b” (Baker & Tickle-Degnen, 2001).  Interventions that manipulated the dependent 
variables discussed in the previous section, were eligible for inclusion provided the studies in 
which they were reported met the criteria for evidence equality outlined in the next section, and 
had been previously shown to produce the hypothesized physiologic effects. 
5.4.2.1 Design and Sample Size  
A priori criteria for eligible investigation designs included randomized controlled trials, repeated 
measures designs with randomized treatment sequences, cohort two-group treatment designs 
with treatment versus control without random assignment, cohort non-randomized repeated 
measures designs with two conditions with non-selective assignment of patients to treatment, and 
cohort one-group pre-post treatment trials.  Retrospective designs were ineligible as were post-
hoc analyses of secondary outcomes data from investigations of other main hypotheses.  Thus, 
the minimum acceptable design rating score for inclusion into this meta-analysis using the Baker 
and Tickle-Degnen (2001) rating system was “III.” 
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Few of the retrieved citations representing the construct under investigation in this meta-
analysis, investigated groups of 20 subjects per treatment.  As a result, the acceptable minimum 
sample size was 10 or more patients per group, or 10 or more patients examined during both the 
experimental and control conditions in single group studies.  Thus, the minimum acceptable 
sample size rating score for inclusion into this meta-analysis using the same rating system was 
“B” (Baker & Tickle-Degnen, 2001).  
5.4.2.2 Validity  
Studies were required to possess sufficiently robust evidence of controls to maintain internal and 
external validity, as defined by Baker and Tickle-Degnen (2001) and summarized in the 
screening form displayed in Appendix D.   
Internal Validity 
Internal validity was required to be moderately high for inclusion in this meta-analysis.  
To be eligible for inclusion, studies were required to report or demonstrate 4 of the 5 following 
criteria:  a) effort to control for sources of bias and error caused by lack of randomization; b) 
evidence of blinding of judges to participant assignment and to other judges’ scores; c) masking 
of participants when appropriate; d) equal treatment outside of experimental and control 
conditions; and e) reasonably robust methods so as to eliminate alternative explanations for the 
outcomes.  Random assignment to treatment groups and/or random ordering of control and 
experimental treatments in investigations of two or more treatments were preferable for 
inclusion.  However, since the criteria for inclusion were developed a priori, and since there are 
few published randomized trials investigating the constructs of interest (Doggett et al., 2001), 
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studies demonstrating sufficient internal experimental controls as to eliminate bias caused by 
lack of masking or randomization were also considered eligible.   
External Validity 
External validity was required to be moderately high for inclusion in this meta-analysis.  
To be eligible for inclusion, studies were required to report or demonstrate a least 3 of the 
following 4 criteria:  a) both treatment and control groups must represent homogeneous, 
neurogenic, dysphagic populations that ordinarily receive the interventions of interest; b) all 
treatments investigated are within the scope of current clinical practice for dysphagic patients 
with biomechanical swallowing impairments as identified in current dysphagia treatment 
textbooks and/or practice guidelines published by agencies such as the American Speech 
Language and Hearing Association; c) studies exhibited no evidence of a possible alternate 
explanation for the observed outcome; d) studies exhibited no evidence of a potential conflict of 
interest. 
Therefore, using the rating system described by Baker and Tickle-Degnen (2001), the 
minimum acceptable internal and external validity rating scores for inclusion into this meta-
analysis were “2” and “b,” respectively. 
5.4.3 Methods 
5.4.3.1  Minimum Acceptable Criteria for Eligibility 
A priori methods of determining eligibility were employed across the 60 citations remaining 
eligible after first-pass screening. 
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Using the rating and coding method described earlier and, the minimum combined score 
for inclusion into the meta-analysis of investigations of treatments for dysphagia biomechanical 
impairments, was “III B 2 b”.  Therefore, minimum eligibility criteria included a non-
randomized, controlled trial of one group or one group pre- post trial with at least 10 participants 
per group or condition and demonstrated moderately high control to maintain internal and 
external validity.  A final set of six articles remained for this meta-analysis, and the results of the 
evidence quality evaluation are displayed in Error! Reference source not found..  
Table 1.  Quality Evaluation of Included Studies-Treatment of Biomechanical Impairments 
First Author, 
Rating 
Design Sample Size Internal 
Validity 
External 
Validity 
Studies of Individually Administered Interventions for Neurogenic Dysphagia 
 (continuous data) 
Shanahan, 1993 
III A 1 a 
Cohort pre-post 30 Neurogenic, liquid 
aspirators 
 
High High 
Logemann, 1995 
III B 2 b 
Cohort pre-post 19 Stroke with 
pharyngeal delay 
 
Moderate Moderate  
Rosenbek, 1996 
III A 2 b 
 
Cohort pre-post 22 Multiple Stroke, 
dysphagia  
Moderate Moderate  
Rosenbek, 1998 
III A 1 b 
Cohort, random 
assignment to four 
dosage groups 
43 Stroke with 
pharyngeal delay 
 
High Moderate 
Shaker, 2002 
III B 2 b 
Cohort, pre-post 18 Neurogenic 
dysphagia; tube fed 
 
Moderate Moderate 
Ludlow, 2007 
III B 1 b 
Cohort pre-post 10 tube fed; chronic 
neurogenic 
High Moderate 
 
The 6 studies included in the final meta-analysis investigated the effects of individual 
therapeutic interventions designed to manage oropharyngeal biomechanical impairments that are 
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expected to cause adverse health sequelae.  All 6 studies contained sufficient raw data or results 
to enable calculation of effect sizes. 
5.4.4 Data Extraction 
5.4.4.1 Description of Included Studies 
A priori criteria for inclusion in the meta-analyses were applied to the 60 remaining citations.  
Despite casting a broad net to capture studies of treatment of all forms of neurogenic dysphagia, 
the studies of adequate evidence quality were almost entirely limited to investigations of 
dysphagia after stroke.  As a result, the evidence quality evaluation rendered a final sample of six 
investigations of treatment investigating the efficacy of individually administered interventions 
for neurogenic dysphagia caused primarily by stroke (described in the first meta-analysis of this 
chapter), and three investigations of the effectiveness of institutional dysphagia protocols 
(described in the second meta-analysis of this chapter). 
The 6 studies included in this meta-analysis investigated treatment methods that were 
designed to eliminate aspiration, increase the flow of swallowed material into the esophagus, 
increase airway closure, or reduce the delay of the pharyngeal stage onset (Logemann et al., 
1995; Ludlow et al., 2007; Rosenbek et al., 1998; Rosenbek, Roecker, Wood, & Robbins, 1996b; 
Shaker et al., 2002; Shanahan, Logemann, Rademaker, Pauloski, & Kahrilas, 1993).  All the 
impairments observed as dependent variables in these investigations had been demonstrated in 
prior research to be predictors or direct causes of dysphagia-related pulmonary sequelae of 
aspiration or of nutritional disability (Eisenhuber et al., 2002; Langmore et al., 1998; Logemann, 
1998; Murray et al., 1996; Rosenbek, Robbins, Fishback, & Levine, 1991).  The characteristics 
of these 6 studies are summarized in Table 2 and described below. 
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Shanahan et al. (1993) investigated the immediate effect of flexion of the head and neck 
(chin down posture), compared to swallowing in the neutral head position, on changing 
protective position of the epiglottis over the laryngeal inlet, diameter of the unprotected laryngeal 
inlet, and on aspiration, in 30 patients with neurogenic dysphagia.  This study generated data 
regarding biomechanical variables of interest as well as dichotomous data regarding aspiration.  
Fifty percent of aspirating patients did not aspirate while employing the chin-down posture 
during the swallow.  These two data types (continuous vs. dichotomous) were incompatible for 
combination in the meta-analysis, but the inclusion of this information regarding aspiration must 
be considered as augmenting the true efficacy of this clinical method. 
Logemann et al. (1995) investigated the immediate effects of sensory stimulation, 
through the addition of sour flavoring to liquid barium during radiographic evaluation, 
comparing it to unflavored barium, on biomechanical swallowing impairments including 
duration of stage transition, and oral and pharyngeal transit durations in 27 patients with 
neurogenic dysphagia, including 19 patients with stroke.  The eight patients with non-stroke 
neurogenic dysphagia were analyzed using different dependent variables that have not been 
shown to directly influence aspiration or health sequelae.  For this reason these data were not 
included in the meta-analysis.  One of the variables reported by the authors in the data for the 
stroke patients was excluded from analysis (oral pharyngeal swallowing efficiency score) 
because it has not been validated. 
Rosenbek et al. (1996b) investigated the effects of a cold, tactile stimulus (thermal tactile 
application) to the anterior faucial pillars in 22 patients with dysphagic stroke.  Outcome 
measures of interest were changes in the duration of stage transition, also known as duration of 
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pharyngeal delay, and total swallow duration, between the stimulated and unstimulated 
swallows.   
Rosenbek et al. (1998) later conducted a larger study using thermal tactile application to 
the anterior faucial pillars in doses of 150 to 600 stimuli per day over two weeks, in 43 patients 
with dysphagic stroke.  Differences between dosage groups’ performance in duration of stage 
transition and in airway penetration and aspiration were reported.   
Shaker et al. (2002) investigated the effects of 6 weeks of an exercise program on upper 
esophageal sphincter (UES) opening duration and diameter in 18 feeding tube-dependent patients 
with chronic neurogenic dysphagia.  This study initially randomized 11 patients to experimental 
and 7 patients to “sham” (false) treatments, after which the investigators ceased random 
assignment of patients.  All 18 subjects underwent pre- and post-treatment biomechanical 
examinations with videofluoroscopy and the authors published complete data from this group of 
participants.  Raw data from patients randomized to the treatment group were published, but raw 
data from the sham treatment group were not published (only “non-significance” was reported 
for this group).  As a result, the data generated by the cohort of randomized subjects (i.e., the 
first 11 subjects), who underwent pre- and post-treatment testing, were converted to effect sizes 
and included in this meta-analysis, as it possessed the required levels of evidence quality 
described above.  Additionally, the result from the original randomized component of the trial 
that took place before randomization was corrupted, in which 11 treated patients were compared 
to seven control patients, was included.  This component found no significant differences 
between groups (p = .40).  This significance level was converted to an effect size and included in 
the meta-analysis along with the two other effect sizes computed from raw data.  Because of the 
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two types of comparisons included, the lower of the two (pre-post cohort) was used to classify 
the study. 
Ludlow et al. (2007) investigated the effects of neuromuscular electrical stimulation to 
the anterior neck on laryngeal and hyolaryngeal range of motion during swallowing, in 10 
patients with chronic neurogenic dysphagia by collecting baseline unstimulated swallows, 
treating the patients for two weeks (per the method’s proprietary protocol), and then repeating 
baseline testing.  Two levels of electrical stimulation were employed while the patients 
swallowed during videofluoroscopic swallowing studies.  All 10 patients underwent testing with 
one level of stimulation (sensory) but only eight underwent testing with the higher stimulation 
intensity (motor).  Several physiologic dependent variables were analyzed and reported by the 
authors, but most have not previously been shown to directly influence aspiration or health 
sequelae.  The only dependent variables qualifying for meta-analysis were airway penetration-
aspiration scores.  The reason that this study’s publication data appears outside of the prospective 
date range is that the study was made available electronically in December 2006; however its 
official publication date and print version appeared in January 2007. 
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Table 2.  Studies of Individually Administered Interventions for Neurogenic Dysphagia 
  *This study violated randomization after 18 (10 treatment, 8 control) patients; and it reported pre-post 
data for treatment patients only.  Statistical significance only, of the randomized trial, was reported.  Only these 
results for these 18 patients were included in the meta-analysis. 
 
First Author,  
Year 
 
Patients 
 
Treatment  
Method 
 
Comparison 
Method 
 
N: Patients,  
Controls 
 
Dependent variables
Shanahan, 1993 Neurogenic  
Dysphagia 
Chin down  
posture (head- 
neck flexion  
while  
swallowing) 
 
Neutral  
posture 
while  
swallowing 
30 pre/post Airway diameter,    
position of epiglottis  
over airway,             
aspiration 
Logemann, 1995 
 
Dysphagic    
Stroke 
Sour barium           
bolus 
Unflavored  
barium bolus
19 pre/post Duration of stage 
transition; oral and 
pharyngeal transit 
durations  
Rosenbek, 1996b Dysphagic    
Stroke 
Thermal tactile 
application 
No  
stimulation 
22  pre/post 
 
Duration of stage 
transition, total        
swallow duration 
 
Rosenbek, 1998 Dysphagic    
Stroke 
Thermal tactile  
application 
Varying  
dosages vs.  
baseline 
 
43  pre/post 
 
Duration of stage  
transition, airway 
penetration or       
aspiration scores 
 
Shaker, 2002 Tube fed  
Dysphagic 
 
Exercise of neck  
flexor group 
Sham  
exercise 
18 pre/post 
*11 Treatment, 
   7 control. 
UES opening          
duration and           
diameter 
 
Ludlow, 2007 Neurogenic  
Dysphagia 
Electrical 
Stimulation (two 
dosages: sensory,  
motor)   
No  
stimulation 
10 pre/post    
(sensory stim.) 
8 pre/post  
(motor stim.) 
 
Airway penetration    
or aspiration scores 
5.4.5 Statistical Procedures 
Researchers have traditionally reported the results of their studies in terms of statistical 
significance levels.  Significance levels express the results as products of formulae that combine 
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information about the size of the experimental effect with the size of the study (Rosenthal, 1994).  
Statistical significance is an essential marker used to indicate whether experimental observations 
are influenced by experimental manipulations (Straus et al., 2005).   
There are two disadvantages of relying solely on statistical significance to quantify 
treatment effect.  First, statistical significance can be influenced by the size of the sample.  The 
significance of a given experimental effect on a dependent variable may appear greater in 
experiments with very large samples than it appears in the same experiment with a smaller 
sample even without a corresponding difference in the magnitude of the effect between the large 
and small samples (Watala, 2007).   Second, statistical significance fails to reveal the magnitude 
of the experimental effect for an individual patient for whom it may be considered a therapeutic 
option (Sackett, Straus, Richardson, Rosenberg, & Haynes, 2000), because a test statistic is 
derived by combining information about the effect of the treatment with the size of the sample 
investigated.  As a result the magnitude of the treatment’s effect on the average patient in the 
sample cannot be surmised (Rosenthal, 1994). 
Modern published behavioral and biomedical research has begun to supplement statistical 
significance with additional information about the magnitude of the experimental effects on their 
dependent variables (Rosenthal & Rubin, 1982).  These estimates of magnitude, or effect sizes, 
express the magnitude of the effect of one variable on another on the average subject within the 
experiment (Cohen, 1988).  The various methods of measuring effect size described in the 
literature include estimation strategies for variables expressed as continuous, dichotomous, 
multiple choice, or ranked data.  These indices provide the research consumer an indication of 
the expected effects of a particular treatment method on specific outcomes in the average patient.  
Rosenthal (1994) discussed two families of parametric effect size measurements that are 
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interchangeable as well as calculable from a variety of published data and statistics:  the r family 
and the d family.  These have been increasingly common in modern published meta-analytic 
work. 
5.4.5.1 Effect Sizes: Individually Administered Interventions for Neurogenic Dysphagia 
The r family of effect size statistics expresses the effect size as a relationship between treatment 
and outcome and includes the familiar Pearson product moment correlation as well as the Fisher 
transformation of r, and various methods using the squared correlation coefficient r.  Rosenthal 
and Rosnow (1982) prefer the unsquared r because it is directional.  Unlike r2, r indicates 
whether the observed change caused by the experimental treatment is positive or negative.  The 
related d family includes Cohen’s d and Glass’s d which express effect size as proportions of 
group raw differences to a measure of variance within the groups. 
Cohen’s d and the effect size correlation r are closely related, and express essentially 
identical information about effect size.  Cohen (1988) has translated the scale of d scores into 
verbal ratings of effect size, with a d of 0.2 indicating a small effect size, 0.5 medium, and 0.8 
large.  Aaron et al. (1998) have published calculations for translating d to r for the purposes of 
equating Cohen’s ratings of effect size, in terms of the numbers of participants in each group 
(treatment, control).  Table 3 displays the qualitative labels small, medium, and large, per Cohen 
(1988) in the left column, the values for Cohen’s d in the center column, and the range of values 
of the effect size correlation coefficient, r, for five subjects per group (the third column) and 100 
subjects per group (the fourth column) (Aaron, Kromrey, & Ferron, 1998).   
For this meta-analysis, the effect size correlation r was selected as the index of summary 
effect size as it is a widely accepted index of summary effect size for combined studies in meta-
analysis. 
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Table 3.  Estimated r, from Cohen’s d (Aaron, et al., 1998). 
Size of effect Cohen’s d r 
(n=5) 
r 
(n=100) 
Small .2 .1000 .1111 
Medium .5 .2437 .2692 
Large .8 .3730 .4083 
5.4.5.2 Effect Size Calculations 
A fixed effects model was used to determine the individual effect size for each included study 
and the summary effect size for the group of included investigations.  
The 6 studies included in this meta-analysis reported results using continuous dependent 
variables, and generated a range of summary results including measures of central tendency, 
computed p values, and exact values of a statistic, enabling conversion of results into a common 
index of effect size: the effect size correlation coefficient (r).  Effect sizes (r) were computed for 
each study. 
Three studies reported the results of their experiment on the dependent variables using 
means and central tendency measures (Rosenbek et al., 1996b; Shaker et al., 2002; Shanahan et 
al., 1993).  For these three studies effect sizes were calculated using means and standard 
deviations.  Cohen’s d was calculated using Equation 1, displayed below, where M2 is the mean 
score for the experimental or treatment group, M1 is the mean score for the control group, and 
SDpooled (Equation 2)  is the pooled standard deviation from both group’s data (Hassleblad & 
McCrory, 1995; Rosenthal & Rosnow, 1991).  In studies that published standard errors, 
conversion to standard deviation was first performed using Equation 3 (Streiner, 1996).  The 
effect size d was  then converted to the effect size correlation coefficient r using Equation 4 
(Rosenthal & Rosnow, 1991).   
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Equation 1.  Cohen's d   
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d
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Equation 2.  Pooled Standard Deviation for Cohen's d   
2/)( 22 ctpooled SDSDSD +=  
    
Equation 3.  Conversion of Standard Error to Standard Deviation 
)( NSESD =  
 
Equation 4.  Effect Size Correlation Coefficient (r) derived from Cohen's d 
42
2
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dr     
Additionally, one variable reported in Shanahan et al. (1993), aspiration, was reported in 
terms of presence or absence both before and after intervention.  All 30 patients aspirated before 
treatment.  While using the intervention during swallowing, 15 of 30 patients aspirated, 
representing a 50% reduction in aspiration using the intervention.        
Two studies reported only p values (Logemann et al., 1995; Rosenbek et al., 1998).  The 
p values were converted to Z scores (one-tailed), using a Z score probability table (Rosenthal & 
Rosnow, 1991).  Effect size r (Pearson product-moment correlation coefficient) was then 
computed using Equation 5 (Rosenthal, 1994).   
Equation 5.  Effect Size Correlation Coefficient (r) derived from Z score  
N
Zr =     
One study reported its results in terms of the exact t statistic (Ludlow et al., 2007).  This 
result was converted to the effect size (r) by using Equation 6 (Rosenthal, 1994).  Each effect 
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size then underwent computation of standard error, 95% confidence intervals, Z scores, and 
statistical significance using Rosenthal’s methods (1994), and were plotted (see Figure 2).   
Equation 6.  Effect Size Correlation Coefficient (r) derived from an Exact T statistic 
edft
tr += 2
2
                                                                 
5.4.5.3 Combining Effect Sizes for Meta-Analysis 
In order to determine the overall effect size for included studies, correlations were first converted 
by using a Fisher’s z transformation of r table, which reflects the results of Fisher’s variance 
stabilizing z transform (Equation 7), where ln is the natural base logarithm (Shadish & Haddock, 
1994). 
Equation 7.  Fisher's z transformation of r 
)]}1()1{ln[(5. rrz −+=  
The product of this transformation, referred to as Fisher’s transformed r, or “Tr”, has 
advantages over the Pearson r that render it preferable for use in meta-analysis, including its 
more rapid convergence to normality than the Pearson r (Lipsey & Wilson, 2001).  After 
transforming each effect size r to Tr, the variance of each Tr ( vr ) was computed using Equation 
8, and the standard error for each transformed r was computed by taking the square root of the 
computed variance for each transformed r (Shadish & Haddock, 1994).   
Equation 8.  Variance of Fisher's r 
3
1
−= nvr  
Upper and lower limits of confidence intervals around each transformed r were then 
computed using Equation 9, where SEr = the standard error of Tr. 
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Equation 9.  95% Confidence Interval for Fisher's Transformed r (Tr) 
)(96.1..%95 rr SETIC ±=  
All mean Tr and the upper and lower limits of their confidence intervals were then 
transformed back to Pearson r using the Fisher’s z transformation of r table.  Z scores were then 
computed using Equation 10, and p values were obtained for each study using the Z probability 
table.  
Equation 10.  Computing Z Score from Effect Size Correlation Coefficient (r) 
)( nrZ =  
The mean effect size (r) with its 95% confidence interval, Z score and p value for the 
entire sample of studies was then calculated, and a forest plot was generated to display the results 
(Figure 2). 
5.4.5.4  Assessment of Homogeneity of the Sample 
Combining effects sizes of several studies to derive an estimate of the effects of their underlying 
common construct is valid when the combined studies can be shown to cause similar effects 
within the population of typical patients receiving the treatments.  Shadish and Haddock  (1994) 
developed statistical tests to detect the absence of homogeneity within a sample of studies, some 
of which were used to assess the homogeneity of the 6 qualifying studies.  The Q statistic, or null 
test of homogeneity among individual effect sizes, which follows the chi-square distribution, is a 
measure of significance across several means.  The null hypothesis of this test of homogeneity is 
that the studies are perfectly homogeneous.  Thus, a non-significant result of test, indicates that 
homogeneity of the sample is not rejected and the effect sizes of the studies in the sample are not 
significantly heterogeneous.  Additionally a non-significant result indicates that the effect sizes 
of the included studies represent the same population effect size (Hedges, 1994; Shadish & 
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Haddock, 1994).  The Q statistic is derived from the squared difference between the computed 
effect sizes from each treatment study in the meta-analysis and the overall computed effect size 
for the meta-analysis.  It is weighted by the inverse of the computed variance of the study’s 
treatment effect.  It is calculated using Equation 11, where wr = the inverse of the variance of the 
meta-analysis, and Tr is the Fisher’s transformed effect size correlation coefficient for the meta-
analysis.  Computed Q is then compared to the critical value of Q, defined as the chi-square 
statistic at p < 0.05 with k – 1 degrees of freedom, where k equals the number of included 
studies, and where df = k - 1.  If the computed Q does not exceed the critical value of Q, the 
result of the homogeneity test is non-significant, and the null hypothesis is accepted.   
Equation 11.  Q Statistic – Continuous Data 
r
rr
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5.4.6 Results 
5.4.6.1 Effect Sizes of Individually Administered Interventions for Neurogenic Dysphagia 
Individual effect sizes and confidence intervals for the 6 studies were computed.  Mean 
effect size for the construct “individually administered interventions for neurogenic dysphagia” 
was computed and the homogeneity of the sample was tested.  A forest plot was produced to 
display the results.  The effect sizes for all but two of the included citations (Ludlow et al., 2007; 
Rosenbek et al., 1998) reached statistical significance. 
 Table 4 displays the effect sizes (r) with their respective 95% confidence intervals, Z 
scores, and statistical significance, for each of the individual treatment studies of the effects of 
individually administered interventions for neurogenic dysphagia, along with a display of the 
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same parameters for the group of studies as a whole.  Figure 2 displays the forest plot of the 
effect size summary.  Effect sizes for the individual studies and the summary effect size (shown 
on the uppermost line of the figure) are represented by the square points, with their 95% 
confidence intervals represented by the diamond (lower limit of confidence interval) and triangle 
(upper end of confidence interval).  The dotted vertical line represents the overall effect size (r = 
.29) to provide context for the individual studies’ results. 
The overall or summary effect size for the construct “individually administered 
interventions for neurogenic dysphagia” was r = .29 (95% CI: .17 - .39), which represents a 
medium to large effect using Cohen’s (1988) descriptors of effect size, and after equating effect 
size correlation coefficients (r) and Cohen’s d (Aaron et al., 1998).  This result was statistically 
significant (Z = 1.87; p = .03).  Individual effect sizes ranged from a “small” low of r = .13 
(95% CI: -.33 - .55; Z = 0.56; p = .26) to a “large” high of r = .45 (95% CI: .18 - .66; Z = 2.98; p 
= <.01).   
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Table 4.  Effect Sizes: Individual Interventions for Neurogenic Dysphagia 
Author Effect size (r) 95% C. I. Z p 
Summary effect size .29 .17 - .39 1.87 .03  
Shanahan, et al., 1993 .25 .00 - .47 1.98 .03 
Logemann, et al., 1995 .43 .13 - .66 2.65 <.01 
Rosenbek, et al., 1996 .45 .18 - .66 2.98 <.01 
Rosenbek, et al., 1998 .14 -.07 - .35 1.30 .10 
Shaker, et al., 2002 .30 .01 - .72 1.74 .02 
Ludlow, et al., 2007 .13 -.33 - .55 0.56 .26 
 
 
p < .05 
Figure 2.  Summary Effect Size: Individual Interventions for Neurogenic Dysphagia 
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5.4.6.2 Homogeneity of the Sample 
The null test of homogeneity, known as Cochrane’s X2 statistic or Q statistic, was used to test the 
assumption that the variation among effects of the included studies was random (Shadish & 
Haddock, 1994).  This test determines the extent to which the studies included in the meta-
analysis actually share a common population effect size.  A significant result indicates 
unacceptable heterogeneity in the sample of studies included in the meta-analysis.  The resulting 
Q statistic for the meta-analysis was Q = 5.11, which did not exceed the critical value of Q of 
11.07 (X2, p = .05, df = 5).  This result indicates that the included studies were not significantly 
heterogeneous.  
5.4.6.3 Adapted Analysis of Summary Effect Size 
The effect sizes of two of the six studies of individually administered interventions for 
neurogenic dysphagia did not reach statistical significance.  One of these studies is the second 
study in a series of investigations which examine the effects of a widely used therapeutic 
intervention for delayed pharyngeal stage onset known as thermal tactile application (Rosenbek 
et al., 1998).  Its very small effect size was in contrast to the medium effect size of the authors’ 
earlier study of the same method, also included in this meta-analysis (Rosenbek et al., 1996b).  
Therefore, its inclusion in this meta-analysis was considered necessary and appropriate. 
However, the other investigation whose effect size did not reach statistical significance in 
this meta-analysis reported on the effects of electrical stimulation on swallowing physiology and 
biomechanics in neurogenic dysphagia patients (Ludlow et al., 2007).  The clinical methods 
employed are available only to clinicians who have enrolled in a proprietary training seminar and 
have purchased equipment from the manufacturer.  All other treatment methods included in this 
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meta-analysis are available to any qualified speech-language pathologist and exist within the 
public domain. 
Electrical stimulation for treatment of dysphagia is a controversial method that has 
received widespread attention in the media and is a subject of substantial debate within the 
professional literature.  It received FDA approval for use on the basis of a single clinical study 
(Freed, Freed, Chatburn, & Christian, 2001)  that has been widely criticized for substantial flaws 
in design, investigator bias, selective assignment of patients, unequal treatment of groups, 
unexplained attrition, and investigator conflicts of interest (Coyle, 2002; Humbert et al., 2006). 
The investigator consulted with a second expert judge, whose qualifications include 
seven peer reviewed experimental publications in the field of oropharyngeal dysphagia, to 
determine the appropriateness of conducting a second analysis of the effect size data excluding 
the Ludlow et al. (2007) article because the instrumentation and methods employed are 
proprietary and unavailable in the public domain, unlike the techniques reported in the other five 
studies.  After reaching a consensus, the meta-analytic calculations were repeated without the 
Ludlow et al. (2007) citation.  Results of the re-analysis appear in Table 5 and Figure 3, and 
show a very small, insignificant increase in overall effect size, and again, reached statistical 
significance (r = .31; 95% CI = .12 – .52; Z = 2.13, p = .02).  The null test of homogeneity was 
repeated and failed to reject homogeneity of the sample (actual value of Q = 5.81; critical Q = 
9.49, (X2, p = .05, df = 4). 
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Table 5.  Effect Sizes Excluding Ludlow (2007) Study 
Author Effect size (r) 95% C. I. Z p 
Summary effect size .31   .12 - .52 2.10 .02 
Shanahan, et al., 1993 .25   .00 - .47 1.98 .03 
Logemann, et al., 1995 .43   .13 - .66 2.65 <.01 
Rosenbek, et al., 1996 .45   .18 - .66 2.98 <.01 
Rosenbek, et al., 1998 .14  -.07 - .35 1.30 .10 
Shaker, et al., 2002 .30   .01 - .72 1.74 .02 
 
 
p < .05 
Figure 3.  Summary Effect Size Excluding Ludlow (2007) study 
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5.4.7 Conclusions from Effect Size Summary 
The meta-analysis of investigations of individually administered interventions for 
neurogenic dysphagia demonstrated a medium to large, significant effect, and that the selected 
investigations were significantly homogeneous.  This result indicates that individually 
administered interventions for neurogenic dysphagia exhibit high efficacy in controlled 
experimental settings. 
5.5 META-ANALYSIS OF ORGANIZED, INSTITUTIONAL DYSPHAGIA 
PROTOCOLS ON PUBLIC HEALTH OUTCOMES 
The search strategy employed in the meta-analysis yielded two complementary sets of 
studies.  The first set, analyzed in the first meta-analysis, included studies that investigated the 
effect of treatments on altering biomechanical properties of disordered swallowing.  The second 
set consisted of studies that evaluated institutional dysphagia protocols that combined screening, 
monitoring, and individual treatment of dysphagic patients in networks of health care facilities 
and institutional health care systems.  This second meta-analysis employed the same methods for 
searching and scoring retrieved articles as described in section 5.3.2.1.  All studies were 
categorized for the second meta-analysis using the previously described Baker and Tickle-
Degnen method (2001) which is summarized in the screening form (Appendix D).  Minimum 
inclusion criteria for this meta-analysis were also identical, however the majority of studies in 
this set were randomized controlled trials with larger samples than retrieved in the first meta-
analysis.  Acceptable dependent variables differed from the first meta-analysis as the outcomes 
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of interest of the studies in the second meta-analysis were global public health outcomes such as 
pneumonia and mortality.  Three studies were of sufficient quality to ultimately qualify for 
inclusion in the second meta-analysis. 
5.5.1 Evaluation of Citations: Evidence Quality for Inclusion 
To be eligible for inclusion in the second meta-analysis of organized, institutional dysphagia 
protocols on public health outcomes, each study was required to meet the following criteria 
related to acceptable treatments and acceptable outcomes.   
5.5.1.1 Acceptable Dependent Variables 
Accepted clinical end points, also the dependent variables, were a diagnosis of pneumonia or 
other clinical endpoints such as a diagnosis of malnutrition or mortality.   
For studies investigating the effects of organized, institutional dysphagia protocols on the 
aforementioned dependent variables, the diagnosis of these conditions was required to have been 
derived using objective, validated standards of care or guidelines such as those published by The 
American Academy of Chest Physicians or The Centers for Disease Control and Prevention 
(Tablan et al., 2007).  Patients enrolled in eligible investigations could not display symptoms 
associated with any of the outcomes of interest at the time of the onset of the disease that caused 
dysphagia.  That is, eligible studies had to demonstrate that they excluded patients if they 
presented at enrollment pre-existing history of dysphagia or symptoms of pneumonia, or were 
unequivocally malnourished.  Dependent variables were required to be either ordinal or interval 
continuous measures, or dichotomous outcomes. 
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5.5.2 Acceptable Treatment Methods 
5.5.2.1 Design and Sample Size 
Eligibility criteria for the second meta-analysis were identical to the first meta-analysis (please 
refer to section 5.4.2).  Since the scope of this group of studies centered on the effect of 
institutional protocols on global indices of public health such as pneumonia and mortality, 
patients in experimental groups were managed using experimental, systematic, institutional 
dysphagia management protocols, while patients in control groups were subject to routine, 
traditional management schemes already in place at participating institutions.  A minimum 
sample size of 10 subjects per group was required, though the majority of studies in this set of 
citations greatly exceeded that number.   
5.5.2.2 Validity 
Studies were required to possess sufficiently robust evidence of controls to maintain internal and 
external validity.  Identical criteria for internal and external validity were required for inclusion 
into this meta-analysis (please refer to sections 5.4.2.2). 
Internal and external validity were required to be moderately high.  Eligible adverse 
health sequelae of oropharyngeal dysphagia (e.g., pneumonia), were required to be 
operationalized prospectively according to standard criteria or diagnostic guidelines. 
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5.5.3 Methods 
5.5.3.1 Minimum Acceptable Criteria for Eligibility 
The minimum acceptable combined score for inclusion was “III B 2 b” for this meta-
analysis of the effectiveness of institutional dysphagia protocols on public health outcomes.  The 
summary of evidence quality evaluations appears in Table 6. 
Table 6.  Quality Evaluation of Included Studies-Organized Dysphagia Protocols 
First Author, 
Rating 
Design Sample Size Internal 
Validity 
External 
Validity 
DePippo, 1994 
I A 2 b 
RCT; 
treatment/control 
77 CVA with 
radiographic evidence of 
dysphagia 
Moderate  Moderate  
Dennis, 2005 
II A 2 a  
Cohort, two group, 
non-random 
assignment, treatment 
vs. control 
859 acute CVA; clinical 
diagnosis of dysphagia 
Moderate  High  
Hinchey, 2005 
II A 2 a 
Cohort, two group, 
non-random 
assignment, treatment 
vs. control 
2330 acute CVA; failed 
dysphagia screen 
Moderate High  
5.5.4 Data Extraction 
5.5.4.1 Description of Included Studies 
Three investigations qualified for this meta-analysis.  A summary of study details appears in 
Table 7 and details are discussed below.  All three studies investigated the morbidity or mortality 
associated with organized, institutional dysphagia management protocols in patients with acute 
stroke, versus unorganized, traditional, individual management.  Articles that were excluded 
from the meta-analysis, included those that a) failed to use objective outcome measures such as 
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mortality, pneumonia incidence, or other morbidity directly related to dysphagia, as their 
dependent variables, or used subjective outcomes such as quality of life or patient satisfaction; b) 
failed to analyze patients in the groups to which they had been randomized, or c) displayed 
unacceptable attrition of more than 10% of patients randomized to treatment or control groups or 
otherwise contained lost data that remained unaccounted for in the published article.  
DePippo, Holas, Mandel, and Lesser (1994) investigated the effect of modest and high 
intensity traditional treatment of post-stroke dysphagia, compared to a control group that 
received no formal therapy, on pneumonia, dehydration and mortality of patients, during 
institutionalization and at three, six, and 12 months follow up.  All patients were dysphagic, and 
received treatment for oropharyngeal dysphagia that included an oral diet supplemented by one 
or more traditional compensatory or rehabilitative maneuvers.  Patients were randomized to a 
control or minimal intensity group (single visit counseling session), or one of two treatment 
groups (i.e., moderate or high intensity) after videofluoroscopic examination revealed aspiration 
on at least 50% of all consistencies assessed.  The methods employed with the high intensity 
group (daily therapy and monitoring) and those employed with the control group (a single 
counseling session following diagnostic examination) were both judged to be sufficiently well-
defined and different from one another to enable comparison in the meta-analysis.  It was unclear 
how the moderate-intensity group treatment differed from the high-intensity group; therefore, 
only the data from the low intensity group (n = 39) and high intensity groups (n = 38) were 
entered into the meta-analysis. 
Dennis et al. (2005) reported the results of a phase of their F.O.O.D. (feed or oral diet) 
trial in patients with dysphagia following stroke.  This study investigated whether the addition of 
early enteral feeding to traditional, institutional management of dysphagia, reduced mortality 
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during a median 6.5 months (no enteral supplementation) to 6.8 months (early enteral 
supplementation) post-randomization follow-up period.  Participants in this study consisted of 
those whose severity of acute dysphagia and other stroke-related impairments were equivocally 
predictive of a need for enteral supplementation by the attending physician.  Patients were 
screened and otherwise managed by a multidisciplinary care team consisting of speech-language 
pathologists, dietitians, nurses, and physicians (FOOD Trial Collaboration, 2003), and for whom 
oral intake was initiated when considered sufficiently safe, using compensatory or other 
measures to facilitate safest oral feedidng.  Patients for whom the attending physician was certain 
as to the safety or danger of oral intake were excluded from this study.  Patients in this study (n = 
859) were randomly assigned to receive either early provision of supplemental nutrition via 
enteral (i.e., feeding tube) means, or to receive no supplemental enteral nutrition for at least 
seven days post-onset.  The dependent variable was mortality. 
Hinchey et al. (2005) compared the effectiveness of a formal dysphagia screening 
protocol that produced increased surveillance and formal dysphagia management to acute stroke 
patients hospitalized in institutions with formal dysphagia protocols, to patients admitted to 
facilities without institutional dysphagia protocols.  The dependent variable of interest was a 
diagnosis of pneumonia during the post-stroke onset acute-care hospitalization.  This study 
followed 2532 patients with a diagnosis of acute stroke, admitted to 15 institutions with either 
formal dysphagia screening and management protocols, or no formal protocol.  Their sample of 
completed and reported and analyzed data sets was slightly smaller at 2330 patients (7.9% 
attrition).  This sample constituted a large cross section of all patients admitted with stroke 
before dysphagia was formally identified.  Follow-up ranged from a median of four days for 
patients managed in a non-screening institution, to 14 days for patients that developed 
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pneumonia.  This multi-center investigation compared pneumonia rates in facilities without a 
formal institutional dysphagia protocols to those that used a formal institutional dysphagia 
protocols for all acute stroke admissions.  
Dependent variables in these three studies were dichotomous, categorical observations or 
endpoints including the presence or absence of mortality, and/or clear-cut adverse health 
outcomes such as pneumonia in treated and untreated patients.  Post hoc analyses of dependent 
variables that were not included in the stated hypothesis were not included in this meta-analysis.    
Table 7.  Included Studies of Organized Dysphagia Protocols 
First Author
  
Patients Treatment Comparison 
Method 
N: Patients/ 
Controls 
Outcome 
DePippo, 
1994 
Stroke Intensive 
Traditional 
therapy 
Low intensity 
therapy-
Single visit 
39 / 38 Mortality, 
dehydration, 
pneumonia 
Dennis, 2005 Stroke Enteral Feeding 
plus traditional 
management 
No enteral 
feeding plus 
traditional 
management 
430 / 429 Mortality 
Hinchey, 
2005 
Stroke Formal Screen 
and 
management 
protocol 
No formal 
screening-
routine care 
704 / 1626 Pneumonia 
5.5.5 Statistical Procedures 
The most widely published method for estimating risk of dichotomous outcomes, such as the 
presence or absence of mortality and morbidity associated with experimental pharmaceutical or 
surgical exposure, is the odds ratio.  The odds ratio is also the appropriate index of effect size to 
employ in investigations reporting the effects of treatment methods in either eliminating 
mortality or specific adverse outcomes (Fleiss, 1994).  Other mathematical indices of predicted 
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comparative risk of outcomes from treated and control groups include the rate ratio, risk 
reduction, and numbers needed to treat (Haynes, Sackett, Guyatt, & Tugwell, 2006).   
Though it would have been preferable to combine effect sizes from both meta-analyses, 
the effect size indices used in the first meta-analysis are not directly comparable with those in 
this meta-analysis which included studies publishing only dichotomous data.  Although a method 
has been developed to calculate an effect size for odds ratios (Chinn, 2000), its relationship to 
established effect size indices has not been clarified despite efforts to contact the author for 
explanation.   
For this meta-analysis, the investigator calculated odds ratios from the reported 
frequencies of the various dichotomous outcomes for the experimental and control treatments in 
each study to determine the odds ratios of their respective end points. 
5.5.5.1 Odds Ratios for Organized Dysphagia Protocols 
Odds ratios summarize the proportion or odds ratio of the adverse outcome of interest between 
the treated and untreated groups of patients.  This figure has become a standard measure of effect 
size in studies reporting categorical data (Rosenthal & Rosnow, 1991).  The odds ratio is the 
proportion of the incidence of outcome in the treated group compared to the incidence of 
outcome in the control group.  Odds ratio outcomes are expressed in terms of increased or 
decreased likelihood of an adverse event such as mortality or morbidity (Straus et al., 2005).  An 
odds ratio of less than one indicates that patients receiving the experimental treatment are less 
likely to experience the adverse outcome of interest than those treated with the control treatment.  
An odds ratio of 0.60 is equivalent to a 40% reduced likelihood of experiencing the adverse 
event, indicating that the treatment is protective from the adverse events supposedly mitigated by 
the treatment. 
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Odds ratios of individual studies were computed from the published data using a fourfold 
table containing raw data indicating the incidence of the outcomes of interest (mortality, 
pneumonia, malnutrition outcomes) in patients exposed to the experimental and control treatment 
methods.  The odds ratios were computed with Equation 12, where OR = odds ratio, A = 
experimental patients with adverse outcome of interest, B = experimental patients without 
adverse outcome of interest, C = control patients with adverse outcome of interest, and D = 
control patients without adverse outcome of interest (Haynes et al., 2006). 
Equation 12.  Odds Ratio 
BC
ADOR =  
The natural logarithm of the raw odds ratios (lnOR) were then used to calculate 
confidence intervals around the odds ratios because unlike OR, lnOR takes on a value of zero 
when no relationship is present between the two factors, providing a similar interpretation as a 
zero effect size (r or d) (Shadish & Haddock, 1994).  Log odds ratios and log odds ratio 
confidence intervals were then antilogged, and the results plotted on a forest plot to display the 
results. 
5.5.5.2 Combining Odds Ratios 
To determine the effect size of the studies included in this meta-analysis, odds ratios were 
combined using the Mantel Haenszel estimate of the odds ratio, displayed in Equation 13, where 
A, B, C, and D are identical to the variables contained in Equation 12, and T = the total number 
of subjects in the sample.  This method is valid for combining few studies with large samples or 
many studies with small samples (Shadish & Haddock, 1994). 
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Equation 13.  Mantel Haenszel Combined Odds Ratio 
∑
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The confidence interval for the combined Mantel Haenszel estimate of the odds ratio 
(ORMH) was computed by first estimating the variance of the log ORMH using cell frequencies 
(Equation 14), where P = A + D, Q = B + C, R = AD / T, and S = BC / T  (Shadish & Haddock, 
1994). 
Equation 14.  Variance for Mantel Haenszel Combined Odds Ratio 
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Significance of the Mantel Haenszel combined odds ratio was evaluated with a Mantel 
Haenszel chi square statistic (Equation 15), using df = 1, where O (observed frequency of 
outcome in experimental groups) = A; E (number expected to have been observed with outcome 
in experimental group) = [(A + C)/T](A + B); and V = E[T – (A + C)/T][T – (A + B))/(T – 1)] 
(Shadish & Haddock, 1994). 
Equation 15.  Mantel Haenszel Chi Square 
[ ]
∑
∑ −−=
V
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X MH
2
2 5.0|)(|  
The combined odds ratio confidence interval was computed using the calculated variance 
among the included studies, along with the individual confidence intervals using the actual 
published proportions of patients achieving a specific outcome in each study. 
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5.5.5.3 Homogeneity of the Sample 
The null test of homogeneity for the Mantel Haenszel combined odds ratio (the Q statistic ) was 
performed on the sample of studies included in the meta-analysis, where, wi = a weighting factor, 
the inverse of the variance for each included study, θi is the common odds ratio for the each 
individual included study, and θ MH is the Mantel Haenszel odds ratio for the entire sample 
(Equation 16) (Strawderman et al., 1998). 
Equation 16.  Q Statistic for Mantel Haenszel Odds Ratio 
2)( MHiiwQ θθ −= ∑  
5.5.5.4 Clinical Significance of the Result 
Finally, to determine the clinical importance of the individual studies, absolute risk reduction and 
number needed to treat were calculated.  Absolute risk reduction (ARR) describes the difference 
in the proportions of patients in treated and control groups that achieve the outcome of interest.  
Number needed to treat (NNT) expresses the approximate number of patients that would need to 
be treated with the experimental method reported in a study to prevent one adverse outcome 
(Haynes et al., 2006; Straus et al., 2005).  Absolute risk reduction (ARR) and numbers needed to 
treat (NNT) were computed for each study and for the combined studies, by entering cell 
frequencies in Equation 17 and Equation 18, where CER = C / (C + D) or the proportion of 
patients in the control group diagnosed with the adverse outcome of interest, and EER = A / (A + 
B) or the proportion of patients in the experimental group diagnosed with the adverse outcome of 
interest.   
Equation 17.  Absolute Risk Reduction 
EERCERARR −=  
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Equation 18.  Number Needed to Treat 
ARRNNT /1=  
5.5.6 Results 
5.5.6.1 Odds Ratios for Individual Included Studies 
Results of computation of odds ratios for the included studies appear in Table 8 .   
Odds ratios for the three included studies were .44 (Hinchey et al., 2005), .78 (DePippo, 
Holas, Reding, Mandel, & Lesser, 1994), and .79 (Dennis, Lewis, & Warlow, 2005), indicating a 
21% to 56% reduction in likelihood of adverse outcomes for patients in these studies.  DePippo 
et al. (1994) exhibited a 95% confidence interval that extended beyond an odds ratio of 1.0, 
indicating poor generalizability of the study, though it is also likely that the small sample 
contributed substantially to the width of the interval. 
5.5.6.2 Combined Odds Ratio for Included Studies 
In combination, these three studies showed a small overall advantage in preventing outcomes 
(i.e., mortality and pneumonia) when organized dysphagia protocols were used (ORMH = 0.60; 95 
% CI = 0.53 – 1.07).  Significance of the combined odds ratio was tested with the Mantel 
Haenszel chi square statistic (Shadish & Haddock, 1994), and was found to be non-significant 
(X2MH = 3.06, df = 1; p = 0.08).  Table 8 summarizes the computed odds ratios for these three 
studies of organized dysphagia protocols on public health outcomes, and Figure 4 displays the 
forest plot summary of odds ratios.   
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Table 8.  Effect Size Summary: Organized Dysphagia Protocols 
Author Odds Ratio 95% Confidence Interval 
Summary Effect Size    .60*           .53 – 1.08 
DePippo et al., (1994)    .78           .25 – 2.41 
Dennis et al., (2005)    .79           .68–    .93 
Hinchey et al. (2005)    .44           .36 –   .53 
                                                                       * p = .08 
 
“Treatment” is Protective ?   ? “Control” is Protective 
Figure 4.  Summary Effect Size: Organized Dysphagia Protocols 
As in the effect size forest plot, the calculated odds ratios are represented by the square 
points on in each row of Figure 4, with the 95% confidence interval represented by the diamonds 
(lower limit) and triangle (upper limit).  Odds ratios below one indicate the percentage reduction 
in odds of acquiring the adverse outcome of interest compared to the control treatment. 
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5.5.6.3 Homogeneity of the Sample 
The null test of homogeneity failed to reject the homogeneity of the sample, generating a Q 
statistic of 2.39, which is below the critical value of X2 at k-1 degrees of freedom of 5.99 (p < 
.05).  This result indicates that the sample was not significantly heterogeneous. 
5.5.6.4 Numbers Needed to Treat 
Since NNT expresses numbers of patients, the actual computed value must be rounded up to the 
nearest whole number.  These results are displayed in Table 9.  These results suggest that for 
every 18 to 35 stroke patients treated with organized dysphagia protocols, one stroke patient 
would be expected to experience mitigated mortality or adverse health outcome. 
Table 9.  Risk Reduction and Numbers Needed to Treat 
First Author ARR NNT 
DePippo 2.97% 34 
Dennis 5.72% 18 
Hinchey 2.94% 35 
  
5.5.7 Conclusions from Odds Ratio Summary 
A small, non-significant benefit in mortality and public health outcomes appears to be caused by 
formal dysphagia protocols in institutional settings for patients with stroke, the most common 
cause of oropharyngeal dysphagia.  However a trend toward statistical significance was present 
(p = .08).  The small sample size in one study (DePippo et al., 1994), in comparison to the two 
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larger studies, may explain the width of its confidence interval and subsequently non-significant 
effect size, and suggests the need for replication on a larger scale. 
5.6 DISCUSSION 
The purpose of this study was to meta-analytically test two hypotheses that were complementary 
to one another in addressing the questions, “Are individually administered interventions for 
neurogenic oropharyngeal dysphagia efficacious in eliminating biomechanical swallowing 
impairments?”, and “Are institutional dysphagia protocols effective at reducing the global health 
consequences of oropharyngeal dysphagia?”  The first hypothesis, that individually administered 
treatment of dysphagia would be found to significantly improve biomechanical functions in 
patients with neurogenic dysphagia, was supported.  Under controlled experimental conditions, a 
significant physiological benefit is produced by the individually administered interventions for 
neurogenic dysphagia, though the small number of studies meeting eligibility criteria widens the 
interval of overall confidence in these results.  However, the second hypothesis, that institutional 
dysphagia protocols would be found to produce statistically significant reductions in dysphagia-
related morbidity and mortality, was not supported.  The second meta-analysis contained only 
three studies, two of which reached significance.  But combined, the three studies did not exhibit 
an effect size that reached the preselected level of statistical significance.  Whether statistical 
significance is necessary to generate a clinically significant difference in public health outcomes 
or expenditures remains to be evaluated. 
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5.6.1 Individually Administered Interventions for Neurogenic Dysphagia 
The results of the first meta-analysis of individually administered interventions for neurogenic 
dysphagia, supported the hypothesis that treatments designed to compensate for, or restore, 
biomechanical oropharyngeal impairments caused by stroke and neurogenic etiologies, produce 
clinically significant, beneficial changes in swallow biomechanics and airway protection.  The 
overall effect size for the construct represented by the set of studies in the first meta-analysis was 
medium to large, and was statistically significant.  This result suggests that overall, such methods 
do what they purport to do in remediating targeted swallowing abnormalities, increasing the 
performance of the average neurogenic biomechanical impairment by approximately one-third of 
one standard deviation from pre-treatment biomechanical performance.  The outcome of such 
interventions, then, reduces the likelihood of aberrant penetration of the upper airway while 
swallowing, and increases the volume of swallowed material delivered to the digestive system 
with each single swallow, thereby reducing potential adverse pulmonary and nutritional 
sequelae.   
In the first meta-analysis of individually administered dysphagia interventions, the study 
by Logemann, et al. and the study by Rosenbek, et al. (1996b) generated robust effect sizes, 
indicating greater potential for the desired biomechanical outcomes.  The two Rosenbek et al. 
(1996b, 1998) studies of thermal-tactile stimulation generated divergent effect sizes and 
confidence intervals, one of which included values below zero, despite using the same clinical 
method of therapy.  As discussed above, such a finding indicates that the true results may differ 
from those observed in the reported research findings.  However the earlier of these two studies 
investigated biomechanical change caused by the treatment rather than to differentiate efficacy 
among varying levels of dosage as in the later study.  This finding may suggest that the true 
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efficacy of this particular method lies somewhere between the two computed effect sizes, and 
that thermal-tactile stimulation as a method, produces a moderate immediate effect, while large 
doses of the same treatment produce no difference in swallow biomechanics, than those 
produced by small doses.  The potential long-term role of this method in producing plasticity of 
the sensorimotor substrates of swallowing physiology, a subject of increased research 
demonstrating the facilitative effects of stimulation of the sensory projections to the swallowing 
cortex on human swallow function, deserves further investigation (Gow, Rothwell, Hobson, 
Thompson, & Hamdy, 2004) 
Another study in this meta-analysis investigated a compensatory posture that places the 
inlet to the airway in a protected position (Shanahan et al., 1993).  This study evaluated two 
types of outcomes: biomechanical and bolus flow measures using continuous data, and the 
presence or absence of aspiration with and without the use of the behavioral maneuver while 
patients swallowed.  As discussed earlier, continuous and dichotomous data are incompatible for 
inclusion into a single statistical meta-analytic model.  However the effect size of this 
intervention of r = .25, a small to medium effect, must be combined with the intervention’s 
resultant reduction of aspiration by 50% in treated patients, when considering the overall value 
of the method.  By considering both the effect size and reduced odds of aspiration, the predicted 
effects of this method of compensatory swallowing are greater than the calculated effect size 
alone.  Since compensation is limited in its effects only by the patient’s failure to perform the 
maneuver while swallowing, these effects will afford additional protective benefit during early 
recovery from neurogenic dysphagia, while rehabilitation and recovery ensue.  Since 
compensation is employed while swallowing, and swallowing occurs many hundreds of times 
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per day, the repeated use of compensatory maneuvers over the long-term, in producing plasticity 
of the target mechanism, may warrant future research.  
Four of the studies in the first meta-analysis investigated the immediate or short-term 
effects of sensorimotor interventions designed to alter oropharyngeal biomechanics while 
swallowing, either during or after application of sensory stimuli (Logemann et al., 1995; Ludlow 
et al., 2007; Rosenbek et al., 1998; Rosenbek et al., 1996b).  All of these methods were designed 
to quicken the onset of pharyngeal activity and closure of the airway in relation to arrival of a 
swallowed bolus at the inlet to the upper airway.  They were not designed to evaluate the lasting, 
restorative effects of these interventions.  The latter of these interventions (electrical stimulation) 
was found to produce a negligible effect on swallow biomechanics and aspiration and its 
confidence interval included values below zero, indicating that the method may not produce the 
intended outcome; it may just as likely produce the opposite effect.  It is also possible that its 
small sample size was partly responsible for the wide confidence interval.  Further investigation 
of this controversial method is encouraged. 
Several of the studies in this meta-analysis required either patient or caregiver behavior to 
perform the intervention.  The chin-down posture (Shanahan et al., 1993) and exercise (Shaker et 
al., 2002) interventions require patient behavior, while thermal stimulation (Rosenbek et al., 
1998; Rosenbek et al., 1996b), sour bolus (Logemann et al., 1995), and electrical stimulation 
(Ludlow et al., 2007) require patient and/or caregiver behavior for implementation.  
Additionally, all but one of these treatments (exercise) are effective only when performed 
immediately before (thermal stimulation) or while (electrical stimulation, sour bolus) 
swallowing.  The nature of such compensatory interventions that require patient or caregiver 
behavioral participation should be considered of varying value in patients with neurogenic 
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diseases because of altering the ability to actively participate in such behaviors.  Fortunately 
some of these methods (head posturing, flavor enhancement, sensory stimulation) can be 
implemented by manipulating the patient’s environment until he is capable of volitional 
performance.  In either event, their use may be beneficial at preventing adverse sequelae of 
dysphagia in the earlier stages of recovery from stroke and related conditions, when participation 
may be more difficult, and may be considered important while patients exhibit more severe 
impairments after stroke.   
The sixth of the studies in this meta-analysis was the only sufficiently well designed 
investigation evaluating a rehabilitative method designed to augment swallow biomechanics over 
time with exercise (Shaker et al., 2002).  A small improvement in swallow physiology was seen 
which translates to a reduction in post-swallow hypopharyngeal residue that has been shown to 
increase the potential for postprandial aspiration (Eisenhuber et al., 2002).  Efforts to 
demonstrate a more robust benefit from this type of intervention, as well as to develop additional 
rehabilitative interventions with which to combine the results of this study, are highly 
encouraged and have been emerging in the literature (Kays & Robbins, 2006; Robbins et al., 
2007). 
All of the included studies investigated methods that caused either immediate change in 
swallow function, or physiologic change caused by prolonged recruitment of musculature in an 
exercise regimen.  Much interest and research into the potential for behavioral motor therapy 
(Kays & Robbins, 2006; Sapienza & Wheeler, 2006) and sensory stimulation (Gow et al., 2004) 
to generate plasticity of the central and peripheral mechanism subserving respirodeglutitive 
functions, has been emerging in the literature. The studies of individual therapeutic interventions 
that were included in these meta-analyses are potentially important steps toward elucidating the 
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effects of long-term implementation of treatment techniques in producing long-term change in 
the function of the swallowing mechanism. 
The studied interventions individually, except Ludlow et al. (2007), and collectively 
produced clinically and statistically significant, beneficial biomechanical changes in swallow 
physiology.  Since patients with neurogenic dysphagia suffer largely from multiple 
biomechanical impairments, it is worthwhile to consider that combinations of appropriately 
implemented therapeutic modalities that are currently employed in every-day clinical practice, 
may generate a beneficial change in these combinations of biomechanical impairments along 
with a possible expectation that they may produce additive effects.  However the cognitive 
demands of combined behavioral interventions will need to be considered in patients with 
neurogenic dysphagia affecting higher level cognitive functions.   
The six investigations generating these results constitute a cross section of traditional 
therapeutic methods available to and in widespread use by speech-language pathologists 
managing swallowing disorders in patients with stroke and neurogenic dysphagia.  But they 
followed patients to short-term clinical end points only.  Since the impairments themselves cause 
the abnormal flow of swallowed material into the upper airway or away from the digestive 
system, and since these biomechanical impairments (aspiration, laryngeal penetration, impaired 
UES opening) predispose to important clinical end points such as pneumonia (Eisenhuber et al., 
2002; Langmore et al., 1998; Langmore, Skarupski, Park, & Fries, 2002), this meta-analysis 
appears to justify the use of properly selected combinations of these treatment modalities to 
reduce risk of adverse, long-term clinical end points such as pneumonia, malnutrition, 
dehydration and mortality associated with neurogenic dysphagia.  Future investigations should 
be encouraged to follow both the efficacy of individual treatment methods at remediating 
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biomechanical impairments, together with the effectiveness of treating patients to these 
important clinical end points, within the same investigations, to generate more robust evidence 
for clinical practitioners, future meta-analyses and guidelines. 
The effect of individually administered interventions for neurogenic dysphagia 
in lowering the degree of impairment in the oropharyngeal swallowing mechanism is expected 
by the clinician to mitigate risks of sequelae of dysphagia such as pneumonia and malnutrition.  
These small scale studies demonstrate the efficacy of the investigated methods but provide little 
evidence regarding their effectiveness in lowering morbidity rates because follow up in each of 
them (and among the majority of studies in this field) was insufficiently long and complete to 
determine their effects on these health outcomes.  For this reason, the second meta-analysis is 
important it connecting impairment-level therapy to interventions designed to improve global 
health outcomes. 
5.6.2 Institutional Dysphagia Protocols on Health Outcomes 
The second meta-analysis investigated the effects of institutional dysphagia protocols on long-
term adverse health outcomes and mortality.  Its results did not support the hypothesis that 
formal protocols designed to institutionalize management of dysphagia through standardized 
surveillance by staff, and timely, aggressive interventions of the types discussed in the first meta-
analysis, produce decreased morbidity and mortality associated with dysphagia after stroke.  
However, too few studies of this type exist, and one of the included studies’ odds ratio exhibited 
a confidence interval that included values greater than 1, indicating that its results may not reflect 
the actual outcome that may be seen in clinical practice.  These overall results are promising, 
though the research consumer and public health system will need far more such evidence to 
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justify systematic changes in institutional dysphagia care.  Further research is needed in this 
important area of long-term outcome. 
One of the studies in this second meta-analysis (Dennis et al., 2005) compared two 
institutional protocols for dysphagic stroke patients that differed only by the timing of and use of 
supplemental enteral nutrition.  This study added early enteral (feeding tube) nutrition to 
traditional interventions by the institutional care team that consisted of speech language 
pathologists, nurses, dietitians and physicians, in one of the treatment groups, while the second 
group received traditional management alone.  This preemptive use of enteral feeding tubes was 
shown to produce a small reduction in risk of mortality though the authors stated that the odds of 
adverse outcomes such as quality of life, and other adverse outcomes, offset these benefits.  
Early enteral feeding may, in some cases, be a controversial preemptive tactic in stroke given the 
rapid recovery of neurological function often observed in the initial days following onset of 
stroke, multiple sclerosis, and some other neurological conditions.  In particular, in light of the 
increased risk of pneumonia imposed by the use of feeding tubes (Marik, 2001; Langmore, et al., 
1998), this study may in fact demonstrate no net gain by the addition of early enteral feeding to 
traditional institutional dysphagia management.   
The quality of life and other subjective measures from this study were not included in the 
meta-analytic calculations because they were not sufficiently clearly operationalized and were 
not entirely objective and replicable.  However the World Health Organization recognizes 
quality of life as a legitimate clinical end point justifying therapeutic interventions in its 
International Classification of Functioning, Disability and Health (World Health Organization, 
2001).  An increase in survival in patients with neurogenic dysphagia may indeed be offset by 
the use of preemptive enteral supplementation, though quality of life may be adversely affected 
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by enteral tube usage.  The relationship between enteral supplemental feeding and patient 
satisfaction warrants further investigation using methods reported in Dennis et al. (2005), but 
they should also include the use of valid, reliable and replicable instruments that evaluate quality 
of life  associated with oropharyngeal dysphagia such as the Swal-QOL (McHorney et al., 2002).  
Meanwhile, it cannot be ignored that quality of life, one of the adverse outcomes cited as 
increasing in the early enteral feeding group in this study, is a legitimate therapeutic target.  It 
would be useful to design an investigation comparing the methods used in this study’s “early 
enteral supplementation” group to aggressive, rather than routine, institutional dysphagia 
management as seen in the second meta-analysis (DePippo et al., 1994), to the same clinical end 
points of mortality, pneumonia, and quality of life. 
Future investigations might consider a larger scale replication of DePippo et al. (1994), 
which specifically examined the effects of the types of behavioral, physiologic interventions for 
swallowing impairments assessed in the first meta-analysis on outcomes such as pneumonia, 
nutritional failure and mortality, while selecting the targeted treatments based on biomechanical 
analysis rather than clinician preference.  Addition of early enteral feeding to mitigate onset of 
malnutrition, the incidence of which is high during the initial weeks after onset of stroke, with 
aggressive therapy and surveillance, may indeed be found to ensure optimal short-term recovery 
and long-term health in stroke survivors, but this requires much more study.  Future investigation 
of this type of question warrants thoughtful development. 
Efforts to investigate more global and pragmatic methods to mitigate dysphagia sequelae 
in routine practice and settings appear to be emerging.  This is the motivation behind the 
performance of the second meta-analysis.  It is representative of research trends within 
institutions and health care systems, and of the priorities of public health funding sources. 
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Hinchey et al. (2005) and DePippo et al. (1994) in particular, identified modest benefits from 
direct dysphagia protocols which combined rehabilitative and compensatory therapeutic methods 
of the types reported in the first meta-analysis, with risk factor management, patient surveillance, 
staff and patient education and/or training, active management of oral hygiene and diet, and 
follow up.  One of these studies in particular showed a considerable improvement in morbidity 
and mortality when the institutional protocol was standardized (Hinchey et al., 2005), while the 
other (DePippo et al., 1994) showed a moderate effect for aggressive dysphagia management, 
though their sample was too small to generalize to populations.  This model of combining 
treatment for swallowing disorders with risk factor management may offer the best blend of 
efforts to reduce dysphagia-related morbidity and mortality and deserves further attention in 
larger studies. 
Both types of interventions investigated in these meta-analyses, individually administered 
treatments and institutional management protocols, are successful at addressing their stated goals 
of remediating oropharyngeal impairments through behavioral interventions, and reducing 
morbidity and mortality through institutional protocols that employ behavioral interventions 
along with additional standardized methods.  However the studies in each of the meta-analyses 
reported in this chapter lacks the strengths of the other.  Individually administered interventions 
for neurogenic dysphagia produce little value to the patient or the health care system, unless a 
predictable benefit is seen in terms of reduced hospitalizations and longer life expectancies.  
Likewise, institutional protocols that fail to provide sufficiently aggressive remediation of 
oropharyngeal biomechanical impairments may produce less positive effects on reduced 
morbidity and mortality associated with dysphagia. 
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Both meta-analyses were rigorously conducted to prevent inclusion of studies without 
high evidence quality.  A recently published meta-analyses investigating published evidence 
regarding electrical stimulation for neurogenic dysphagia (Carnaby-Mann & Crary, 2007), 
exhibited substantially less rigor than the present meta-analysis, accepting and including studies 
that did not meet eligibility criteria for the present meta-analyses reported in this chapter.  It 
failed to exclude studies whose controls for sources of bias such as blinding of judges and  
conflict of interest, measurement error, and other aspects of internal and external validity were of 
significantly lesser quality that in the meta-analyses.  Meta-analysts must maintain diligence and 
integrity in the rigor of their evidence quality appraisal, to produce meaningful research 
synthesis.  The absence of sufficient numbers of high quality research does not justify meta-
analytic inference regarding the effects of treatments that were investigated in poorly designed, 
biased, or otherwise compromised research. 
Strengths of the present meta-analyses include adherence to rigorous and strictly defined 
inclusion criteria, extensiveness of the search strategy, consultation with a librarian expert in 
constructing the search, and inclusion of both electronic and hand searches.  Weaknesses include 
the use of a single meta-analyst, and the relative lack of sufficient numbers of high quality 
literature on the subjects under investigation.  Significantly more, high quality evidence is 
needed to enable health care systems and governmental agencies to formulate guidelines 
regarding interventions for oropharyngeal dysphagia.  These meta-analyses have highlighted the 
weaknesses in the current body of literature and, hopefully, will provide a road map for the 
design and evidence quality of future clinical investigation. 
The small number of sufficiently good quality published investigations of the constructs 
evaluated in these meta-analyses points directly to the types of changes necessary in current and 
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future research into the effects of dysphagia interventions.  Unlike pharmaceutical trials in which 
a single variable, taking one pill or another, is manipulated, large, randomized controlled trials 
investigating dysphagia interventions are difficult to design and successfully complete.  Such 
studies are complicated by gradients of human compliance, involvement of numerous health care 
providers in each patient’s care, social and ethical dilemmas inherent in age-related disease 
management, and the shortening length-of-stay of patients in modern health care facilities in the 
United States.   
With increasing demand for this type of information, rigorous studies are beginning to 
emerge.  Large studies of the type recently concluded by the Communication Sciences and 
Disorders Clinical Trials Research Group (CSDRG), whose publication of results is imminent at 
the time of this dissertation, which investigated short- and long term effects of dysphagia therapy 
on aspiration while swallowing, and on morbidity and mortality over a three month follow up, 
deserve attention by potential investigators and research funding sources.  The results of this 10 
year randomized controlled treatment study, in which the author of this dissertation participated 
as a regional principal investigator and member of the central laboratory as a judge for 
videofluoroscopic data, were presented by the investigators at the American Speech Language 
and Hearing Association convention in 2006 and have been emerging in the literature 
(Logemann et al., 2006; Logemann et al., 2001; Logemann & Robbins, 2007).  This study 
examined the effects of postural and textural modifications on aspiration of fluids in groups of 
patients with neurogenic dysphagia caused by Parkinson’s disease or dementia.  Its long-term 
follow up component followed patients to clinical end points of pneumonia and mortality while 
monitoring secondary variables of hydration and nutrition during a 3-month post-randomization 
follow up period.  This study could not be included in this meta-analysis because it had not 
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cleared peer review at the time of this meta-analysis; however, it is very likely that findings will 
be suitable for inclusion into future updates of this research synthesis.   
There is little speculation regarding the link between aspiration of swallowed material 
and pneumonia pathogenesis (Marik, 2001), or between impaired oral intake and malnutrition.  
As elucidated in this meta-analysis, studies have investigated short-term results of treatment of 
swallowing impairments, and others have investigated the outcome of dysphagia protocols on 
health outcomes.  To date, no published studies have directly investigated the long-term 
outcomes associated with individually administered interventions for neurogenic dysphagia on 
adverse health sequelae.  As a result, the more important question concerning the likelihood of 
disease reduction afforded by specific interventions remains unanswered.  These meta-analyses 
begin to address this important question using available research of sufficiently robust quality 
and rigor. 
5.6.3 Conclusion 
Meta-analyses identified small to large and significant therapeutic effects of individually 
administered interventions for neurogenic dysphagia in mitigating biomechanical swallowing 
impairments in patients with neurogenic dysphagia, and a small, non-significant effect for 
institutional dysphagia protocols designed to identify and manage dysphagia through institutional 
protocols.  The studies in the each meta-analysis were not designed to investigate the 
complementary outcomes studied in its counterpart meta-analysis.  That is, the link between 
remediation of biomechanical impairments and mitigation of adverse health consequences of 
dysphagia was addressed by neither group of studies.  However the medical community, and 
specifically speech language pathologists, needs to connect individually administered 
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interventions for neurogenic dysphagia to reasonable predictions of improved health outcomes, 
to justify treatment at the impairment level.   
Though too few studies show the effects of institutional dysphagia protocols in mitigating 
global health outcomes such as pneumonia and mortality, the findings from the two meta-
analyses appear to suggest a need to conduct more research connecting the efficacy of 
remediation of swallowing impairments to their effectiveness over time, in mitigating the public 
health effects of oropharyngeal dysphagia in at-risk populations.  Such research may produce 
more robust evidence supporting the need to advocate more strongly for a public health strategy 
that encourages and provides resources for treatment of biomechanical dysphagia impairments 
within organized, institutional, surveillance and management protocols for stroke patients.  The 
clinical research community bears much of the responsibility for generating credible, high-
quality evidence that points toward methods and combinations of methods to best mitigate the 
public health and individual burden of disease-produced oropharyngeal dysphagia. 
The sheer volume of available published scientific research investigating dysphagia 
treatment indicates the relative importance of dysphagia in the management of public health.  It 
also reveals two main areas of interest among published investigations of dysphagia therapy and 
its effects that have garnered funding and attention.  These meta-analyses are early steps toward 
bridging the gap between these two complementary areas of clinical research. 
Until investigations of common therapeutic methods include larger numbers of patients 
randomized to various protocols, sufficient follow up to morbidity or mortality endpoints, 
provide economic analysis to determine the relative cost-to- benefit ratio of management to 
health outcomes, and supply the research consumer with adequate information to facilitate 
further research synthesis, predictions of successful outcome will continue to be weak and 
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difficult to support.  Particularly in the United States where the population is aging and diseases 
of aging are expected to rise, efforts to clarify the advantages and disadvantages of dysphagia 
rehabilitation with risk factor mitigation warrant current and future research.  
Therapeutic interventions designed to alter oropharyngeal physiology and biomechanics 
in the short term are prescribed because they are expected to reduce adverse health sequelae.  
The first meta-analysis gives some support to the notion that similar methods and targeted 
dependent variables in sensory and motor manipulation should produce a modest benefit in 
dysphagic patients with stroke.  There is also evidence that formal screening and monitoring 
protocols may reduce the risk of morbidity.  The nine included studies in the two meta-analyses 
contained relatively robust methods and also controlled for experimental errors that cause 
uncertainty in the clinical marketplace.  They are also good examples of research from which 
clinicians can reasonably estimate likelihood of successful outcomes as necessitated by the codes 
of ethics of the profession of Speech-Language Pathology among others (American Speech-
Language-Hearing Association, 2003).  These studies also provide reasonable models for future 
investigators to emulate.  Certainly the cost associated with hospitalization for pneumonia can be 
considered a potential economic target of dysphagia therapy, and its reduction is measurable in 
dollars and other tangible and intangible outcomes.  This meta-analysis serves as a useful starting 
point for future research synthesis to further clarify the effects of treatments for dysphagic 
patients.  Future focus on impairments as they relate to both activity and participation, as well as 
on global indices of nutritional and pulmonary health in relation to oropharyngeal dysphagia, is 
recommended. 
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5.7 CHAPTER SUMMARY 
In summary, several hundred articles were retrieved on the topic of oropharyngeal dysphagia 
assessment and treatment which have been published in the past 15 to 20 years.  Studies 
reporting efficacy of individual interventions designed to alter swallowing physiology were 
“meta-analyzed” alongside studies evaluating the effectiveness of institutional dysphagia 
protocols designed to reduce adverse sequelae of dysphagia.  Robust evidence is shown to exist 
supporting individual treatment modalities and their benefit to dysphagic patients.  However the 
question of institutional protocols and their effect on reduced morbidity and mortality remains 
unanswered.  The methods of research synthesis demonstrated in this study can begin to address 
the gap between behavioral treatment strategies and the purported health outcomes claimed to be 
affected by them.  Future efforts at randomized trials should seek to fuse the two ends of this 
question together. 
The next and final chapters describe the implementation of a carefully designed, 
prospective, experimental research investigation of the effects of a behavioral intervention on 
swallow physiology in healthy participants.  This type of research, when extended to populations 
of dysphagic patients, will provide a growing body of evidence that future meta-analysts can test 
to update the research synthesis performed in the present chapter.  As that body of high-quality 
evidence grows, so too will the ability of clinicians to select therapeutic interventions with more 
confidence. 
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6.0  INVESTIGATION OF THE IMMEDIATE EFFECTS OF SURFACE 
ELECTROMYOGRAPHIC BIOFEEDBACK ON BEHAVIORAL TRAINING OF THE 
MENDELSOHN MANEUVER 
6.1 INTRODUCTION 
Oropharyngeal dysphagia is a common result of conditions associated with aging, especially 
stroke.  As many as half of stroke patients exhibit dysphagia at some point after onset, which 
increases their overall likelihood for developing pneumonia, malnutrition, or other sequelae of 
impaired swallowing function and airway protection (Dziewas et al., 2004).  In many cases, 
patients are reported to benefit from interventions designed to compensate for the acquired 
sensorimotor abnormalities that cause misdirection of swallowed material.  Some of these 
interventions require behavioral training to teach the patient to swallow safely using one or more 
novel maneuvers under the guidance of the speech-language pathologist  (Logemann, 1999).   
The most clinically important outcomes of dysphagia are caused by misdirection of 
swallowed food or liquids into the upper airway, or aspiration.  Pneumonia is a major 
consequence of oropharyngeal dysphagia when aspiration is present.  Hospitalization rates for 
aspiration pneumonia have increased by 94.5% (Baine et al., 2001) in the past two decades.  
Mitigation of this important public health problem is a desired outcome of proposed dysphagia 
treatments. 
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Surface electromyographic (sEMG) biofeedback-mediated strengthening programs have 
been validated as an effective adjunct to therapeutic rehabilitative efforts to assist neuromuscular 
reeducation in limb and trunk rehabilitation, bladder training, and other impairments of 
locomotion, self care, and activities of daily living, in patients with disorders affecting 
neuromuscular functions (Bolgla & Uhl, 2005; Dursun et al., 2004; Heymen, Jones, Scarlett, & 
Whitehead, 2003; Jerkins et al., 1987; Moreland, Thomson, & Fuoco, 1998; Petrofsky, 2001).  
Recent interest and evidence regarding the value of sEMG as an adjunct to dysphagia 
rehabilitation has emerged (Crary & Groher, 2000). 
A randomized experiment was conducted to compare the effects of traditional training of 
healthy young participants in performance of the Mendelsohn maneuver to traditional training 
augmented with visual biofeedback using the sEMG activity in submental/floor of mouth 
musculature.  This musculature is known to contribute to upper esophageal sphincter (UES) 
opening.   
6.2 METHODS 
6.2.1 Design 
This was a two-group, repeated measures, randomized experiment designed to quantify the 
effects of an initial, single training session on the duration and amplitude of myoelectric activity 
of the submental musculature while swallowing, using a trained compensatory swallowing 
maneuver.  All participants were trained to perform the Mendelsohn maneuver while swallowing 
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5 ml sips of water.  Visual biofeedback was added during the training phase for one of the 
groups.   
Participants were randomly assigned to two groups.  Submental muscle group sEMG was 
recorded for all participants.  The sEMG waveforms represented the raw data from which 
dependent variables were measured.  All participants were masked from the sEMG waveform 
and underwent pre-training sEMG sampling to establish baseline deglutitive submental 
myoelectric activity before they were given any specific information regarding the Mendelsohn 
maneuver.  Both groups received identical written instructions for performance of the 
Mendelsohn maneuver taken from a textbook in widespread use in academic programs for 
educating speech-language pathology students (Logemann, 1998).  A hierarchy of identical 
verbal instructions and cues was provided until participants demonstrated they understood the 
maneuver (See Appendix E for script of instructions and cues).   The ‘traditional training’ (TT) 
condition included only verbal and tactile cues.  The ‘biofeedback-mediated training’ (BT) 
included the same verbal/tactile cues and visual cues from the sEMG muscle recordings during 
the training phase.  All participants were masked from the sEMG waveform display during the 
data collection phases of the experiment.  In summary, participants participated in three phases 
of activity: collection of pre-training baseline data, training in the Mendelsohn maneuver, and 
collection of post-training data. 
6.2.2 Hypotheses 
It was hypothesized that both participant groups would produce significantly longer swallow 
duration of sEMG activity while swallowing, and higher average and peak amplitudes of 
measured muscle groups when asked to swallow using the Mendelsohn maneuver.  It was also 
 103 
hypothesized that sEMG biofeedback-mediated training (BT) would produce significantly 
greater increases in the duration, peak and average sEMG swallow amplitudes, and more 
consistent sEMG duration and amplitudes, than traditional training.  No significant group 
differences were expected with regard to minimum amplitude of submental musculature during 
either experimental condition.   
6.2.3 Subjects 
6.2.3.1  Inclusion and Exclusion Criteria 
Eligible participants were of either gender, between 20 and 39 years of age, free of pre-existing 
medical diagnoses or histories of conditions associated with oropharyngeal swallowing disorders 
(e.g., neurological conditions, head and neck surgery or irradiation, and/or had never sought 
medical care for difficulty swallowing), and free of known allergies or sensitivity to skin 
products.  Additionally, participants could not have facial hair in the submandibular region 
which would interfere with reliable performance and adhesion of surface electrodes.  Students 
enrolled in clinical education and training in a speech-language pathology program, and speech 
language pathologists were not eligible.  Of 29 study volunteers, 27 met all eligibility criteria.  
Two volunteers were excluded - one reported a prior reaction to a skin care product and one was 
no longer within the eligible age range.   The remaining 27 participants (25 females and two 
males) gave written informed consent, were enrolled, and completed the study.     
6.2.3.2 Sample size 
Pilot data revealed that a sample size of ten participants per group was necessary to detect an 
effect size of d = 0.8, at p < .05. 
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Data collected prior to this investigation was used as pilot data to estimate the necessary 
sample size for this experiment.  Pilot participants were four females who met all study criteria 
with the exception that they were speech pathology students.  SEMG data were recorded from 
submental muscles for 5 ml water boluses while swallowing normally and while performing the 
Mendelsohn maneuver.  Instrumentation used to collect both the pilot and experimental data 
allowed for quantification of four dependent variables:  sEMG duration, sEMG peak amplitude, 
sEMG average amplitude, sEMG minimum amplitude.  Two of these variables (sEMG duration, 
sEMG peak amplitude) are directly affected by the Mendelsohn maneuver  (Logemann, 1998; 
Mendelsohn, 1993).  
From the pilot data, effect sizes (Cohen’s d) were computed for each of the four 
dependent variables of interest.  These values are reported in Table 10. 
Table 10.  Power Analysis: Effect Sizes for Pilot Data 
Dependent variable d 
Duration of sEMG 1.60
Peak sEMG Amplitude .98
Average sEMG Amplitude 2.66
Minimum Amplitude .05
 
A power analysis using the dependent variables duration, peak sEMG amplitude, average 
sEMG amplitude, and minimum sEMG amplitude (p < .05, one-tailed) revealed that a sample 
size ranging from five to 12 participants, assuming an effect size (d) range of 1.6 to 0.8 
respectively, would detect a significant difference caused by sEMG biofeedback-mediated 
Mendelsohn maneuver training Table 11. 
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Table 11.  Power Analysis of Pilot Data   
 
Effect Size (d) 
Required n 
2-tailed 1-tailed 
1.6   6   5 
1.5   6   5 
1.4   7   5 
1.3   7   6 
1.2   8   6 
1.1   9   7 
1.0 10   8 
0.9 12 10 
0.8 15 12 
 
A sample size of 10 complete data sets for each participant group (i.e., control and 
experimental) was selected for the following reasons:  (a) the effect sizes for the dependent 
variables of interest (i.e., sEMG duration and sEMG peak amplitude) were greater than 0.8, (b) 
the power analysis was obtained from a small sample, and (c) because the planned experiment 
was expected to produce a larger effect than the method used with pilot participants.  To ensure 
10 useable data sets in each group, 12 to 15 participants were recruited per group. 
Twenty-seven participants were recruited and completed the study, 25 females and two 
males.  The two male participants were randomized into the same group.  There is little evidence 
of between-gender differences in swallow physiology, though some studies have reported 
differences in swallow apnea between males and females (Hiss, Treole, & Stuart, 2001).  Since 
fewer males were recruited than expected, the proportion of male to female participants was 
extremely unbalanced.  After discussing this with the statistical consultant, a decision was made 
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to exclude the data generated by the two male participants from the analyses to maintain 
homogeneity of the sample.  The final participant pool was comprised of 25 female participants. 
6.2.4 Overview of Procedures 
Participants were initially screened for eligibility in person, electronically, or by telephone.  
After informed consent was obtained, participants were randomized to experimental and control 
groups, and underwent pre-training testing, training, and post-training testing.  Sessions lasted 
approximately two hours.  After data collection ended, participants were given an incentive 
payment of $20.00.  A subject flow diagram appears in Figure 5. 
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 Figure 5.  Subject Flow Chart 
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6.2.4.1 Recruitment 
After approval of the experiment by the University of Pittsburgh Institutional Review Board, 29 
healthy, young graduate students responded to an IRB approved, posted recruitment 
advertisement within the School of Health and Rehabilitation Sciences at the University of 
Pittsburgh.  No clinical speech-language pathology students were included in the participant pool 
for the investigation conducted for this dissertation. 
6.2.4.2 Screening 
Criteria for inclusion were established a priori to limit sources of variability among participants 
and were adapted from previous investigations of normal oropharyngeal deglutition (Robbins et 
al., 1992).  All respondents were pre-screened by telephone or in person before inclusion.  After 
they responded to posted recruitment notices, potential participants were informally pre-screened 
by phone or in person to determine their eligibility, using information contained on a screening 
form (Appendix F).  An appointment was made to participate in the experiment if potential 
participants met age criteria (between 20 and 39 years of age) and denied a history of swallowing 
disorders or symptoms.  Formal, in-person screening was conducted during the appointment, 
using the screening form (Appendix F) to document eligibility. 
Twenty-nine potential participants passed the pre-screening and visited the laboratory for 
formal screening.  During this final screening, one participant was disqualified because she no 
longer met age limitations, and one was disqualified because she admitted to skin sensitivity to 
tape or other products.  The final pool of participants consisted of 25 females and two males. 
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6.2.4.3 Randomization 
A single block randomization plan was developed for an expected recruitment pool of 20 
participants.  The randomization plan was developed a priori using an internet-based program 
(Dallal, 2003) which employs a previously published pseudo-random number generator 
(McLeod, 1985; Wichmann & Hill, 1982).  This plan randomly assigned participants to either of 
two groups within a single block while keeping the sizes of the two groups similar (Altman, 
1990).   
  Since recruitment was more successful than anticipated, and the block randomization 
scheme was developed a priori to ensure equal-sized groups of 10 per group, eligible participants 
entered into the research after the twentieth participant were assigned by coin toss at the time of 
their visit.  Twelve participants were randomized to the traditional training (i.e., Group 1, TT; the 
control group), and thirteen were randomized to experimental biofeedback-mediated training 
(i.e., Group 2, BT; the experimental group). 
6.2.4.4 Subject Preparation 
After randomization, participants and instrumentation were prepared for the experiment. 
Participants were not provided with specific explanations of the Mendelsohn maneuver to reduce 
inadvertent, confounding behavior that could influence baseline swallowing data.   
Electrode Placement 
Prior to electrode placement, the skin overlying each participant’s submental musculature (i.e., 
anterior and lateral borders are made up of the mandible; posterior border is made up of the body 
of the hyoid bone) was swabbed with isopropyl alcohol impregnated prep pads (Webcol ® 
alcohol preps, Tyco Healthcare, Mansfield, MA, USA) to remove skin oil and to ensure adequate 
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adhesion of the surface electrodes.  Bipolar surface electrodes (Bio-Med GS-27 ® 
saline/adhesive pre-gelled disposable sEMG sensors; 3.175cm. x 1.90 cm. rectangular pads) 
were applied to skin overlying the submental geniohyoid-mylohyoid-anterior digastric region.  
There was sufficient separation of electrode pads from the mandible to prevent erroneous signals 
from the facial musculature originating on the mandible (e.g., platysma) (Ertekin et al., 1998; 
Ertekin et al., 2001; Ertekin et al., 2002; Ertekin, Yuceyar, & Aydogdu, 1998).  This electrode 
placement has been shown to capture activity from the three submental hyoid elevators (Palmer 
et al., 1999; Perlman, Palmer, McCulloch, & Vandaele, 1999; Schultz, Perlman, & Vandaele, 
1994).  
The participant’s forehead was similarly prepped prior to placing a third electrode.  A 
reference, or ground electrode was placed on the skin of the forehead (Ding, Larson, Logemann, 
& Rademaker, 2002; Goodman, Robbins, Wood, Dengel, & Luschei, 1996).  Adhesive tape 
(Micropore ™ Hypo-Allergenic Surgical Tape, 3M™ Corp. St. Paul, MN, USA) was used with 
some participants to ensure adequate adhesion.  Participant preparation took approximately 10 to 
15 minutes.  Figure 6 and Figure 7 display the instrumentation and electrode placement on a 
volunteer not included in the experiment. 
After electrode placement, each participant was seated comfortably facing the examiner 
and away from the sEMG display.  Participant identification was recorded into a log and 
anonymous participant numbers were entered into the database to de-identify participants. 
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Figure 6.  Instrumentation and Electrode Placement 
 
Figure 7.  Submental Electrode Placement 
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6.2.4.5 Training of Participants 
Each group of healthy volunteers was trained identically with the exception of the addition of 
sEMG biofeedback in the experimental group.  For both groups, training sessions lasted no more 
than 20 minutes (range: 7 to 20 minutes) and concluded when both the participant and 
investigator agreed, using the feedback available for the method of training, that the participant 
was able to prolong the duration of palpable laryngeal elevation (TT group), or the duration of 
the submental sEMG waveform (BT group). 
Traditional Training (TT) 
The control group (TT) received traditional clinical training via investigator instruction to 
prolong laryngeal elevation during the swallow by using sensory information and tactile cues to 
“hold” the swallow following Logemann’s (1998) instructions.  Participants were instructed to 
palpate the laryngeal framework while swallowing to judge the effect of their efforts to prolong 
the swallow, while the investigator provided verbal reinforcement.  Participants in the TT group 
were masked to the sEMG display.  To ensure standardization, instructions and feedback were 
scripted (see Appendix E), thus ensuring that all participants were given the same directions and 
cues. 
Biofeedback-Mediated Training (BT) 
In addition to the clinical training provided to the control group (TT), the experimental group 
was unmasked from the sEMG waveform display and was provided with written and verbal 
instructions for use of the sEMG biofeedback waveform display during their training (refer to 
script in Appendix E).  Therefore, the BT received the control training method plus visualization 
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of the sEMG waveform and instructions on how to use the visual display to prolong the swallow 
waveform.   
6.2.5 Instrumentation and Variables Measured 
6.2.5.1 Instrumentation:  sEMG Data Collection 
In this experiment, myoelectric waveforms were displayed on a standard LCD video monitor and 
were represented as an image of continuously captured myoelectric activity from the sampled 
muscle group.  Myoexorciser hardware and software (Myoexorciser 1000, Verimed 
International, Coral Gables, FL, USA) were used for data collection and analysis in this 
experiment.  This hardware consists of receiving and filtering equipment, input terminals for 
receiving electromyographic signals from surface electrodes, and a serial interface for connection 
to a personal computer.  Electrode leads were attached to electrode pads at one end and to the 
electromyographic signal receiver at the other end.  This device was connected to the serial port 
of a laptop computer (Dell Latitude CPt, Dell Inc., Round Rock, TX, USA) running Windows 
98© operating system (Microsoft, Redmond, WA, USA), that contained the Myoexorciser 
software (Verimed International, 1995).  The software recorded and displayed sEMG data from 
the signal receiver in real time.     
The Myoexorciser package captures sEMG data with a common mode rejection rate of 
100 dB at 60 Hz to filter electrical noise between 25 Hz and 1 kHz from internal or external 
sources (Verimed International, 1995).  Channel cross-talk rejection for this instrument is rated 
at greater than 80 dB, however only a single channel and a ground electrode were used in this 
experiment.  The hardware device contains pre-set signal processing parameters which provide a 
clear visual representation of the myoelectric activity for “online monitoring” of data, and also 
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for later use during data analysis.  Signals undergo software filtering and rectification to produce 
smoothed, positive-going waveforms which represent averaged myoelectric activity across the 
target event.  For data analysis, the software package contains subroutines for signal integration 
(i.e., the process of calculating the area under the EMG signal curve over a certain interval of 
time) to produce amplitude values expressed in microvolt*seconds (μV*sec).  
Microvolt*seconds is an electromyographic correlate to the amount of force exerted by a muscle 
(De Luca, 1997). 
An example of an sEMG waveform from a normal swallow of 5 ml of water appears in 
Figure 8.  The horizontal axis shows elapsed time in seconds within a pre-set time interval (i.e., 
Figure 8 shows a 10 s time interval).  The duration of data displayed per screen can be set at 10, 
15, or 30 seconds.  The sEMG waveform scrolls continuously from left to right until it reaches 
the end of the pre-set screen duration, after which the screen refreshes and displays the next 
interval.   The sweep duration (horizontal axis) was set to display 30 s during the training phase 
and viewed at either the 10 s or 15 s screen interval for data analysis and [text] display. 
  The vertical axis represents sEMG amplitude.  In this figure, the values on the x axis 
represent percentages of the preset sEMG amplitude range.  For example, in Figure 8, the 
participant’s preset sEMG amplitude range was 0 μV*sec to 20 μV*sec.  The values displayed in 
the vertical axis for amplitude (i.e., 25, 50, 75, and 100) represent percentages of the maximum 
value of the preset amplitude range. Hence, a peak rising to the “50% FS” level in a participant 
whose amplitude range was preset to 0-20 μV*sec, represents 20μV*sec times 50%, or a peak 
amplitude of 10μV*sec.   The Myoexorciser software requires the investigator to pre-set the 
upper limit of the vertical (amplitude) axis of the waveform display before data collection.  This 
investigator determined the appropriate setting for each participant’s maximum myoelectric 
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amplitude using a 5 ml water swallow.  Thus, settings were specific to each participant’s own 
level of muscle activation while performing the target behavior.   
 
Submental 
sEMG 
swallow 
Pre-swallow 
Baseline 
Activity 
Post-swallow 
Baseline 
Activity 
Figure 8.  sEMg Waveform from a 5 ml Baseline Swallow 
Myoelectric events which generate greater amplitude than the scale’s pre-set maximum 
are truncated in both the visual display and data collection modules by the software.  Under these 
conditions, portions of the EMG signals would appear flat and information about the peak 
amplitude would be lost.  Therefore, it was imperative that the amplitude scale be set with an 
upper limit that would not truncate the raw data.  Also of concern, would be pre-setting the scale 
to an excessively broad range.  For example, a pre-set upper limit of 80 μV*sec would capture 
absolutely all myoelectric perturbations, but such an extensive scale would yield tiny waveforms 
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lacking the necessary detail for making precise visually-based measurements and judgments. 
Therefore, the investigator predetermined the scale for the vertical axis for each participant in 
order to prevent data loss due to peak attenuation or peak compression, as well as to facilitate 
judgment accuracy for later data analysis.  The investigator’s experience with the Myoexorciser 
hardware and software suggested that some participants would produce peak waveforms that 
exceeded 10 μV*sec and some would not.  For this investigation, the vertical (amplitude) axis 
was set at either 10 μV*sec or 20 μV*sec depending upon the amount of submental muscle 
activity exhibited during the masked, 5 ml practice swallow.  
As seen in Figure 8, the swallow onset and offset remain visually distinct and are not 
influenced by small fluctuations in the baseline.  Myoexorciser software permits cursor 
placement of markers onto the image for subsequent measurement.  Software generates actual 
timer (i.e., onset and offset) and amplitude (i.e., minimum, mean, peak amplitude) values 
between the cursors.  The dotted horizontal line that appears in Figure 8 also appears on the 
video display monitor during data collection.  It serves as a visual target for patients on muscle 
strengthening programs and/or a way to illustrate consistency of muscle activation while 
performing the target behavior.  
6.2.5.2 Measures 
Dependent Variables 
Based on the pilot data, the primary dependent variables of interest in this experiment were 
sEMG duration and sEMG peak and average amplitude during the swallow.  The secondary 
dependent variable was minimum amplitude.   
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The Mendelsohn maneuver is designed to prolong the duration of muscular forces 
employed while swallowing.  Recent studies investigating the Mendelsohn maneuver have 
suggested that increased myoelectric amplitude from this muscle group may also be caused by 
training (Ding et al., 2002).  Therefore, all three selected dependent variables of interest were 
expected to exhibit significant changes after training. 
Average myoelectric amplitude over an entire swallow is a byproduct of the amplitude of 
myoelectric activity over the duration of the myoelectric event.  It does not appear, on the 
surface, to be particularly interesting as a dependent variable, as it may be quite high though the 
swallow duration may fail to be prolonged by the participant.  Conversely, average myoelectric 
amplitude may be quite low over the course of a significantly prolonged swallow, due to the long 
duration of the swallow itself.  For this reason, hypotheses regarding average myoelectric 
amplitude were not generated, though these data were included in the analysis. 
Minimum sEMG amplitude was considered a secondary dependent variable of interest, 
hypothesized to remain at its pre-training level after training was completed.  Since the 
Mendelsohn maneuver is a compensatory maneuver performed while swallowing a bolus, it is 
not expected to alter the pre- or post-swallowing myoelectric activity in the target muscle group.  
For this reason minimum amplitude from the swallow waveforms was included as a secondary 
dependent variable that would act as a control variable (i.e., minimum amplitude is not expected 
to exhibit change with training).  
Independent Variables 
The independent variables for this investigation were group (TT, BT) and time (pre-training, 
post-training). 
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6.2.5.3  Data Recording and Processing 
Raw sEMG waveforms were recorded and processed in a masked fashion by the investigator and 
entered into spreadsheets.  Pre-training data measurements were performed independent of post-
training data measurements. 
Pretest / Posttest Data Collection 
Pre- and post-training data collection sessions were identical to one another. After preparation 
and masking from the sEMG waveform display, and before any instruction regarding the training 
were provided, participants performed ten swallows for each condition (pre- and post-training).  
The investigator measured 10 to 12 5-ml water boluses with graduated syringes which were 
dispensed into small cups for each participant.  Participants were instructed to self-administer 
each bolus and then swallow after hearing the verbal command to swallow.  The investigator 
recorded the approximate time (time mark) of each swallowing command on a data collection 
form to facilitate identification of swallowing waveforms of interest during data reduction and 
analysis.  The recorded data were labeled and saved to a file.  The investigator provided no 
prompts or cues to participants during the data collection.  Baseline (pre-) and experimental 
(post-) data collection took approximately 10 to 20 minutes per participant per condition. 
Two data collection logs were used to ensure investigator masking to group assignment.  
The initial log was used to record the names of participants, their subject identification number, 
and randomization assignment.  The investigator was masked to this log during data analysis.  A 
different log, identifying participants only by number and group, was used during data collection 
to record approximate time of swallows and any miscellaneous comments (e.g., participant was 
talking). 
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To dissociate measurement of post-training data from pre-training data, baseline and 
experimental swallows were analyzed independently.  Measurements were recorded on separate 
sheets.  Additional precautions were taken to reduce investigator bias caused by subject number 
familiarity.  All 25 pre-assigned subject numbers were entered into a random number generator 
so that measurement of the post-training swallows was done in random order. 
The data were transferred by the investigator from data collection logs to a spreadsheet 
(Excel, Microsoft, Redmond, WA), and later imported into the SPSS © version 14 statistical 
software package (SPSS Inc., Chicago, IL).  Durations of swallow events were calculated by 
subtracting time of onset from time of offset.  Amplitude values were generated by the 
Myoexorciser software. 
6.2.5.4 Examples of Baseline and Experimental sEMG Waveforms 
Examples of pre-training swallow sEMG waveforms from a participant appear in Figure 9 and 
Figure 10.  Examples of post-training swallow sEMG waveforms from the same participant 
appear in Figure 12 and Figure 13.  Figure 9 (pre-training) and Figure 12 (post-training) display 
the participant’s raw sEMG waveforms.  Figure 10 and Figure 13 display the same swallow 
events with the cursor markers placed by the investigator to indicate swallow onset and offset.  
Sample measurements performed on the aforementioned waveforms appear in Figure 11 and 
Figure 14.  The actual timer values used to calculate event durations are shown in the Channel 1 
column of the summary, above the amplitude values. 
The horizontal axis of the waveforms display reflects time in seconds and indicates the 
approximation of the time points within the 15 second display-interval rather than the actual 
timer value.  Exact timer values are generated when the waveforms are marked and then 
displayed in a data summary screen (Figure 11).   
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The vertical axis of these figures reflects sEMG amplitude as a percentage of the pre-set 
calibrated maximum amplitude.  This axis was set prior to any data recording in accordance with 
the participant’s own baseline level of EMG activity while swallowing.  This was done to avoid 
loss of data due to peak attenuation of sEMG signals. 
The vertical lines which appear at the left and right ends of the sEMG waveform peak in 
Figure 10 and Figure 13 are the cursors placed by the investigator.  Markers correspond to the 
onset (left vertical cursor) and offset (right vertical cursor) of the waveform.  Visual comparison 
of pre- and post-training swallows from the same participant (Figure 9 and Figure 12) shows that 
differences in the width (duration) and height (peak amplitude) can be observed and measured. 
6.2.5.5 Procedures for Swallow Identification on Raw Data 
Figure 11 and Figure 14 display data measurements from a marked swallow.  Onset and offset of 
the swallow waveforms were marked by the investigator using Myoexorciser software (Figure 
10).  Once markers were placed, the software displayed the peak, average, and minimum 
amplitude for each measured swallow interval (Figure 11).  The start (onset) and end (offset) of 
each marked waveform was recorded onto a data collection log and later converted to ‘duration’ 
by subtraction.   
The peak of each waveform represented the point at which maximum myoelectric 
amplitude was generated during the swallow.  The ascending and descending phases surrounding 
this peak indicate the rise from pre-swallow resting and the fall to post-swallow resting, 
respectively.  Onset of deglutitive submental myoelectric activity was defined as the point of 
onset of a continuous or steep, systematic upward vertical deflection of the sEMG waveform 
from the pre-swallow baseline, toward the peak.  This deflection approximated the time-coded 
swallow event that had been recorded by the investigator during data collection.  Offset was 
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defined as the end of downward vertical displacement of the waveform corresponding to the end 
of the time-coded swallow event.  Therefore, the typical waveform began when continuous 
upward deflection from the pre-swallow baseline toward the waveform peak was observed 
(onset).  It lasted until the end of the descending phase from the waveform peak (offset) at which 
point a stable post-event baseline was observed (Crary & Groher, 2000; Ding et al., 2002).  
When the post-event baseline was achieved but did not remain stable, the initial return to 
baseline was selected as the offset.  This occurred occasionally when participants spoke or 
lowered the mandible after the swallow, thus, recruiting the submental musculature.  This 
extraneous movement was noted by the investigator during data collection.  
 
Figure 9.  A Pre-Training (Baseline) Swallow Waveform 
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 Figure 10.  Markers Placed at Onset and Offset of a Baseline Swallow Waveform 
 
Figure 11.  Measurements from Baseline Swallow Displayed in Figure 9 and Figure 10 
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 Figure 12.  A Post-Training Swallow from Subject Recorded in Figure 9 – Figure 11 . 
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 Figure 13.  Markers Placed at Onset and Offset of a Post-Training Swallow Waveform 
 
Figure 14.  Measurements from Post-training Swallow Displayed in Figure 12 
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6.2.6 Statistical analysis 
This repeated-measures, two-group investigation was designed to investigate the effects of using 
visual biofeedback as an adjunct to the traditional way that speech-language pathologists train 
patients to perform the Mendelsohn maneuver.  Statistical tests were performed to evaluate the 
homogeneity of the groups before training, and the effects of the two training methods on the 
four dependent variables.  Additionally, evaluation of the variability of myoelectric performance 
before and after training was performed, to determine whether the consistency of performance of 
the Mendelsohn maneuver was differentially influenced by the two training methods.     
To test homogeneity of the groups before training, and to assess the effectiveness of the 
randomization, independent samples t-tests were performed on participant ages, and on pre-
training data from each of the four dependent variables (duration, mean amplitude, minimum 
amplitude, peak amplitude).  Additionally, the variability of participant myoelectric activity 
while swallowing before training was evaluated using an independent t-test of the coefficients of 
variation from each participant’s pre-training raw data, to determine the physiologic 
homogeneity of the groups before training, and to evaluate the effectiveness of the 
randomization.  All participants were females, so a gender comparison was unnecessary. 
To test whether changes in myoelectric activity were caused by either of the two methods 
of training, a mixed two-way analysis of variance (ANOVA) was performed to determine the 
main effect of the independent variable time (pre-training to post-training), main effect of the 
independent variable group (TT, BT), and the interaction of group X time, on the three primary 
dependent variables (duration of sEMG waveform, average and peak sEMG amplitudes 
produced during the swallow), and one secondary dependent variable (minimum sEMG 
amplitude). 
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To test the hypothesis that sEMG mediated training would produce more consistent 
performance of the Mendelsohn maneuver than traditional training, the coefficient of variation 
(CV) was calculated for the each of four dependent variables for each participant, using Equation 
19, where X  represents the mean value for the dependent variable of interest, and SD represents 
the standard deviation of the dependent variable of interest (Munro, 2001).  The CV is the ratio 
of the sample standard deviation to the sample mean, expressed as a percent.  It is used when 
comparing standard deviations (SD) between studies that investigated the same variables or 
when comparing standard deviations in studies that investigated the same dependent variables in 
two or more groups receiving different treatments.   
Equation 19.  Coefficient of Variation 
)/(100 XSDCV =  
Paired samples t-tests were performed on each group’s pre- and post-training coefficients 
of variation to determine whether training produced significant perturbations in participants’ 
variability of myoelectric activity while swallowing, by comparing pre-training CV to post-
training CV.   
To test whether the two training methods differentially affected the variability of sEMG 
activity while swallowing using the Mendelsohn maneuver, a mixed methods two-way analysis 
of variance (ANOVA) was performed to determine the main effect of time (pre-training to post-
training), main effect of group (TT, BT), and the interaction of group X time, on the coefficients 
of variation of the four dependent variables.   
Finally, effect sizes (Cohen’s d), perhaps the most clinically relevant index of the likely 
effect of a therapeutic technique with a particular patient (Haynes et al., 2006), were calculated 
for each dependent variable to determine the clinical importance of the results.  Cohen’s d is an 
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expression of the expected difference between the effects of two treatments (or one treatment 
versus control treatment) in units of standard deviations. Cohen’s d is an effect size statistic that 
uses published research findings to derive the predicted difference a treatment would be expected 
to produce when compared to the investigated control treatment (Cooper & Hedges, 1994).  
Since each group in this study contributed a series of pre-training/control swallows and a series 
of post-training/compensatory swallows, each group has participated in a randomized controlled 
trial and generated data from which effect sizes for each training method can be computed.  
Additionally, the effect sizes for the different treatment conditions (TT and BT) can be compared 
to one another. 
Effect sizes (Cohen’s d) were computed for each of the dependent variables within each 
group using Equation 1 (see also description in Chapter 5.0 for meta-analysis), where M2 
represents the post-training value and M1 represents the pre-training values.  Raw pre- and post-
training means and standard deviations (reported in Table 13 ) were used to derive the displayed 
effect sizes. 
Equation 1.  Cohen’s d 
pooledSD
MM
d 12
−=  
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6.3 RESULTS 
6.3.1 Demographics 
Twenty-five female participants, with a mean age of 25.04 + 3.59 years were randomly assigned 
to the two groups.  Independent t-test was used to compare groups’ age.  The demographics data 
appear in Table 12.  There was no significant difference in age between groups (t = 0.79, p = 
0.22). 
Table 12.  Demographics of Groups 
 TT (n = 12) BT (n = 13) 
Mean Age (SD) 25.57 (3.92) 24.46 (3.26) 
6.3.2 Experimental Results  
Twelve participants were randomized into the control group (TT), and 13 into the experimental 
group (BT).  TT produced 130 measurable pre-training swallows (mean 10.83 per participant) 
and 128 measurable post-training swallows (mean 10.66 per participant).  BT produced 143 
measurable pre-training swallows (mean 11.0 per participant) and 145 post-training swallows 
(mean 11.15 per participant).  Descriptive statistics for each of the four dependent variables 
appear in Table 13. 
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Table 13.  Descriptive Statistics 
Variable Pre-Training     
Mean (SD) 
Post-Training 
Mean (SD) 
Traditional Training (TT), n = 12 
Duration (s) 2.03 (0.45) 4.58 (2.32)  
Peak Amplitude (μV*sec) 3.16 (1.75) 4.33 (3.53) 
Average Amplitude (μV*sec) 1.10 (0.48) 1.51 (0.94) 
Minimum Amplitude (μV*sec) 0.20 (0.05) 0.19 (0.07) 
 Biofeedback-Mediated Training (BT), n = 13 
Duration (s) 2.09 (0.46) 4.21 (1.65) 
Peak Amplitude (μV*sec) 3.88 (2.09) 4.41 (2.32) 
Average Amplitude (μV*sec) 1.33 (0.65) 1.64 (0.87) 
Minimum Amplitude (μV*sec) 0.18 (0.07) 0.19 (0.06) 
6.3.3 Homogeneity of Cohort at the Start of the Experiment 
Pre-training data were analyzed to determine the physiologic homogeneity of the groups before 
training. 
Independent t-tests were performed for each of the four dependent variables to determine 
whether there were any between-group differences prior to the training phase of the experiment.  
There were no significant differences between groups with regard to any of the four dependent 
variables before training (p = .32 – .75).  Independent t-tests comparing the groups’ pre-training 
coefficients of variation for the dependent variables were performed.  There were no significant 
differences in the coefficients of variation between groups before training for any of the four 
dependent variables (p = .08 – .85).  Thus, the groups were similarly variable before the trial. 
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6.3.4 Results of Two-Way ANOVA for Effects of Mendelsohn Maneuver 
6.3.4.1 Main Effects of Time and Group 
A significant main effect for time was detected for two of the three primary dependent variables.  
Surface EMG myoelectric duration (p < .01) and sEMG average amplitude (p = .02) were 
significantly greater after training in both groups.  A non-significant increase for peak amplitude 
was observed though a trend toward significance was present (p = .07).  No significant change 
was present for the secondary dependent variable, minimum amplitude (p = .99), which remained 
essentially unchanged.  These results are displayed in Table 14. 
Table 14.  Main Effect of Time 
Source df MS F p 
Duration 1   68.223   32.29  <.01
Peak Amplitude 1     9.027     3.72    .07
Average Amplitude 1     1.615     5.94    .02
Minimum Amplitude 1    < .001     0.00    .99
                  
No significant main effect for group was present for any of the four dependent variables 
(p = 0.34 – 0.75).  These results are displayed in Table 15. 
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Table 15.  Main Effect of Group 
Source df MS F p 
Duration 1 0.583 0.28 .61
Peak Amplitude 1 1.278 0.53 .47
Average Amplitude 1 0.028 0.10 .75
Minimum Amplitude 1 0.001 0.96 .34
6.3.4.2 Group X Time Interactions  
No significant time x group interactions were observed (p = .49 – .71).  These results are 
displayed in Table 16, and in Figure 15 (Duration), Figure 16 (Peak Amplitude), Figure 17 
(Average Amplitude), and Figure 18 (Minimum Amplitude).   
Table 16.  Time X Group Interactions 
Source df MS F p 
Duration 1 0.314 0.15 .70
Peak Amplitude 1 2.020 0.20 .66
Average Amplitude 1 0.427 0.49 .49
Minimum Amplitude 1 0.001 0.15 .71
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Figure 15.  Time X Group ANOVA:  Duration 
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Figure 16.  Time X Group ANOVA:  Peak Amplitude 
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Estimated Marginal Means of Average Amplitude
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Figure 17.  Time X Group ANOVA:  Average Amplitude 
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Figure 18.  Time X Group ANOVA:  Minimum Amplitude 
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6.3.5 Variability of Performance 
The coefficients of variation were computed for each dependent variable by participant, using 
Equation 19.  The coefficient of variation (CV) is the ratio of the sample standard deviation to 
the sample mean, expressed as a percent.  It is used when comparing standard deviations (SD) 
between studies that investigated the same variables or when comparing standard deviations in 
studies that investigated the same dependent variables in two or more groups receiving different 
treatments.   
Coefficient of Variation (CV) means for all four dependent variables, separated by group, are 
displayed in Table 17.  Independent t-tests were performed to evaluate pre-training variability in 
CV data, and a two way analysis of variance (ANOVA) was performed to evaluate the effect of 
time, group, and time x group interactions, in CV data for the four dependent variables 
Table 17.  Coefficient of Variation Data by Group 
 Group TT  Group BT  
Measure Mean 
CV 
Pretest 
Mean 
CV 
Posttest 
% 
difference 
Mean 
CV 
Pretest 
Mean   
CV 
Posttest 
% 
difference 
Duration 22.64 31.81 40.5 22.10 24.50 10.8 
Peak 
Amplitude 17.74 19.52 10.0 16.22 22.44 38.3 
Average 
Amplitude 18.64 18.66   0.0 18.28 23.50 28.6 
Minimum 
Amplitude 18.22 25.54 40.2 32.62 29.82 -9.4 
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6.3.5.1 Between-Groups Variability Before Training 
Independent t-tests were performed on the pre-training CV data for the four dependent variables 
to evaluate the homogeneity of groups’ variability before training, and to further evaluate the 
effectiveness of the randomization.  No significant differences were observed for the pre-training 
CV for any of the four dependent variables (p = .08 – .85).  TT displayed a 40.2% increase in CV 
for minimum amplitude after training while BT exhibited a 9.4% decrease in CV for minimum 
amplitude (Table 17).  This may represent a systematic maintenance or increase in the 
consistency of preparatory pre-swallow myoelectric activity caused by anticipation of the 
swallow event in the BT trained group, while the TT trained group exhibited greater variability 
in assuming a preparatory pre-swallow posture. 
6.3.5.2   ANOVA Results for CV Data 
The two-way ANOVA revealed no significant main effect of time or group, and no significant 
interaction effects for CV data for any of the four dependent variables.    
Non-significant main effects of time were observed for CV data for all four dependent 
variables (p = .10 – .71) (Table 18).   
Table 18.  Main Effect of Time (CV)  
Source df MS F p 
CV Duration 1 417.642 2.100 .16 
CV Peak Amplitude 1 199.287 2.186 .15 
CV Average Amplitude 1 85.569 2.932 .10 
CV Minimum Amplitude 1 63.564 .146 .71 
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Non-significant main effects of group were observed for CV data for all four dependent 
variables (p = .10 - .42) (Table 19).   
Table 19.  Main Effect of Group (CV) 
Source df MS F p 
CV Duration 1 143.082 .719 .40 
CV Peak Amplitude 1 61.625 .676 .42 
CV Average Amplitude 1 83.893 2.874 .10 
CV Minimum Amplitude 1 319.124 .734 .40 
 
Similarly, no significant group x time interactions were observed (p = .052 - .76) for the 
CV data for any of the four dependent variables (Table 20), however a trend toward significance 
was observed for the CV for minimum amplitude (p = 0.052) suggesting greater consistency of 
minimum amplitude in the BT group after training, while the TT group displayed reduced 
consistency of minimum amplitude after training (Figure 19). 
Table 20.  Time X Group Interactions (CV) 
Source df MS F p 
CV Duration 1 192.406 1.260 .27 
CV Peak Amplitude 1 6.178 0.094 .76 
CV Average Amplitude 1 62.657 2.180 .15 
CV Minimum Amplitude 1 1088.434 4.197 .052 
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Figure 19.  Time X Group Interactions:  CV for Minimum Amplitude 
6.3.6 Effect Sizes 
Cohen’s d was computed for each of the four dependent variables to determine the magnitude of 
change produced by each training method in the four dependent variables, and the difference in 
the magnitude of each training method’s effects.  Equation 1 was used as discussed in Chapter 5, 
to compute effect sizes.   
To compute the within-groups and between-groups effect sizes of the individual training 
methods on each dependent variable, the pre-training mean value for each of the four dependent 
variables was designated as M1, and the post-training means were designated as M2, using 
Equation 1 (Rosnow & Rosenthal, 1996).  Table 21 displays the within-groups effect size 
summary, and Table 22 displays the between-groups effect size summary. 
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Table 21.  Within-Groups Effect Size Summary (Cohen's d) 
 Duration Peak 
Amplitude 
Average 
Amplitude 
Minimum 
Amplitude 
TT Group 
M2 (post-training) 4.58 4.33 1.51 .19 
M1 (pre-training) 2.03 3.16 1.10 .20 
SDpooled 1.63 2.75 .73 .06 
Effect Size (d) 1.56 .04 .56 -.14 
BT Group 
M2 (post-training) 4.21 4.41 1.64 .18 
M1 (pre-training) 2.09 3.88 1.33 .19 
SDpooled 1.23 2.21 .77 .07 
Effect Size (d) 1.72 .24 .40 .14 
 
The within-groups effect size summary indicates that both methods of training produced 
very large effect sizes for duration, with an advantage apparent for BT.  The within-groups effect 
size for BT (d = 1.72) is slightly larger than the effect size for TT (d = 1.56) despite the relatively 
similar changes in the two groups’ mean durations, because the pooled standard deviation for BT 
is much smaller.  Again, the greater consistency of performance in the BT group, compared to 
TT, is illustrated by this result. 
Small to medium within-groups effect sizes were observed for peak amplitude and 
average amplitude for both groups with a slight advantage for TT.  Minimum amplitude 
exhibited a negative effect size for TT (d = -0.14) indicating a small decrease in pre-swallow 
myoelectric activity after training in this method while an increase was seen in the BT group (d = 
0.14) 
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Table 22.  Between-Groups Effect Size Summary (Cohen’s d) 
 Duration Peak 
Amplitude 
Average 
Amplitude 
Min. 
Amplitude 
M2  (BT post-training)  4.21 4.41 1.64 0.18 
M1 (TT post-training)  4.58 4.33 1.51 0.19 
(SDpooled)  2.01 2.99 0.90 0.07 
Effect Size (d) -0.19 0.03 0.15 0.00 
 
The between-groups effect size summary (Table 22) indicates that biofeedback assisted 
training produced a small effect size of d = .15 for average amplitude compared to traditional 
training.  A small effect size of d = -.19 was also identified favoring traditional training for the 
dependent variable “duration”.  There was no measurable effect size for peak amplitude or 
minimum amplitude.  This result suggests that a single training session using sEMG biofeedback 
produces a small increase in myoelectric amplitude over the course of the Mendelsohn maneuver 
swallow, compared to traditional training.  The negative comparative effect size value for 
duration may be the result of the higher variance in the pre-swallow myoelectric activity seen in 
the TT group as identified by the ANOVA of the coefficients of variation, or the small size of the 
sample.  Given the larger individual effect size for duration for BT, and the nearly 30% greater 
pooled standard deviation for TT, the comparative effect size may have been skewed, suggesting 
that the individual effect sizes may be more reliable predictors of each method’s effects than the 
between-methods effect size.  Though the results of the ANOVA did not reach statistical 
significance, this result warrants further investigation to determine whether a larger sample, 
longitudinal study, or both, might further elucidate these observed trends. 
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6.3.7 Measurement Reliability 
Intra- and inter-judge reliability for measurement of the sEMG waveforms was calculated.  A 
second judge was trained in selection of both onset and offset of waveforms (i.e., dependent 
variables).  Intraclass correlation coefficients were computed on a random sample of ten percent 
of swallow waveforms in each of the experimental conditions for these variables.  Fifty-nine 
swallows were independently analyzed yielding a within-judge agreement of 0.978 (95% CI 
0.963 – 0.987) and between-judge agreement of 0.873 (95% CI 0.795 – 0.922).  This degree of 
intra- and inter-rater agreement is considered high and indicates that the measures obtained from 
the raw data were both valid and repeatable.  A complete summary of the testing of intra- and 
inter-judge reliability, including methods and data plots of reliability measures appears in 
Appendix G. 
6.4 DISCUSSION OF EXPERIMENT 
This experiment sought to confirm whether training two groups of healthy participants to 
perform the Mendelsohn maneuver while swallowing, in a single training session, significantly 
changed swallow-related submental myoelectric activity compared to non-Mendelsohn 
swallows.  It also sought to determine whether the addition of sEMG biofeedback to traditional 
training, generated significantly more change when compared to traditional training alone.  It is 
the first comparison of its kind in that it has used a strict randomization schedule to assign 
participants, masking procedures to mitigate bias of examiner familiarity with participant or 
condition, and controls to eliminate the judges’ knowledge of subject group assignment when 
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performing measurements on the raw data.  It is also unique in that it employed standard clinical 
hardware and software available to ordinary practitioners, and, as is ideal in initial therapy visits, 
compared the immediate, initial-session training effects of traditional training versus traditional 
training including sEMG biofeedback.  Previous studies have described the use of sEMG to 
measure training outcomes in groups of healthy participants without comparing biofeedback vs. 
no biofeedback conditions, used sEMG as an adjunct in the treatment of individual patients, or 
reported training effects on subjective variables that cannot be verified or replicated with 
precision.  The long-term goals of the research agenda that this investigation has initiated 
includes pursuit of a model by which patients with impaired UES opening would be identified 
and treated appropriately toward the clinical endpoints of avoiding surgical or other invasive 
intervention for impaired UES opening dysphagia, or reversing a pattern of malnutrition or 
aspiration syndromes. 
The results indicate that a single session of training produced similar and significant 
overall increases in the duration and amplitude of swallow myoelectric activity in groups trained 
traditionally either with or without sEMG biofeedback, though a greater effect was caused by the 
addition of sEMG biofeedback.  Small differences between the investigated methods were 
observed.  Of particular interest is the unexpected increase in pre-swallow myoelectric 
consistency in the submental musculature in the group trained with sEMG biofeedback while the 
traditionally trained group displayed more variability in pre-swallow activity after training.  This 
finding may suggest a potential benefit of increased muscular efficiency resulting from sEMG 
mediated training.  If more stable pre-swallow muscle activity is later shown to translate to 
increased efficiency of muscular forces during the swallow, the addition of sEMG biofeedback 
may contribute to increased transsphincteric bolus flow through the UES.  Additional study of 
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the difference between resting myoelectric activity and pre-swallow minimum myoelectric 
activity before and after training will be beneficial in elucidating whether this observation is an 
artifact of the small number of participants investigated, or an actual effect of the BT training 
method. 
A slightly larger effect size for sEMG duration was seen for BT than for TT indicating 
that BT is potentially a more effective method of eliciting a treatment effect for the Mendelsohn 
maneuver than traditional training, particularly in the initial training session.  The effect size 
data, which demonstrated a greater effect size in the BT group for duration while producing a 
smaller effect size for peak and average amplitude, may suggest that BT can produce prolonged 
duration of hyolaryngeal traction forces with less muscular effort.  Future investigations could 
investigate this possible increase in neuromuscular efficiency caused by the BT training, and 
determine whether an even larger benefit in sEMG duration can be attained if peak amplitude 
and duration, rather than duration alone, were actively targeted in treatment paradigms. 
Given the fact that this maneuver is typically required during every swallow attempted by 
the dysphagic patient to mitigate postprandial aspiration or ineffective clearance into the 
esophagus, consistency and efficiency of performance is an enormously important outcome of 
interest.  Higher performance efficiency would indicate that systematically different acquisition 
of a training effect is present with added sEMG biofeedback, and may add further information to 
recent research into neuromotor plasticity caused by behavioral training in dysphagia.  It is 
possible that with a larger sample size, the between groups sEMG differences may become 
clearer.   
Strengths of this investigation include rigorous randomization, masking of judges during 
data reduction and analysis, standardization of experimental methods to enable replication by the 
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research consumer, use of a clinically common methodology and accessible instrumentation and 
software in the experiment, the analysis of both changes to the dependent variables themselves as 
well as changes in variability of performance caused by the investigated training methods, and 
the measurement of participant homogeneity in demographic and physiologic domains. 
There are also several weaknesses of this investigation.  First, the small sample may have 
produced a degree of variance that a larger sample may not exhibit.  However the inclusion of 
only female participants should not have affected the results as there are no reported differences 
between male and female swallow physiology.  The fact that the groups were chronologically 
homogeneous is important as age-related differences in swallow physiology have been reported 
in the literature.   
Additionally, this study implemented only a single dosage of training in a single visit.  
Recent studies, including one reported in the first meta-analysis in Chapter 5, have shown the 
beneficial effects of certain rehabilitative swallowing interventions over time (Kays & Robbins, 
2006; Robbins et al., 2007; Shaker et al., 2002).  Though the immediate effects of Mendelsohn 
maneuver training was the focus of this study, the effect of therapeutic repetition and mass 
training, and the amount and type of reinforcing activity necessary to elicit stable increases in the 
targeted dependent variables, warrants further investigation.  Moreover, establishment of the 
swallow-specific outcome associated with prolonged hyolaryngeal excursion during swallowing, 
(i.e., quantifying UES opening diameter and/or duration during videofluoroscopic swallowing 
examination) will be necessary to enable researchers and clinicians to determine the actual value 
of this method of training to the dysphagic population. 
A longitudinal design that includes a longer duration of follow-up would have more 
power in detecting differences over time; however this study sought to limit its scope to a single 
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training session for several reasons.  First, patients considered candidates for training in the 
Mendelsohn maneuver are typically individuals with intractable dysphagia characterized by 
impairments in UES opening that have chronic diagnoses associated with them, including 
brainstem stroke (Robbins & Levine, 1993), late effects of radiotherapy for head and neck cancer 
(Lazarus, Logemann, & Gibbons, 1993; Lazarus, Logemann, Song, Rademaker, & Kahrilas, 
2002), and iatrogenic or traumatic peripheral vagal injury (Beutler et al., 2001) to name a few.  
Individuals with acute etiologies causing dysphagia are most often critically ill for days to 
weeks, with the overwhelming majority of their health care resources spent in life sustaining 
efforts.  As a result, clinicians appropriately employing the Mendelsohn maneuver in chronic 
dysphagia are working with outpatients rather than inpatients.   
The type and expected success of outpatient intervention is dependent on the training 
schedule which rarely, in modern medical settings, provides for daily visits.  Moreover, the need 
to predict which patients are appropriate candidates for specific treatment modalities and 
generate quicker, measurable training effects predictive of longer term success and reduced 
dysphagia-related morbidity is critical under modern reimbursement limitations and concerns 
regarding access to care.  The effect of sEMG biofeedback mediated-training reflected in the 
experimental group’s more consistent performance after a single training session, may predict 
more rapid acquisition compared to traditional training, and a need for less therapeutic 
intervention using this sEMG mediated training, hence, potentially reducing overall cost to final 
outcome.   
Perhaps the nature of the Mendelsohn maneuver, and the need to perform it during each 
volitional swallow, exposes a potential rehabilitative benefit of the type of training investigated 
in this study.  The Mendelsohn maneuver is designed as a compensatory maneuver rather than a 
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restorative maneuver.  That is, when successfully trained and performed accurately it increases 
the duration of UES opening, but only when it is performed; it does nothing to augment 
swallowing when it is not performed.  However the Mendelsohn maneuver causes the patient to 
prolong muscular contraction during swallowing, hundreds of times per day (presumably during 
each volitional swallow), effectively performing prolonged, isometric contractions of the 
submental musculature during each swallow (Bandy & Hanten, 1993; Kent-Braun, Ng, Doyle, & 
Towse, 2002; Nicosia et al., 2000; Robbins et al., 2007).  Given the nature of isometric exercise, 
the fact that mass practice is the natural extension of initial training visits of the type investigated 
in this study, and that mass practice is an essential component of strengthening exercise and 
motor learning (Judge, Moreau, & Burke, 2003; Kays & Robbins, 2006) such mass repetition of 
the Mendelsohn maneuver over time, and the influence of mass practice on motor learning and 
neuromuscular efficiency, may produce not only increased performance efficiency, but also 
might be found to increase the strength of submental musculature over time.  The potential 
restorative effects of the Mendelsohn maneuver deserve further investigation. 
Finally, patients selected for training in the Mendelsohn maneuver traditionally require 
higher levels of auditory comprehension given the complex nature of instructions eliciting its 
performance, and patients with stroke and other neurological diseases exhibit varying degrees of 
impaired language abilities.  Visual biofeedback as investigated in this study offers the potential 
to augment or replace verbal instructions that can confound learning after stroke and other 
disease.  Before investigation of the potential benefit of sEMG-mediated training on patients 
with stroke or other diseases affecting swallowing and cognitive linguistic functions, treatment 
effects with healthy individuals must first be elucidated on a larger scale, starting with this 
dissertation study. 
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7.0  SUMMARY OF DISSERTATION   
This dissertation sought to accomplish two main aims.  First, it sought to rigorously evaluate the 
quality of available published evidence regarding the management and treatment of 
oropharyngeal dysphagia on patients with neurogenic dysphagia, and to evaluate the size and 
significance of the effects produced by these interventions on individual patient biomechanics 
and longer term outcomes such as pneumonia and mortality.  Second, it sought to conduct a 
randomized experiment to determine which of two available methods of training healthy 
individuals to perform the Mendelsohn maneuver is more effective in producing prolonged 
myoelectric submental swallowing duration.  Additionally the randomized experiment sought to 
use rigorous design characteristics in the form necessary for inclusion in future, rigorous meta-
analyses. 
This dissertation represents a practitioner’s attempt to bridge the divide between clinical 
and scientific practice, by distilling a large body of evidence into a concentrated corpus of well 
supported, rigorously achieved inference, while conducting rigorous experimentation that can be 
replicated in a clinical setting.  Treatment of oropharyngeal dysphagia is shown herein to 
produce a modest effect toward improved swallow biomechanics and overall global health 
indices.  However, the fact that only nine studies were sufficiently “clean” from over 300 found 
in the literature is a testament to the need for researchers to cobble together the will to exercise 
 147 
sufficient care and control over their research in order to generate a body of useful evidence for 
the “line” clinician to consume.   
Therapeutic interventions for dysphagic patients may be described in a textbook, but they 
must not be selected because they are found in a textbook.  They must be selected because the 
patient exhibits specific impairments shown for which the treatment’s efficacy has been 
established, and there is a reasonable expectation of effectiveness in achieving decreased 
mortality and medical sequelae of dysphagia.  The experiment testing the effects of biofeedback 
mediated behavioral training versus traditional training in performance of the Mendelsohn 
maneuver, illustrated strategies for refining treatment using modern techniques.  It also showed a 
potentially important clinical improvement in efficiency over its traditional counterpart, as 
evidenced by the effect size analysis which showed increased stability of pre-swallow 
preparatory myoelectric activity in the biofeedback trained group.  It has also demonstrated that 
the rigors of clean research design are suitable for clinical practice.   
Once clinicians in the field have selected interventions, they must be applied by the 
clinical practitioner with the same rigor, operationalized methods, and objective and unbiased 
data collection and measurement tactics we expect from our researchers.  Such an agenda in our 
clinical settings and research laboratories cannot help but produce the sorts of answers textbooks 
could only strive to contain. 
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APPENDIX A 
SUMMARY DESCRIPTION OF STAGES OF OROPHARYNGEAL SWALLOWING 
Oral Stage  
The oral stage described in 1813 by Francois Magendie is subdivided into oral preparatory and 
oral transit stages, both of which contain sensory and motor events (Magendie, 1813).   
Oral Preparatory Stage 
When solid foods or liquids are introduced into the oral cavity, humans perform actions designed 
to contain and prepare the ingested material into a bolus to be propelled into the digestive 
system.  The oral preparation of solid food requires the ingested material to be processed into a 
semi-fluid bolus through the mechanical destruction of fibrous and other structural connections.  
In dentate individuals, mastication involves crushing and shearing the solid bolus between the 
occlusal surfaces of the posterior dentition (or molars) through a series of vertical, axial, and 
lateral motions (Mishellany, Woda, Labas, & Peyron, 2006).  Salivation during the oral 
preparatory stage contributes to the maintenance of bolus cohesion through its lubricating and 
softening properties, while salivary enzymes begin the process of starch digestion (Pedersen, 
Bardow, Jensen, & Nauntofte, 2002).  Molars, which are specialized for crushing, are positioned 
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posteriorly on the opposing mandible and maxillae bilaterally, where maximal occlusal force 
during mastication is generated by the combined contractions of the masseters and medial 
pterygoid muscles (Pereira, Duarte Gaviao, & Van Der, 2006).  The solid bolus is transferred 
between left and right molars by combined actions of the tongue and mandible with head lateral 
flexion.   
Oral containment is maintained anteriorly, posteriorly, and laterally.  The lips remain 
relatively closed in relation to the inertia of the bolus and its tendency to flow passively.  
Contraction of the palatoglossus muscle creates a posterior valve between the velum (or soft 
palate) and base of tongue; thus, maintains posterior oral containment of the bolus during 
mastication.  Bilateral tension of the lateral walls of the oral cavity produced by buccinators and 
orbicularis oris opposing one another prevents material from entering the lateral sulci of the 
mouth during oral preparation.  Materials of less viscosity (e.g., liquids and thinner solids) 
require greater lateral, anterior and posterior valving to maintain containment due to their 
tendency to flow in the direction favored by gravitational forces, but the pattern of containment 
is similar.  Most solid bolus consistencies are reduced to a condition of granularity before the 
average healthy individual terminates oral preparation and prepares to swallow the bolus (Pereira 
et al., 2006). 
Oral motor activities are mediated by several motor nerves that originate in motor nuclei 
in the pons or medulla.  Rotary mastication requires alternating and coordinated actions of the 
bilateral masseter, temporalis, medial and lateral pterygoids, which are innervated by lower 
motor neurons supplied through the principal motor nucleus of the trigeminal nerves.  Labial 
closure which is partially responsible for anterior oral containment is produced by orbicularis 
oris and adjacent smaller muscles through the facial motor nerve.  Posterior oral containment is 
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produced by the contact of the velum to the base of tongue, each of which serves as opposing 
attachments for the palatoglossus and facial musculature which is innervated by vagal motor 
efferent fibers.  There is some evidence that palatoglossus activity at the end of the oral stages is 
modulated by bolus volume (Tachimura, Ojima, Nohara, & Wada, 2005). 
Two general categories of oral sensation are active during oral stages.  General sensory 
information is transmitted from oral mucosa in the entire oral cavity anterior to the velum by 
branches of the trigeminal nerve.  Taste is mediated by special sensory afferents traveling in the 
facial nerve from the anterior two-thirds of the tongue, and through the glossopharyngeal nerve 
from the posterior tongue to the rostral solitary nucleus in the medulla oblongata.  Remaining 
afferent, proprioceptive input from the various structures of the oral cavity has been described 
among some oral skeletal muscles; however such studies with humans are problematic due to the 
relative size of the musculature in question in relation to total muscle volume, and location.  A 
single post-mortem investigation has identified primitive spindle-like structures in human 
genioglossus and geniohyoid muscles in human embryos (Mitchenok, 1979).  Pathways carrying 
proprioceptive signals from oral musculature would be expected to lie within the respective 
peripheral motor nerves innervating the individual muscles. 
Oral Transit Stage 
The oral transit stage begins when volitional propulsion of the bolus toward the pharynx is 
observed.  During oral transit the tongue and velum reverse their functions. The oral transit stage 
is momentarily characterized by a brief period of bolus compression during which both anterior 
labial and posterior linguavelar valves remain tightly closed while the tongue’s contact with the 
hard palate progressively widens in an anterior-to-posterior direction (Tasko, Kent, & Westbury, 
2002).  This causes an increase in intrabolus pressure that precedes posterior bolus movement 
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and propulsion as well as a resultant increase in pressure gradient between oral and pharyngeal 
cavities.  Contact of the tongue base and velum which are maintained during oral containment by 
the palatoglossus muscle is then reversed as each structure is displaced in opposing directions.  
The velum begins a transition from the role of oral containment to that of intrabolus pressure 
maintenance and protection of the nasal cavity.  Levator veli palatini elevates the velum while 
tensor veli palatini maintains the velum’s stiffness, beginning its transition to the posture it 
assumes during the pharyngeal stage. The tongue similarly reverses its containment position to 
that of propulsion of the bolus.  The tongue base is depressed by hyoglossus while the anterior 
tongue continues to widen its palatal surface contact and retract.  The bolus is described as 
having entered the pharyngeal cavity when its leading edge crosses the tonsillar fossa, an 
anatomical landmark that is represented radiographically by the ramus of the mandible (Robbins 
et al., 1992).   
Oral to Pharyngeal Stage Transition 
Transition from the oral to pharyngeal stage contains both oral and pharyngeal events.  This 
“stage transition” is defined as the duration between the moment of bolus head exit from oral 
cavity and entry into the pharynx, and the onset of pharyngeal deglutitive activity as 
characterized by the first deglutitive maximal movement of the hyoid (Lof & Robbins, 1990).  
The identical event has been called “pharyngeal delay time” in earlier studies and texts, and was 
first described as an important measurement in Jerilyn Logemann’s seminal textbook on 
evaluation and treatment of swallowing disorders (Logemann, 1983).   
Stage transition includes release of palatoglossus contraction and its important role of 
posterior oral containment, to facilitate bolus flow from the posterior oral cavity.  The soft palate 
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then begins its reversal of position from the lingual contact to oppose the posterior pharyngeal 
wall, thereby occluding the entrance to the nasal cavity.  Initiation of hyolaryngeal displacement, 
responsible for both extrinsic airway protection and a considerable proportion of UES opening, 
begins during the stage transition. 
A critical component of the stage transition and ensuing pharyngeal state is the inhibition 
of UES resting tone that later facilitates the forces acting to pull the UES open and displace the 
upper airway out of the bolus pathway (Miller, 1986). 
Healthy young subjects tend to initiate pharyngeal deglutitive activity before the head of 
the oncoming bolus enters the pharynx (Logemann, 1998).  Aging has been shown to alter this 
relationship so that with older individuals the bolus head enters the pharynx before the onset of 
pharyngeal activity.  Since pharyngeal activity onset is marked by the radiographically observed 
onset of maximal hyoid bone motion, the natural consequence of excessively long stage 
transition is the arrival of the bolus into the pharynx while the larynx remains open and 
unprotected (Lof & Robbins, 1990).  The implications of normal age-related alterations is the 
timing of deglutitive events become germane if the aging individual encounters catastrophic 
illness  
Pharyngeal Stage 
Once the pharyngeal stage begins, a rapid series of biomechanical events takes place.  The exact 
moment of onset for each event is somewhat stereotyped, though age-associated, progressive 
changes in timing of the various events are well known (Ekberg & Feinberg, 1991; Robbins et 
al., 1992).  The important protective closure of the upper airway is perhaps the most critical 
event of the pharyngeal stage from a safety standpoint.  As submental musculature apply traction 
forces to the hyolaryngeal complex, the complex itself is pulled anteriorally and superiorally 
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toward the mandible.  Given the common wall shared between the posterior larynx and anterior 
UES, these traction forces not only displace the larynx from the path of the oncoming bolus, it 
pulls the UES open (i.e., assuming the aforementioned inhibition of UES resting tone has 
occurred beforehand).   An additional and fortunate outcome of this hyolaryngeal excursion is 
the motion of the esophageal inlet toward the oncoming bolus producing an effective increase in 
the relative speed of the swallowed bolus.  Hyolaryngeal excursion, then, is responsible for 
airway protection, UES opening, and to a degree, bolus transfer toward the UES.  
As the tongue continues to propel the bolus the pharyngeal constrictors continue 
contracting in a semi-circumferential pattern from superior to inferior in conjunction with the 
descending and propelling tongue base.  Toward the end of the pharyngeal stage the tongue of a 
healthy normal young individual is in contact with the posterior wall of the pharynx.  Due to the 
propulsive forces of the bolus, the free edge of the epiglottis is pushed posteroinferiorally to 
approximate the laryngeal inlet.  At the same time, submental musculature pulls the root of the 
epiglottis upward and forward.  Altogether, this series of events facilitates epiglottic inversion 
and airway closure.  Once the bolus has entered the UES, the pharyngeal structures begin to 
return to rest.  In most healthy individuals, the reopening of the upper airway is immediately 
followed by the resumption of expiration which has been shown to begin during the onset of the 
swallow (Hiss, Strauss, Treole, Stuart, & Boutilier, 2003; Hiss et al., 2001; Leslie, Drinnan, 
Ford, & Wilson, 2005; Perlman, He, Barkmeier, & Van Leer, 2005). 
Treatment of Impaired Posterior Oral Containment 
Oropharyngeal biomechanical errors are the target of the majority of individually administered 
dysphagia intervention strategies.  These interventions are intended to improve swallowing 
efficiency and safety by augmenting impaired biomechanical functions.  Some of these 
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remediation techniques were investigated in the treatment studies included in the meta-analysis 
portion of this dissertation (Chapter 5).   
 
Incomplete, absent, or premature release of any portion of a bolus by the linguapalatal 
valve results in material flowing toward an unprotected airway.  Incomplete laryngeal closure 
during the swallow can occur due to numerous anatomic and/or physiologic variables, but 
ultimately results in swallowed material entering the unprotected airway.   
Flexion of the head and neck anteriorly, sometimes called the “chin down” posture, 
places the bolus head slightly forward as compared to its position while swallowing in a head- 
neutral posture.  Researchers have demonstrated that this maneuver can influence several UAT 
variables related to swallowing including, volume (i.e., widen the valleculae to catch premature 
spillage), pressure generation, as well as timing relationships among the various anatomic 
structures (Bulow et al., 1999; Shanahan et al., 1993).   This compensatory strategy is relatively 
easy to perform, can be assessed during the MBS, and has been used successfully by selected 
patients. 
Treatment of Impaired Hyolaryngeal Displacement 
Displacement of the hyolaryngeal complex contributes to airway closure and esophageal 
clearance.  This ‘complex’ is attached anteriorally/superiorally to the mandible and 
posteriorally/superiorally to the skull base.  The result of reflexive contraction of these muscles 
during the pharyngeal portion of the swallow is a net superior/anterior displacement of the 
hyolaryngeal complex, inversion of the epiglottis, and distension of the upper esophageal 
sphincter.  Therefore, minimal or reduced hyolaryngeal displacement can result in incomplete 
laryngeal closure during the swallow and/or partial UES distension causing separation of the 
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bolus’s tail.  Hypopharyngeal residue which remains after the swallow is more likely to be 
aspirated as its volume increases (Eisenhuber et al., 2002) 
Anterior/superior displacement of the larynx pulls the inlet to the airway away from the 
path of an oncoming swallowed bolus.  Therefore, the timing of this action must occur prior to 
the arrival of swallowed material at the laryngeal inlet.  Research has shown that the head of a 
liquid bolus reaches the posterior margin of the larynx several milliseconds after the larynx has 
been displaced anteriorally and superiorally from the path of the oncoming bolus, and the 
epiglottis has been securely inverted over the laryngeal vestibule (Dodds et al., 1990).  Evidence 
suggests that normal aging in the absence of pathology may cause slight delays in the onset of 
hyolaryngeal movement, and that small amounts of the bolus may enter the pharynx prior to 
initiation of the swallowing (Lof & Robbins, 1990).  Research has demonstrated that many 
elderly adults remain healthy despite the presence of occasional laryngeal penetration and/or 
premature arrival of the bolus at the laryngeal inlet as the hyolaryngeal complex moves from the 
bolus path (Robbins, Coyle, Rosenbek, Roecker, & Wood, 1999).  The cumulative effects of 
normal aging and any co-existing health problems involving sensorimotor pathways could pose a 
significantly greater aspiration risk in the elderly if relative strength or timing of hyolaryngeal 
excursion is affected. 
The epiglottis is attached to the posterior surface of the anterior wall of the thyroid 
laminae at midline, just superior to the vocal ligament.  During deglutition, the epiglottis is 
pulled anteriorally and superiorally along with the larynx to a horizontal orientation in relation to 
its free margin, forming a horizontal barrier to oncoming swallowed material.  This inversion, 
together with the forceful lingual propulsion of the bolus, produces a temporary seal between the 
epiglottis and the roof of the larynx.  Incomplete hyolaryngeal excursion is responsible for 
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incomplete epiglottic inversion and a “leak” into the larynx is possible under these conditions 
(Kendall, Leonard, & McKenzie, 2004). 
Complete hyolaryngeal excursion is also responsible for the majority of UES opening, 
enabling a swallowed bolus to enter the esophagus completely (Cook et al., 1989a).  This 
phenomenon was discussed in detail in chapter 3, section 3.1.  Reduced diameter of UES 
opening or consequences of mistimed closure of the airway’s uppermost valve enables the 
pressurized bolus to leak into the larynx and trachea during or after the swallow.     
These impairments are addressed therapeutically by attempts to either increase the 
distance and duration of hyolaryngeal excursion, or to compensate for its delayed or incomplete 
excursion by volitional, preprandial airway closure, effortful multiple swallowing, and 
postprandial airway clearance with cough.  
Treatment of Impaired Intrinsic Laryngeal Closure  
In the event of vocal fold paralysis, the glottic space remains patent during deglutition.  This is 
not problematic in terms of aspiration risk in and of itself because sufficient airway protection is 
achieved from the combined actions of early and complete hyolaryngeal displacement and 
adequate intrabolus pressure generation.  However, when incomplete laryngeal closure is 
accompanied by deficits in either one of these events, the airway is vulnerable to aspiration.  
Some patients have reported limited success using a compensatory maneuver which involves 
learning to hyperadduct the uninvolved vocal fold, thereby forcing closure.  Due to comorbidities 
and greater health risks, the majority of patients with aspiration due to permanent vocal fold 
paralysis require surgical intervention in conjunction with behavioral compensatory swallowing 
treatment (Logemann, 1998). 
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Treatment of Impaired UES Opening 
Impaired UES opening causes a swallowed bolus to fail to enter the esophagus completely.  The 
result is separation and retention of a portion of the swallowed bolus in the hypopharynx.  In 
turn, the patient must swallow consecutively to deliver the bolus remnant remaining in the 
pharynx, or the bolus residue may enter the airway after the swallow or at the onset of the 
subsequent swallow (Eisenhuber et al., 2002). 
The Mendelsohn maneuver, discussed in Chapter 6, is the primary method used to 
increase impaired UES opening. 
Treatment of Impaired Intrabolus Pressure Generation 
Intrabolus pressure is a dominating force contributing to the flow of material from the oral cavity 
top the esophagus (Cook et al., 1989b; Robbins et al., 2005b).  It is generated by the propulsive 
force imparted by the tongue and pharyngeal constrictors, and it is maintained by closure of the 
various valves in the oropharyngeal mechanism (e.g., velopharyngeal valve, laryngeal valve). 
Intrabolus pressure can be increased in patients with weakness, by augmenting bolus 
parameters (Dantas et al., 1990; Dodds et al., 1988), by effortful swallowing (Hind, Nicosia, 
Roecker, Carnes, & Robbins, 2001), or through exercise (Kays & Robbins, 2006; Robbins et al., 
2005a).  
Pharmacological Management of Dysphagia 
Medical professionals have been interested in the pharmacological management of dysphagia.  
Researchers have investigated the effects of systemic medication regimens that biochemically 
alter swallow physiology in dysphagic patients (Brandt, 1999; Nakagawa, 1999; Perez, Smithard, 
Davies, & Kalra, 1998).  Pharmaceutical manipulation of swallow function is designed to change 
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synaptic and tissue physiology of involved structures.  Endoscopy is used by physicians to treat 
dysphagia, especially balloon dilatation in cases of cricopharyngeal dysfunction (Wang, 
Kadkade, Kahrilas, & Hirano, 2005; Zepeda-Gomez, Loza, Valdovinos, Schmulson, & 
Valdovinos, 2004).  Studies investigating the effectiveness of using botulinum toxin injections 
into the cricopharyngeal segment of the inferior constrictor muscle to alleviate inadequate upper 
esophageal sphincter opening are becoming more prevalent for the treatment of chronic 
dysphagia (Zaninotto et al., 2004).   
Surgical Management of Dysphagia 
Surgery is sometimes used to reduce the volume of aspiration while swallowing.  
Cricopharyngeal myotomy has been shown to reduce inertia and flow resistance within the UES 
in conditions such as medullary stroke and cricopharyngeal achalasia (Cook, 2000).  However, 
patients unable to generate sufficient oropharyngeal pressures and those with 
esophagopharyngeal reflux are poor candidates for this type of management (Bammer, Salassa, 
& Klingler, 2002; Cook, 2000).  Surgical procedures are also used in cases of intractable 
dysphagia after failure of conventional interventions.  This type of surgery can range in severity 
from relatively noninvasive/reversible (e.g., tracheostomy), to radical reconstruction of the UAT 
(i.e., total laryngectomy), to placement of an enteral feeding tube (Bammer et al., 2002; 
Broniatowski et al., 2001; Kelly, 2000).  Tracheostomy, a less invasive and reversible surgical 
technique, is used to facilitate mechanical ventilation in patients with respiratory failure, 
however, provides a mechanical barrier to aspiration.  A tracheostomy tube with an inflatable 
cuff effectively increases airway protection and reduces inhalation of aspirated material by 
partially to completely obstructing the communication between the upper and lower airways 
(Broniatowski et al., 2001).   
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Surgical placement of an enteral feeding tube directly into the lower gastro-intestinal tract 
is performed when a patient is unable to adequately sustain nutrition and hydration by oral means 
and to reduce the health consequences associated with prandial aspiration (Dennis et al., 2005).  
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APPENDIX B  
META-ANALYSIS SEARCH STRATEGY 
1. randomized controlled trial.pt. 
2. randomized controlled trials/ 
3. controlled clinical trial.pt. 
4. controlled clinical trials/ 
5. random allocation/ 
6. double-blind method/ 
7. single-blind method/ 
8. clinical trial.pt. 
9. exp clinical trials/ 
10. (clin$ adj25 trial$).tw. 
11. ((singl$ or doubl$ or tripl$ or trebl$) adj25 (blind$ or mask$ or dummy)).tw. 
12. placebos/ 
13. placebo$.tw. 
14. random$.tw. 
15. research design/ 
16. (clinical trial phase i or clinical trial phase ii or clinical trial phase iii or clinical trial 
phase iv).pt. 
17. multicenter study.pt. 
18. meta-analysis.pt. 
19. Prospective Studies/ 
20. Intervention Studies/ 
21. Cross-Over Studies/ 
22. Meta-Analysis/ 
23. (meta?analys$ or systematic review$).tw. 
24. control.tw. 
25. or/1-24 
26. Animal/ 
27. Human/ 
28. 26 and 27 
29. 26 not 28 
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30. 25 not 29 
31. exp DEGLUTITION DISORDERS/ 
32. deglutition/ or deglutition.tw. 
33. (dysphagia or swallow).tw. 
34. or/31-33 
35. exp muscular diseases/ 
36. ((muscle$ or muscular) adj5 (disease$ or disorder$)).tw. 
37. 35 or 36 
38. 34 and 37 
39. 30 and 38 
40. exp Cerebrovascular Accident/ 
41. (cerebrovas$ adj5 accident).mp. 
42. stroke.tw. 
43. 40 or 41 or 42 
44. 34 and 43 
45. 30 and 44 
46. exp dementia/ 
47. 34 and 46 
48. 30 and 47 
49. exp Amyotrophic Lateral Sclerosis/ 
50. (amyotro$ adj5 lateral$).tw. 
51. 49 or 50 
52. 34 and 51 
53. 30 and 52 
54. exp Multiple Sclerosis/ 
55. (mult$ adj5 scler$).tw. 
56. 54 or 55 
57. 34 and 56 
58. 30 and 57 
59. exp Myasthenia Gravis/ 
60. (myasth$ adj3 grav$).tw. 
61. Myasthenia.tw. 
62. 59 or 60 or 61 
63. 34 and 62 
64. 30 and 63 
65. exp Parkinson's Disease/ 
66. parkinson$.tw. 
67. 65 or 66 
68. 34 and 67 
69. 30 and 68 
70. exp Neurodegenerative Diseases/ 
71. 34 and 70 
72. 30 and 71 
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APPENDIX C 
SCREENING FORM FOR META-ANALYSIS 
First Author_________________________________________   Rater initials ______ 
 
Short Title ________________________________________Year ________________ 
 
Reference Manager Meta-Analysis Database Number:  _______________ 
 
Investigated treatment: ___________________________________________________ 
______________________________________________________________________ 
 
Comparison Treatment: ___________________________________________________ 
______________________________________________________________________ 
 
Dependent-Outcome Variables: ____________________________________________ 
______________________________________________________________________ 
 
Design (circle one)    
 
I.  RCT   Repeated measures w/randomized seq. of treatments 
 
   
II. Non-RCT 2 groups  2 group tx vs. ctrl non randomized 
     Repeated design w/o randomization but with >2 conditions 
 
III.  Non-RCT 1 group  One group pre post one intervention 
 
IV.  Single Subject Design One person evaluated pre and post intervention 
 
V.  Narrative or case study 
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Sample Size 
A.  n> 20 subjects or observations per group  
B.  n< 20 subjects or observations per group 
 
Internal Validity 
1.  High; no alternative explanation for outcome; excellent control for error 
2.  Moderate; attempts to control for lack of randomization biases or other errors 
3.  Low; two or more serious alternative explanations for outcome; serious bias 
 
External Validity 
a.  High; participants/setting represents population/current practice 
b.  Moderate; between high and low 
c.  Low; heterogeneous sample w/o ability to determine whether effects differed 
by diagnosis, or treatments do not represent current practice 
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APPENDIX D  
Standard instructions to all subjects, used in traditional training (TT) and biofeedback 
training (BT)   
 “Swallow your saliva several times and pay attention to your neck as you 
swallow.  Tell me if you can feel that something (your Adam’s apple or voice box) lifts and 
lowers as you swallow.  Now, this time, [water bolus is self-administered by subject] when you 
swallow and you feel something lift as you swallow, don’t let your Adam’s apple (or voice box) 
drop.  Hold it up with your muscles for several seconds.” 
Alternative instructions 
 “As you swallow can you feel that everything squeezes together in the middle of 
the swallow?  When you can feel this, swallow and hold the squeeze.” 
Standard permissible prompts and cues for training of TT subjects 
 a. subject may palpate the laryngeal framework while training. 
 b. trainer may palpate the subject’s laryngeal framework while training. 
 c. trainer may verbally answer “yes” / “no” questions posed by subject. 
 d. subject and investigator are blinded to sEMG waveform display 
Standard permissible prompts and cues for training of BT subjects 
 a. as listed for TT. 
b. subject and trainer may observe the sEMG waveform display to assist subject 
with prolongation of the swallow gesture. 
 c. investigator explains target waveform shape to subjects. 
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d. “The red line shows what your swallowing muscles are doing when you 
swallow.  Try to make the top or peak of the tracing remain “up” for several 
seconds longer.” 
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APPENDIX E 
SCREENING FORM FOR SEMG PROJECT 
SUBJECT NUMBER_____________SUBJECT INITIALS_____________ 
SCREENED BY_________________SCREENING DATE_____________ 
SCREENING TIME_____________ 
Investigation of Effects of Surface Electromyographic Biofeedback in the Training of a 
Compensatory Oropharyngeal Swallowing Maneuver in Normal Healthy Young Adults 
 
University of Pittsburgh IRB# 0604116 
 
James L. Coyle, M.A., Principal Investigator 
 
Screening Questionnaire 
1. Are you between the ages of 20 and 39? 
a. YES  
b. NO (ineligible) 
2. Have you ever been diagnosed with a swallowing disorder? 
a. YES (ineligible) 
b. NO 
3. Do you have any difficulty swallowing food or liquids? 
a. YES (ineligible) 
b. NO 
4. Except for routine tonsillectomy, have you ever undergone surgery of the head or neck 
areas? 
a. YES (ineligible) 
b. NO 
 
 167 
5. Have you ever been diagnosed with or treated for head or neck cancer? 
a. YES (ineligible) 
b. NO 
6. Have you ever received radiation (or x-ray) therapy in the head or neck areas? 
a. YES (ineligible) 
b. NO 
7. Have you ever had a stroke, or been diagnosed with a neurological such as Multiple 
Sclerosis, Myasthenia Gravis, Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease), or 
Parkinson’s Disease? 
a. YES (ineligible) 
b. NO 
8. Do you have an allergy or sensitivity to rubbing alcohol? 
a. YES (ineligible) 
b. NO 
9. Do you have an allergy or sensitivity to adhesive tape? 
a. YES (ineligible) 
b. NO 
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 MEASUREMENT OF INTRA- AND INTER-RATER RELIABILITY IN WAVEFORM 
MEASUREMENTS 
Intra- and Inter-Rater Reliability of Measurements 
A second judge was trained in the waveform analysis and served as an inter-rater reliability 
measure.  A random number generator was used to renumber all recorded swallow waveforms.  
Ten percent of swallow waveforms from each of the pre-training and post-training data sets from 
each group were randomly selected, randomly numbered and de-identified for repeated 
measurement by the investigator and for a second, trained judge.  A blank data sheet with the 
randomly selected swallow number was prepared for data recording by judges. 
The investigator’s inter- and intra-rater reliability in measuring fluoroscopic, magnetic 
resonance, and other physiologic data from swallowing imaging studies has been established in 
prior peer-reviewed and published work (Coyle, Robbins, Levine, & Roecker, 1999; Coyle, 
Wood, Robbins, Ford, & Harari, 1994; Dengel, Robbins, Coyle, & Sonies, 1996; Ershler, Coyle, 
Ford, Harari, & Robbins, 1995; McCullough, Rosenbek, Robbins, Coyle, & Wood, 1998; 
Robbins, Coyle, Dengel, & Kennell, 1998; Robbins et al., 1999; Rosenbek et al., 1996a).  
Likewise, the second judge’s reliability in measurement of sEMG and other instrumental 
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videofluoroscopic events has been established in prior published work (Coyle et al., 1994; 
Goodman et al., 1996; McCullough et al., 1998; Robbins et al., 1995; Robbins et al., 1999; 
Rosenbek et al., 1996a; Rosenbek et al., 1996b).  Thus, both judges have been thoroughly trained 
and successfully demonstrated sufficient levels in inter- and inter-rater reliability in published 
investigations associated with normal and disordered swallowing physiology. 
Findings-Reliability Measures 
Intraclass correlation coefficients were computed to determine the degree of within-judge and 
between-judge agreement in measures of swallow waveform onset, offset, and duration.  Ten 
percent of swallow waveforms from each of the pre-training and post-training data sets from 
each group were randomly selected, randomly numbered, and de-identified for repeated 
measurement. 
A second judge was trained in the selection of swallow onset and offset.  Both judges 
conducted onset and offset measurements on fifty-nine swallow waveforms (i.e., 10% of total 
waveforms).  Intra-rater agreement for the investigator, Judge 1, was 0.978 (95% CI 0.963 – 
0.987), and is shown in Table 23 and Figure 20.  Inter-rater agreement for Judge 1 and Judge 2 
was 0.873 (95% CI 0.795 – 0.922) and is shown in Table 24 and Figure 21.  This degree of intra- 
and inter-rater agreement is considered high.  Combined with justification for selection of sEMG 
event onset and offset, this finding indicates that the measures obtained from the raw data were 
both valid and repeatable. 
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 Table 23.  Intraclass Correlation Coefficient -Within Judge 1 Reliability 
  
Intraclass 
Correlation 
95% Confidence 
Interval F Test with True Value 0 
    
Lower 
Bound 
Upper 
Bound Value df1 df2 Sig 
Single 
Measures 
.978 .963 .987 88.561 58.0 58 .000
Average 
Measures 
.989 .981 .993 88.561 58.0 58 .000
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Figure 20.  Intra-rater Agreement 
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 Table 24.  Intraclass Correlation Coefficient – Between Judges Reliability 
 
Intraclass 
Correlation 
95% Confidence 
Interval F Test with True Value 0 
    
Lower 
Bound 
Upper 
Bound Value df1 df2 Sig 
Single 
Measures 
.873 .795 .922 14.700 58.0 58 .000 
Average 
Measures 
.932 .886 .960 14.700 58.0 58 .000 
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Figure 21.  Inter-rater Agreement 
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